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Extended summary 
 
Depression is characterized by cardinal symptoms such as negative affect and depressed 
mood. However, this disorder also can include motivational symptoms such as anergia, 
fatigue and psychomotor slowing. These are highly resistant to treatment and often 
remain as residual symptoms after antidepressant drug therapy. In fact, the most common 
class of antidepressants, the serotonin (5-HT) transporter (SERT) inhibitors, are useful 
for treating mood and anxiety symptoms in depression, but it has been observed that they 
are relatively ineffective at treating motivational dysfunction, and in fact, they can 
exacerbate fatigue. It has been suggested that these effort-based symptoms are related to 
dysfunctions in mesolimbic dopamine (DA) (specifically in the nucleus accumbens 
(Nacb)) and related forebrain circuitry. Across multiple paradigms of effort-based 
decision-making in animal models, low doses of DA antagonists or Nacb DA depletions 
reduce the willingness to work for a high reward option and increase selection of low 
reward alternatives that require very little effort. Moreover, in depressed people, fatigue 
problems interfere with participation in exercise, and it has been observed that a lack of 
activity can contribute to the development of depression. Of course, engaging in voluntary 
physical activity is always undertaken in relation to the possible selection of other 
alternatives, such as sedentary behaviors or food consumption. 
Voluntary wheel running occurs spontaneously in mice of all strains, sexes, and ages. 
Thus, a recently developed 3-choice-T-maze task establishes voluntary running in a wheel 
as the high effort/highly preferred option competing with palatable food and a fruit odor. 
This test can be used to study spontaneous preferences for reinforcers that require 
vigorous activity, and to evaluate the impact of DA manipulations and the potential 
therapeutic effects of different type of antidepressants. This test can assess anergia in a 
non-stressful setting, while traditional rodent models for the study of antidepressant 
drugs, such as the forced swim test (FST), assesses behavioral activation induced by 
stressful conditions. Thus, in the present dissertation I characterized the impact of DA 
depletion in several animal models that evaluate behavioral activation to escape an 
aversive situation (in the FST) or to approach and vigorously interact with a highly 
preferred reinforcer (a running wheel in the 3-choice-T-maze) that competes with 
reinforcers by more passive behaviors. The effect of DA depletion also was studied in 
rodent models of anxiety-related behavior, another symptom common in some depressed 
people. 
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The first chapter of the present dissertation characterizes and validates this 3-choice-T-
maze task as a model of preference for physical activity versus sedentary options. These 
studies employed a model of anergia induced by DA depletion, by using a VMAT-2 
blocker (tetrabenazine, TBZ) to alter choice behavior, and comparing those results with 
the effects on the FST and also with other manipulations that change the homeostatic or 
emotional value of the reinforcers that are available in the T-maze task. In Chapter 2, 
bupropion, a catecholamine transport blocker that elevates extracellular DA levels and is 
used as an antidepressant, was administered to animals tested on the FST or the 3-choice-
T-maze task. This antidepressant was administered on its own, and also in combination 
with TBZ. Metabotropic markers of DA receptor activation are used to assess the impact 
of these pharmacological manipulations in Nacb. In addition, since clinical practice has 
focus on pharmacological strategies that increase serotoninergic transmission via SERT 
inhibitors such as fluoxetine, Chapter 3 studies evaluated the impact of fluoxetine on 
behavioral activation in both paradigms; the FST and the 3-choice-T-maze task, and its 
capability to alleviate TBZ-induced anergia. DARPP-32 phosphorylation was used as a 
cellular marker related to DA activity. Finally, it is important to emphasize that little is 
known about the behavioral activation impairments in animal models using female 
subjects, despite the fact that depression is twice as common in women than in men, and 
the response to antidepressants differs between sexes. Thus, Chapter 4 of the present 
thesis focuses on the impact of DA depletion on behavioral activation comparing female 
and male mice in several tests of behavioral activation and anxiety. The therapeutic effect 
of both types of antidepressants (bupropion and fluoxetine) after DA depletion were also 
assessed using the FST.  
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Resumen 
 
La depresión se caracteriza por un conjunto de síntomas fundamentales como el afecto 
negativo o el humor depresivo. Sin embargo, este trastorno también incluye síntomas 
motivacionales como la anergia, fatiga o enlentecimiento psicomotor. Estos síntomas son 
muy resistentes a tratamiento y con frecuencia permanecen como síntomas residuales tras 
la terapia farmacológica. De hecho, el tipo de antidepresivos más común, los inhibidores 
de la recaptación de serotonina (5-HT) son útiles para tratar síntomas emocionales o 
ansiosos que aparecen en la depresión, pero se ha observado que estos fármacos son 
relativamente ineficaces para tratar los síntomas motivacionales y, de hecho, pueden 
exacerbar la fatiga. Se sugiere que estos síntomas motivacionales están relacionados con 
alteraciones en la dopamina (DA) mesolímbica (específicamente en la zona núcleo 
accumbens (Nacb)) y con circuitos relacionados del prosencéfalo. A través de múltiples 
paradigmas animales de toma de decisiones basados en el esfuerzo, bajas dosis de 
antagonistas de DA o depleciones de DA en el Nacb reducen la disposición de trabajar 
para conseguir una elevada recompensa e incrementan las elecciones a alternativas con 
bajas recompensas pero que requieren poco esfuerzo para conseguirlas. Además, en 
personas con depresión, la fatiga interfiere con la participación en hacer ejercicio y se ha 
demostrado que una baja actividad física puede contribuir a desarrollar depresión. Por 
supuesto, la actividad física voluntaria siempre se realiza en relación con la posible 
selección de otras alternativas, como los comportamientos sedentarios o el consumo de 
alimentos. Correr de forma voluntaria en una rueda de actividad ocurre de forma 
espontánea en ratones de todas las cepas, sexos y edades. Por lo tanto, una tarea 
recientemente desarrollada de 3 opciones de laberinto en T establece la carrera voluntaria 
en una rueda como la opción de alto esfuerzo / altamente preferida que compite con 
alimentos sabrosos y un olor a frutas. Esta prueba se puede utilizar para estudiar las 
preferencias espontáneas para los reforzadores que requieren una actividad vigorosa, y 
para evaluar el impacto de las manipulaciones de DA y los posibles efectos terapéuticos 
de diferentes tipos de antidepresivos. Esta prueba puede evaluar la anergia en un entorno 
no estresante, mientras que los modelos tradicionales de roedores para el estudio de 
fármacos antidepresivos, como la prueba de natación forzada (FST), evalúa la activación 
conductual inducida por condiciones estresantes. Por lo tanto, en la presente tesis he 
caracterizado el impacto de la depleción de DA en varios modelos animales que evalúan 
la activación conductual para escapar de una situación aversiva (en el FST) o para 
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acercarse e interactuar vigorosamente con un reforzador altamente preferido (una rueda 
en movimiento opción-T-laberinto) que compite con los reforzadores en el que se 
requieren comportamientos más pasivos para conseguirlos. El efecto de la depleción de 
DA también se ha estudiado en modelos de ansiedad en roedores, otro síntoma común en 
algunas personas con depresión. 
 
El primer capítulo de la presente tesis caracteriza y valida esta tarea de 3 opciones de 
laberinto en T como un modelo de preferencia por la actividad física frente a las opciones 
sedentarias. Estos estudios han empleado un modelo de anergia inducida por la depleción 
de DA, mediante el uso de un bloqueador VMAT-2 (tetrabenazina, TBZ) para alterar el 
comportamiento de elección, y comparando esos resultados con los efectos sobre el FST 
y también con otras manipulaciones que cambian el valor homeostático o emocional de 
los reforzadores que están disponibles en la tarea del laberinto en T. En el Capítulo 2, el 
bupropión, un bloqueador del transporte de catecolamina que eleva los niveles de DA 
extracelular y se usa como antidepresivo, se administró a los animales probados en el FST 
o en la tarea del laberinto en T de 3 opciones. Este antidepresivo se administró solo, y 
también en combinación con TBZ. Los marcadores metabotrópicos de la activación del 
receptor DA se utilizan para evaluar el impacto de estas manipulaciones farmacológicas 
en Nacb. Además, dado que la práctica clínica se centra en las estrategias farmacológicas 
que aumentan la transmisión serotoninérgica a través de los inhibidores de SERT como 
la fluoxetina, los estudios del Capítulo 3 evaluaron el impacto de la fluoxetina en la 
activación conductual en ambos paradigmas; el FST y la tarea de 3 opciones de laberinto 
en T, y su capacidad para aliviar la anergia inducida por TBZ. La fosforilación de 
DARPP-32 se utilizó como marcador celular relacionado con la actividad de DA. 
Finalmente, es importante enfatizar que se sabe poco sobre los impedimentos de 
activación conductual en modelos animales que usan roedores femeninos, a pesar de que 
la depresión es dos veces más común en mujeres que en hombres, y la respuesta a los 
antidepresivos difiere entre sexos. Por lo tanto, el Capítulo 4 de la presente tesis se centra 
en el impacto de la depleción de DA en la activación conductual comparando ratones 
machos y hembras en varias pruebas de activación conductual y ansiedad. El efecto 
terapéutico de ambos tipos de antidepresivos (bupropión y fluoxetina) después de la 
depleción de DA también se evaluó utilizando el FST. 
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General Introduction 
 
1. The activational component of motivation. 
Motivation is defined as a set of processes that allow organisms to regulate the 
probability, proximity and availability of significant stimuli (Salamone and Correa, 2002; 
2012; Salamone et al, 2018, 2016). The ability of organisms to interact with the 
environment in order to obtain significant stimuli such as water, food and sex is critical 
for survival and it requires to overcome environmental obstacles with the objective to 
gain these stimuli (Salamone et al, 2018, 2016). Therefore, motivated behavior is 
composed of several components that can be dissociated from each other, for instance; a 
directional component (preference for specific stimuli or activity) and an energetic or 
activational component (what are you willing to do in order to obtain those stimuli) 
(Salamone and Correa 2002, 2012; Kelley et al, 2005).  
The directional component of motivation requires that the organism approaches selected 
positive stimuli, but also works to get away from negative stimuli (e.g. painful conditions, 
predators or stressors). The distinction between directional and activational components 
of motivation has been an important center of interest in psychology for many decades 
(Duffy, 1963; Cofer and Apley, 1964; Salamone 1997). The ability to produce vigorous 
and rapid responses and maintain them over time, is a fundamental and highly adaptive 
feature of motivational processes because these responses enable organisms to exert the 
effort necessary to reach the work-related limitations that separate them from important 
stimuli (Salamone et al, 2018). 
Studies of behavioral activation are important for understanding some aspects of 
psychopathology. Thus, symptoms such as anergia, psychomotor retardation, apathy and 
fatigue refer to a lack of behavioral activation that can be seen in multiple psychiatric 
disorders such as depression and schizophrenia and also, in some neurological diseases 
such as Parkinson disease (Treadway et al, 2012; Yang et al, 2015; Gold et al, 2013; 
Chong et al, 2016). The severity of these behavioral activation impairments is highly 
correlated with problems in social function, employment and treatment response (Tylee 
et al, 1999; Stahl et al, 2002). The development of animal models of behavioral activation 
dysfunctions could enhance the understanding of the neurochemical basis of motivational 
symptoms in pathologies, as well as it would allow to develop efficient 
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psychopharmacology strategies to treat these motivational symptoms (Salamone et al, 
2018, 2016).   
 
2. Implication of dopamine and nucleus accumbens in behavioral activation 
and effort-related choice.  
Usually, behavioral activation and effort-related decision making are evaluated using 
tasks that offer animals a choice between a preferred reinforcer that can only be obtained 
doing a high effort versus a lower effort/lower value option (Salamone et al, 2016, 2018). 
Operant behavioral methods such as fixed ratio (FR) or progressive ratio (PROG) 
schedules allow the study of response allocation under conditions in which animals have 
to choose to work for a preferred food by pressing a lever in the high-effort option or 
simply approach and consume a less preferred food as the low-effort option (Salamone et 
al, 1991; Randall et al, 2012; Sommer et al, 2014; Yohn et al, 2016a,b,c,d; Rotolo et al, 
2019; Nunes et al, 2013).  
Considerable evidences, from basic animal studies, indicate that dopamine (DA) in the 
nucleus accumbens (Nacb), is the central component that regulates behavioral activation 
and energy expenditure (Salamone and Correa, 2002, 2012; Salamone et al, 2016; 
Robbins and Everitt, 2007; Beller et al, 2012, 2015). DA depletions and injections of DA 
receptor antagonists into the Nacb impair these active behaviors that lead to obtaining 
palatable and preferred food, but, in parallel, they increase the consumption of the less 
preferred food that is available and does not require effort (Robbins and Koob, 1980; 
Wallace et al, 1983; Salamone et al, 1986; 1988; McCullogouh and Salamone, 1992). DA 
antagonism and Nacb DA depletions interact with operant ratio requirements. Thus, 
impairments are greater when the schedules require larger ratios (Aberman and Salamone, 
1999; Caul and Brindle, 2001; Salamone et al, 2002; Ishiwari et al, 2004). In addition, in 
different type of effort-choice tasks, such as the T-maze procedure in which a barrier can 
be placed in the arm where there is a high quantity of food reinforcer (food pellets), and 
in the other arm of the maze there is no barrier but there are fewer reinforcers, DA 
depletion and DA antagonisms decrease choice for the high density arm and increase the 
selection of the low density arm with no barrier (Salamone et al, 1994; Cousins et al, 
1996; Mott et al, 2009; Pardo et al, 2012).  
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Mesolimbic DA also regulates social behaviors that allow animals to approach or avoid 
social stimuli. Thus, dopaminergic transmission in the Nacb modulates social motivation 
(Achterberg et al, 2016; Robinson et al, 2011; Trezza et al, 2011, 2012) and tasks that 
evaluate and instigate the interaction between rodents can increase DA levels in the NAc 
(Pellis and Pellis, 2009; Manduca et al, 2016; Trezza et al, 2011, 2012). 
Interference with Nacb DA does not impair food intake, preference for different types of 
food and does not reduce sucrose preference or hedonic reactivity as seen in free feeding 
preference studies (Salamone et al, 1991; Koch et al, 2000; Nunes et al, 2013; Pardo et 
al., 2015). Thus, dopaminergic manipulations than alter effort-related choice are not 
altering choice based on the quality of food (Salamone and Correa, 2002, 2012; Salamone 
et al, 2016, 2018).  
Finally, although dopaminergic systems are involved in motor function, previous studies 
have indicated that changes in effort-related decision making produced by DA depletions 
are not depending of the total amount of lever presses the animal can generate because, 
when there is not free food available and the animal has no other choice, rats with 
moderate DA depletions still press the lever in a FR5 operant procedure (Salamone et al, 
1994b). Thus, animals with impaired DA transmission are capable of responding, 
although they select the way that requires less effort.  
 
3. Active reinforcers as a tool to evaluate behavioral activation in animal 
models.  
Effort-related tasks are based upon the election of the animal to exert an active response 
by pressing a lever or climbing a barrier in order to obtain palatable food. In addition, 
some animal studies have developed other methods in which behavioral activation can be 
studied by using the possibility of engaging in vigorous activities which is a highly 
preferred reinforcer in rodents. Therefore, running on a running wheel (RW) appears to 
be motivationally regulated like other appetite behaviors (Mueller et al, 1997; Sherwin, 
1998; Belke and Pierce, 2014). This reinforcer can be used as the motivational stimulus 
for the establishment of a conditioned place preference (Lett et al, 2000), and also as a 
reinforcer in operant-conditioning procedures (Premack and Premack, 1963; Belke and 
Pierce, 2014). Moreover, if a RW is present in a complex environment that offers other 
alternatives such as drugs of abuse, animals will spend a significantly amount of time 
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engaged in running on a RW (McMillan et al, 1995; Cosgrove et al, 2002), and rodents 
often choose running over food consumption when the choice between food and RW is 
available (Premack and Premack, 1963; Routtenberg, 1968; Mueller et al, 1997).  
A novel T-maze task has been developed in order to assess preferences between active 
reinforcers versus sedentary ones (Correa et al, 2016; López-Cruz et al, 2018; Carratalá-
Ros et al, 2020). This T-maze task, in contrast to other effort-related tasks, does not 
involve lever pressing or climbing a barrier with the objective to get a reinforcer of which 
the animal is partially deprived (i.e food), but instead allows the possibility of freely 
engaging in consumption of reinforcers that are not present usually in their environment; 
wheel running, consuming palatable food or sniffing a non-social odor. Rodents do not 
need to be food deprived in order to consume the palatable food reinforcer that contains 
50% carbohydrates, although they need to be exposed to this new test and in order to 
reduce neophobia (Correa et al., 2016). The non-social odor used for these type of studies 
is a fruit odor (strawberry) that has demonstrated to not generate avoidance as is the one 
that generates more exploration among several floral or fruit odors (López-Cruz et al., 
2017). Finally, mice have a high preference for engaging in physical activities, and 
specially running on a voluntary RW (Routtenberg et al, 1968; Correa et al, 2016; López-
Cruz et al, 2018; Carratalá-Ros et al, 2020). Moreover, this rodent task offers the 
opportunity to evaluate changes in preferences between these concurrently presented 
reinforcers, as measured by time interacting with each stimuli (Correa et al., 2016). Thus, 
this task could be used to evaluate the brain mechanisms involved in the decision-making 
processes that are involved in the spontaneous preference for active reinforcers and 
sustaining vigorous behaviors over time. 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the 3-choice T-maze task settings. 
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4. DARPP-32 phosphorylation at threonine 34 and 75 as an indicator of DA 
receptor D1 and D2 function.  
 
As described before, multiple behavioral studies have been performed in order to 
characterize the role of DA as a modulator of effort-related decision making tasks (Nunes 
et al, 2013; Randall et al, 2014; Yohn et al, 2014, 2015a,b). In addition, NAcb DA release, 
tissue content and electrophysiological properties have been studied in relation to those 
behaviors (Segovia et al., 2011; Nunes et al, 2013; Floresco, 2007; Smith-Roe and Kelley, 
2000, Seamans and Phillips, 1994; Salamone, 1996). Finally, other studies assessing 
effort-based decision making have specifically focused on DA in NAcb at the 
metabotropic intracellular level (Nunes et al, 2013; Segovia et al., 2011; Randall et al, 
2014; Mai et al, 2012; Valjent et al, 2005; Svenningson et al, 2004).  
 
Dopamine- and cAMP-regulated phosphoprotein, Mr 32 KDa (DARPP-32) is highly 
present in medium spiny neurons (MSNs) in the ventral and dorsal striatum projection 
neurons (Greengard et al, 1999; Ouimet et al, 1998). MSNs are divided into two subtypes 
which selectively express one of two peptides: enkephalin or dynorphin. MSNs than 
contain dynorphin, which also express the peptide substance P, principally express 
dopamine D1 receptors while enkephalinergic MSNs mainly express dopamine D2 
receptors (Nishi and Shuto, 2017; Svenningson et al, 2005; Valjent et al, 2005). In 
addition, when D1 and D2 receptors are activated, DARPP-32 phosphorilates and this can 
be interpreted as an index of DA receptor activation (Svenningson et al , 2004, Nunes et 
al, 2013). The function of DARPP-32 depends on its relative state of phosphorylation at 
two main regulatory sites: threonine 34 and 75 (Thr34 and Thr75). When DARPP-32 
phosphorilates at Thr34 by the action of the protein kinase A (PKA), DARPP-32 inhibits 
the protein phosphatase 1 (PP-1) leading to the phosphorylation of several classes of 
effector proteins, including tanscription factors, ionotropic receptors and ion channels 
(Greengard et al, 1999). However, DARPP-32 produces the opposite effect when its 
phosphorylation occurs at Thr75: DARPP-32 inhibits the PKA signaling and allows the 
activation of the PP-1 protein (Bibb et al, 1999; Svenningson et al, 2004). Therefore, the 
phosphorylation of DARPP-32 at Thr34 or Thr75 seems to be directly related with the 
activation of DA D1 or D2 receptors (Nunes et al, 2013; Randall et al, 2015; López-Cruz 
et al, 2018; Svenningson et al, 2004) (Figure 2). 
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Activation of D1 receptors increases the activity of adenylyl cyclase and this increase in 
turn activates cyclic AMP-dependent protein kinase (cAMP-PK) resulting an increase of 
the phosphorylation of DARPP-32 at Thr34. For instance, administration of DA D1 
agonists such as SKF 81297 increases pDARPP-32(Thr34) but this effect is blocked after 
the administration of the D2 agonist quinpirole (Svenningson et al, 1999). Moreover, the 
administration of D2 antagonists such as haloperidol or eticlopride increases pDARPP-
32(Thr34) and this action is blocked by the action of D1 antagonists (Svenningson et al, 
1999). In addition, activation of D2 receptors decreases cAMP levels and produces, as a 
result, the increase of DARPP-32 at Thr75, although there is less information about this 
intracellular pathway (Greengard et al, 1999). Therefore, the opposite modulation in D1 
and D2 receptors produced by antagonists or agonists contributes to the knowledge that 
DARPP-32 phosphorylation is taking place in different populations of neurons 
(Svenningson et al, 2004; Bateup et al, 2008; Nunes et al, 2013). 
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Figure 2. Diagram showing the intracellular cascade in the D1 and D2 receptor and effect of DA 
on DARPP-32 phosphorylation. D1 receptor stimulation increases c-AMP production and PKA 
activity, which phosphorylates DARPP-32 to yield pDARPP-32(Thr34). D2 receptor stimulation 
decreases c-AMP production and PKA activity, which increases the phosphorylation of pDARPP-
32(Thr75) expression (for details, see Svenningson et al, 2004; Bateup et al, 2008; Nunes et al, 
2013; López-Cruz et al, 2018). 
 
 
5. Tetrabenazine as a tool to induce behavioral activation impairments in 
animal models: impact of DARPP-32 phosphorylation patterns. 
Reduced selection of high-effort choices can be induced in rodents by multiple conditions 
such as stress (Shafei et al, 2012), administration of DA antagonisms as we described 
before (Salamone et al, 1994b; Pardo et al, 2012) or injections of proinflammatory 
cytokines (Nunes et al, 2014; Yohn et al, 2015a). In addition, the decrease of the high-
effort election can be produced by the administration of Tetrabenazine (TBZ) a DA 
depleting agent. 
TBZ inhibits the vesicular monoamine transporter type-2 (VMAT-2), reducing the 
vesicular storage and leading to a depletion of monoamines. TBZ at low doses exerts its 
greatest effects depleting striatal DA (Pettibone et al, 1984; Tanra et al, 1995; Nunes et 
al, 2013). Usually, TBZ is used for treating the hyperkinetic movements in Hungtington’s 
disease, but it has reported to induce depressive symptoms including fatigue as major side 
effects in people that have used it chronically (Frank, 2009; Guay et al, 2010; Chen et al, 
2012). TBZ has been used in classical animal models of depression (Preskorn et al, 1984; 
Kent et al, 1986; Wang et al, 2010; Carratalá-Ros et al, 2020) and also in effort-related 
decision-making tasks in rats (Nunes et al, 2013; Yohn et al, 2015a, 2016; Randall et al, 
2014; Pardo et al., 2015; Rotolo et al, 2019) where the administration of low doses of 
TBZ alters effort-related choice behavior as assessed in FR/choice and PROG/choice 
tasks. This VMAT-2 blocker shift behavior of rodents towards the election of less-costly 
but less-valued reinforcers however, it does not alter the preference for food (Nunes et al, 
2013) or sucrose (Pardo et al., 2005). Moreover, TBZ does not produce effects on 
reinforcer devaluation like those induced by pre-feeding (Randall et al, 2012, 2014; Pardo 
et al, 2015) and it does not alter hedonic reactions to sucrose (Pardo et al, 2015). In mice, 
TBZ decreases the preference for active reinforcers, increasing time doing more sedentary 
activities as seen in the 3-choice-T-maze task (López-Cruz et al, 2018; in the present 
dissertation Carratalá-Ros et al, 2020). 
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In addition, it has been observed that TBZ reduces DA content and release in NAcb core 
assessed by microdialysis (Randall et al, 2013) or tissue punctures of ventral striatum 
(López-Cruz et al, 2018). TBZ also affects DA-related signal transduction which results 
in a consistent reduction of NAcb D1 and D2 receptor transmision (Robertson and 
Fibiger, 1992; Bateup et al, 2008). TBZ reduces C-fos expression in NAcb core and shell 
indicating a reduction in D2 transmission (Robertson and Fibiger, 1992). Moreover, 
immunohistochemical studies in rats have observed that administration of TBZ produces 
a significant increase of DARPP-32 expression phosphorylated at Thr34 and at Thr75 in 
NAcb (Nunes et al., 2013). Results from previous studies suggest that TBZ-induced 
increases in DARPP-32(Thr34) would indicate a reduction of the D2 receptor 
transmission while the increase of DARPP-32(Thr75) would mark a reduced transmission 
of D1 receptors (Svenningsson et al, 2004; Bateup et al, 2008; Nunes et al, 2013; Yger 
and Girault, 2011) (Figure 3). Therefore, TBZ has demonstrated to be connected with 
DA transmission, in particular, with NAcb DA considered the main key to regulate 
motivational processes. Moreover, TBZ is a useful pharmacological tool to evaluate 
pharmacological strategies in order to restore these effort-based behavioral impairments. 
15 
 
 
Fig 3. TBZ, which depletes DA, is hypothesized to have the opposite effect of DA, increasing 
pDARPP-32(Thr75) in substance P-positive neurons and pDARPP-32(Thr34) in enkephalin-
positive neurons (For more details: Nunes et al, 2013; López-Cruz et al, 2018).  
 
6. Two categories of antidepressants with different mechanisms of action differ 
in their therapeutical impact on anergia. 
 
Behavioral activation and effort-related processes are important aspects of normal 
motivation. The impairment of these aspects, leads to disabling features of human 
psychopathology, specifically, in depressed people (Tylee et al, 1999; Salamone et al, 
2006, 2015; Treadway and Zald, 2011). The need to develop pharmacological strategies 
in order to alleviate these motivational symptoms should be taken into consideration in 
preclinical research.  
16 
 
Serotonin (5-HT) selective uptake inhibitors (SSRIs) are the most commonly used 
antidepressants. However, it has been observed that motivational symptoms such as 
fatigue and anergia are resistant to SSRI treatment, and in fact, this type of antidepressant 
can make these symptoms worse (Sthal, 2002; Cooper et al, 2014; Fava et al, 2014; 
Rosthchild et al, 2014). In animal models of effort-related decision making, the use of 
fluoxetine, a SSRI, fails to increase behavioral activation on their own. For instance, 
fluoxetine (SERT blocker) and atomoxetine (NET blocker) do not increase PROG lever 
pressing across a wide range of doses (Yohn et al, 2016c). Atomoxetine also does not 
improve performance on a ratio-discounting task (Hosking et al, 2015). Moreover, these 
type of drugs are not able to alleviate the effort-related impairment produced by TBZ on 
FR5/chow-feeding tasks (Yohn et al, 2016b).  
On the other hand, catecholamine uptake inhibitors seem to treat efficaciously behavioral 
activation impairments among people with depression (Fabre et al, 1983; Rampello et al, 
1991; Pae et al, 2007; Cooper et al, 2014). This type of drugs has been tested in animal 
models and they result in an effective attenuation of the effort-related actions of TBZ. 
One of the catecholamine uptake inhibitors most used in the clinical field is bupropion 
also known as Wellbutrin commercially. Several studies have reported that this 
antidepressant is more effective than the SSRIs at treating fatigue symptoms in depression 
(Papakostas et al, 2006; Cooper et al, 2014). Bupropion is able to reverse the effects 
produced by TBZ in FR5/choice tasks (Nunes et al, 2013; Yohn et al, 2016a), 
PROG/choice tasks (Randall et al, 2015a) and in T-maze barrier tasks (Yohn et al, 2015a). 
On its own, bupropion is also able to increase the selection of high effort options in order 
to obtain high value reinforcers assessed in PROG/choice tasks. Moreover, it has been 
demonstrated that this catecholamine uptake inhibitor increases DA in Nacb and DARPP-
32 immunoreactivity at both phosphorylation sites; Thr34 and Thr75 (Randall et al, 
2014b).  
Taking these studies into consideration, it seems that drugs acting on DA transmission 
appear to be effective at reversing effort-related impairments produced by TBZ and also 
enhances the behavioral output by its own while 5-HT inhibitors do not produce these 
effects (Yohn et al, 2016a).  
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Objectives 
 
Since the clinical literature seems to indicate that different classes of antidepressants that 
act as monoamine uptake inhibitors, differ in their therapeutical improvement of 
motivational symptoms, such as fatigue and psychomotor slowing, frequently seen in 
people with depression, the present group of studies will assess and compare the effect of 
two of the most used antidepressants; fluoxetine and bupropion, an SSRI and a DAT 
inhibitor. 
We will evaluate the impact of these drugs on a mouse model of preference for voluntary 
running as a reinforcer that has to compete with other more sedentary options 
concurrently presented in the recently developed 3-choice-T-maze task (López-Cruz et 
al, 2018). The present dissertation studies, not only the role of these antidepressants on 
their own, but also in animals that had previously received a DA depleting agent. TBZ is 
used to induce anergia, thus mimicking this symptom present in some depressed patients. 
The 3-choice-T-maze task allows the assessment of spontaneous preferences between 
reinforcers with different effort demands in a setting that does not involve stressful 
conditions. The results in this T-maze task will be compared with the results in a classical 
animal model to assess the therapeutic properties of antidepressants the Forced Swim Test 
(FST). The FST evaluates the persistence in trying to escape a stressful situation, thus it 
also assesses behavioral activation as an activity that is negatively reinforced. In addition, 
we will evaluate behavioral activation and anxiety related parameters in classical rodent 
models for the evaluation of anxiety (another important symptom in some depressed 
people).  
Because DA in Nacb has been demonstrated to be a key player in behavioral activation 
and in effort-based decision making, phosphorylation of DARPP-32 will be studied to 
understand the impact of these treatments in Nacb function. 
Finally, we will evaluate potential differences between male and female mice in these 
behavioral paradigms and in response to these drugs. Moreover, we will evaluate these 
sex differences in another rodent species; rats. The choice-T-maze task will be used for 
these rat studies. 
These objectives will be treated in different chapters: 
27 
 
Chapter 1 studies the effect of a wide range of TBZ doses, which is known to induce 
depressive symptoms in humans, in measures of behavioral activation, depressive-like 
behaviors and anxiety. In addition, this chapter explores how the effects produced by TBZ 
on behavioral activation can be mimicked by manipulating reinforcement value under 
multiple conditions; food deprivation, aversive conditions, increase in force required, etc. 
This chapter has already been published: Carratalá-Ros C, López-Cruz L, SanMiguel N, 
Ibáñez-Marín P, Martínez-Verdú A, Salamone JD, Correa M. (2020). Preference for 
exercise versus more sedentary reinforcers: validation of an animal model of 
tetrabenazine-induced anergia. Frontiers in Behavioral Neuroscience. 13: 289. doi: 
10.3389/fnbeh.2019.00289 
Chapter 2 evaluates the impact of the catecholamine uptake inhibitor bupropion by its 
own and given after the DA depleting agent TBZ on behavioral activation, depressive-
like behaviors and anxiety. Intracellular markers of DA receptor activity are also 
evaluated after the administration of TBZ-Bupropion. 
Chapter 3 explores the effect of the serotonin uptake inhibitor fluoxetine on its own, or 
in combination with TBZ on depressive-like behaviors, behavioral activation and anxiety. 
In addition, this chapter also studies if the effect produced by fluoxetine on the T-maze 
task can be mimicked by changing the value of food. Intracellular markers of DA receptor 
activity will be also evaluated. 
Chapter 4 compares the impact of DA depletion induced by TBZ in male and female 
mice on behavioral activation, depressive-like behaviors, anxiety and social interaction. 
In addition, this chapter also explores the effectivity of bupropion and fluoxetine in 
alleviating behavioral activation impairments induced by TBZ in male and female mice. 
Appendix I uses the T-maze choice task in male and female rats and compares the impact 
of fluoxetine and a selective 5HT-2C receptor antagonists on preference for active 
reinforcers. 
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Preference for exercise versus more sedentary 
reinforcers: validation of an animal model of 
tetrabenazine-induced anergia. 
 
CHAPTER I 
Chapter published: Carratalá-Ros C., López-Cruz L., SanMiguel N., Ibáñez-Marín P., Martínez-Verdú 
A., Salamone JD., Correa M. (2020) Preference for exercise versus more sedentary reinforcers: 
validation of an animal model of tetrabenazine-induced anergia. Frontiers in Behavioral 
Neuroscience. 13: 289. doi: 10.3389/fnbeh2019.00289 
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Abstract  
Physical activities can have intrinsic motivational or reinforcing properties. The choice 
to engage in voluntary physical activity is undertaken in relation to the selection of other 
alternatives, such as sedentary behaviors, drugs or food intake. The mesolimbic dopamine 
(DA) system plays a critical role in behavioral activation or exertion of effort, and DA 
antagonism or depletion induces anergia in effort-based decision-making tasks. However, 
little is known about the neural mechanisms underlying the decision-making processes 
that establish preferences for sedentary versus activity-based reinforcers. In the present 
work with male CD1 mice, we evaluated the effect of tetrabenazine (TBZ), a DA 
depleting agent, on a 3-choice-T-maze task developed to assess preference between 
reinforcers with different behavioral activation requirements and sensory properties (i.e., 
a running wheel (RW) vs. sweet pellets or a neutral non-social odor). We also studied the 
effects of TBZ on the forced swim test (FST), which measures climbing and swimming 
in a stressful setting, and on anxiety tests (dark-light box; DL, and elevated plus maze; 
EPM). In the 3-choice task, TBZ reduced time running in the wheel but increased time 
spent consuming sucrose, thus indicating reduced activation but relatively intact sucrose 
reinforcement. The effect of TBZ was not mimicked by motivational manipulations that 
change the value of the reinforcers, such as making the RW aversive or harder to move, 
food-restricting the animals, inducing a binge-like eating pattern, or introducing social 
odors. In the FST, TBZ decreased time climbing (most active behavior), and increased 
immobility, but did not affect anxiety in the DL or EPM. These results indicate that the 
3-choice-T-maze task could be useful for assessing DA modulation of preferences for 
exercise based on activation and effort requirements, differentiating those effects from 
changes in preference produced by altering physical requirements, food-restriction state, 
and stress during testing. 
 
 
Dopamine, Accumbens, voluntary exercise, reward, depression, binge eating, aversion. 
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Introduction 
 
Motivated behavior is characterized by a high degree of behavioral activation, as 
demonstrated by the speed, vigor or persistence seen in the instigation and maintenance 
of instrumental responding (Salamone and Correa, 2002, 2012; Robbins and Everitt, 
2007; Mai et al, 2012; McGinty et al, 2013; Floresco, 2015). Animal research has 
demonstrated that this activational aspect of motivation is partly regulated by the 
mesolimbic dopamine (DA) system (Salamone et al., 2006, 2016, 2018). In particular, 
nucleus accumbens DA and related neural systems have been implicated in motivational 
dysfunctions such as anergia and fatigue seen in many neurological and psychological 
pathologies (Stahl 2002; Salamone and Correa, 2002, 2012; Treadway et al, 2012).  
Diverse tasks have been used in rodents for evaluating behavioral activation and effort-
related decision making, including tasks that give animals the option of vigorously 
working (lever pressing or climbing a barrier) to obtain access to more highly valued 
reinforcers versus approaching and consuming a less preferred reinforcer (Cousins et al, 
1994; Salamone et al, 2002, 2016; Mott et al, 2009; Pardo et al, 2012, 2015; Randall et 
al, 2012; Mai et al, 2012; Sommer et al, 2014; Yohn et al, 2015a,b; SanMiguel et al., 
2018; Correa et al., 2018). In these tasks, conditions that alter DA transmission, such as 
administration of DA antagonists or tetrabenazine (TBZ), can alter behavioral activation 
and reduce selection of high effort choices in rats (Nunes et al, 2013; Randall et al, 2014; 
Pardo et al, 2015; Yohn et al, 2015a,b, 2016a; Hosking et al, 2015; Contreras-Mora et al, 
2018; Rotolo et al, 2019). TBZ acts by inhibiting the vesicular monoamine transporter-
type 2 (VMAT-2), which leads to a blockade of vesicular storage and a depletion of 
monoamines, with its greatest effects at low doses being on striatal DA in rats and mice 
(Pettibone et al, 1984; Nunes et al, 2013; López-Cruz et al, 2018). In humans, TBZ is 
used to treat Huntington’s disease, but major side effects include depressive symptoms, 
including fatigue and depression (Frank, 2009; Guay, 2010; Chen et al, 2012). In fact, 
TBZ administered chronically in a mouse model of Huntington’s disease (Wang et al., 
2010) improved motor deficits, but increased depression-like measures in the forced swim 
test (FST). 
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The FST is the classical rodent task for assessing the antidepressant properties of many 
substances. This test is based on the observation that rodents exposed to a stressful non-
escapable situation such a deep tank full of water initially try to escape in a vigorous way, 
but eventually they will cease these vigorous attempts and will instead passively float in 
the chamber (Porsolt et al, 1977). Thus, immobility is the classical parameter that is 
typically measured, and antidepressant drugs have repeatedly been shown to reduce 
immobility time (Porsolt et al, 1977; Armario et al, 1988; Costa et al, 2013). However, 
escape-related mobility such as climbing or struggling are active behaviors that also are 
modified by antidepressant drugs (Armario et al, 1988; Lucki 1997). These active 
behaviors are more likely to be affected by DA manipulations than the traditional 
immobility measure (Gil and Armario, 1998; Costa et al, 2013). Thus, drugs that affect 
dopaminergic transmission such as haloperidol have been shown to decrease climbing or 
struggling behavior in rats (Gil and Armario, 1998). However, TBZ has not been assessed 
in relation to active behaviors such as climbing or struggling in the FST.  
Recently, a T-maze choice task has been developed that assesses the impact of drugs on 
behavioral activation and effort-related choice (Correa et al, 2016; López-Cruz et al, 
2018). This task allows the animal to freely choose between running on a wheel, 
consuming sucrose pellets, or sniffing a neutral non-social odor. Although foods high in 
sucrose are generally highly preferred, inducing strong hedonic reactivity in rodents 
(Berridge, 2000; Levine et al, 2003), voluntary wheel running occurs in mice of all 
strains, sexes, and ages (Walker and Mason, 2018). Previous studies in our laboratory 
have demonstrated that adult male CD1 mice strongly preferred the RW in the T-maze 
choice task, and that DA antagonism or DA depletion partially shifted choice behavior, 
reducing time running but increasing time eating sucrose (Correa et al, 2016; López-Cruz 
et al, 2018). This T-maze task does not involve the use of food restriction, as is the case 
with other effort-based choice tasks like the T-maze-barrier-climbing task for food 
reinforcement (Pardo et al., 2012; Correa et al., 2018), and does not involve stressful 
conditions, such as the FST. Moreover, since mice have a high preference for engaging 
in physical activities (Routtenberg et al, 1968; Correa et al, 2016; López-Cruz et al, 2018) 
the present task offers a good test for the evaluation of the brain mechanisms involved in 
the decision-making processes that establish spontaneous preference for active and 
vigorous behaviors.  
 
33 
 
In the present work, we explored the impact of a broad range of TBZ doses that have been 
demonstrated to deplete accumbens DA in mice (López-Cruz et al, 2018), comparing their 
impact on different measures of behavioral activation induced by stressful conditions 
(FST), or by spontaneous preference for physical activity in the T-maze-choice task. In 
addition, we explored if the ability of TBZ to reduce RW preference and increase 
palatable food preference can be mimicked by manipulating reinforcement value of the 
various conditions. Thus, we did a series of behavioral manipulations that attempted to 
increase the value of the sweet pellets by food restricting the animals prior to the T-maze 
tests or, in another group of animals, by inducing a binge-like eating pattern after 
randomly presenting sweet pellets during short sessions several days a week previously 
to the T-maze sessions. We also increased the potential value of the odor stimulus by 
using conspecific same or different sex odors. Finally, we reduced RW value increasing 
the resistance of the wheel or introducing an anxiogenic light over the RW. The effect of 
TBZ on anxiety paradigms (dark/light box, DL; and elevated plus maze, EPM) was also 
assessed in order to identify anxiolytic-like actions that could be affecting the results in 
the T-maze and the FST. 
 
Materials and Methods 
 
Animals. CD1 adult male mice (N=166) purchased from Janvier, France S.A. were 8-10 
weeks old (30-40 g) at the beginning of the study. Mice were housed in groups of three 
or four per cage, with standard laboratory rodent chow and tap water available ad libitum. 
The colony was kept at a temperature of 22 +  2 ºC with lights on from 08:00 to 20:00 h. 
All procedures were covered by a protocol approved by the Institutional Animal Care and 
Use committee of Universitat Jaume I. All experimental procedures complied with 
directive 2010/63/EU of the European Parliament and of the Council, and with the 
“Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral 
Research”, National Research Council 2003, USA. All efforts were made to minimize 
animal suffering, and to reduce the number of animals used. 
Pharmacological agents. Tetrabenazine (TBZ, CIMYT Quimica SL, Spain) was 
dissolved in a vehicle solution of 0.9% saline (80%) plus dimethylsulfoxide (DMSO 20%, 
final pH 5.5), and administered 120 minutes before testing. Time elapsed after injection 
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and range of doses was selected based on previous work (López-Cruz et al., 2018; Correa 
et al., 2018) and pilot studies demonstrating that in mice this is an optimal dose and time 
lead to deplete DA. DMSO (20% v/v) was used as the control group. TBZ and DMSO 
was administered intraperitoneally (IP). 
 
Testing procedures.  
All behavioral procedures started two hours after the light period onset. The behavioral 
test room was illuminated with a soft light, and external noise was attenuated. 
T-maze RW-sucrose-odor choice task. The T-maze apparatus consisted of a central area 
that leads to 3 arms (see figure 1). In one of them, sucrose pellets (TestDietTM, 50% 
sucrose, 45 mg each) were available, in another arm there was a RW, and in the third arm 
there was a hole with a cotton ball socked with a fruit odor (based on López-Cruz et al, 
2018). This concentration of sucrose in the pellets was selected after piloting different 
concentrations (i.e. 100% sucrose pellets generate avoidance), and the non-social odor 
used for the present studies (strawberry) was the one that generated more exploration 
among non-social odors in previous studies (López-Cruz et al, 2017). In general, mice 
were allowed to freely explore and interact with the stimulus during 15 minutes sessions, 
once a day, 5 days a week. Training phase 1: to avoid neophobia to the sweet tasting 
pellets, animals were enclosed in that arm with the food during 5 sessions (no exploration 
of the other arms was allowed during this phase). Training phase 2: during 2 weeks 
animals had free access to the three stimuli until a stable baseline was obtained. Test 
phase: This phase lasted during 4 more weeks. For each week, there were 4 baseline drug 
free sessions plus a testing session in which animals received TBZ or were tested under 
different behavioral manipulations. The day before the test for the behavioral 
manipulation was considered as the baseline (BL) for those experiments. Sessions were 
videotaped and a trained observer manually registered several parameters. Time 
interacting with the stimulus was selected as the main dependent measure because it 
allowed for the evaluation of the three stimuli with the same units. Time allocation is a 
useful measure of preference, relative reinforcement value, and response choice (Baum 
and Rachlin, 1969). Entries into the arms and time spent in the arms of the T-maze were 
also simultaneously recorded. All these measures were taken based on previous studies 
(Correa et al., 2016; López-Cruz et al., 2018). 
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Forced swim test (FST). This paradigm is considered to be a model of behavioral despair 
and is used as a test for assessing depressive-like states (Porsolt et al, 1977). Naïve mice 
were placed in a transparent cylindrical glass tank (26 cm high and 18 cm diameter) filled 
with water (14 cm) and maintained at a temperature of 25ºC. Water was changed between 
animals. During the 6-minute test, mice were videotaped from the side, and 
struggling/climbing, immobility and swimming were later measured by an observer 
unaware of the experimental condition. Immobility was defined as a period when the 
animal remained motionless, making only minor movements to balance the body and 
keep the head above the water. In addition, we also assessed escape-related mobility 
behavior such climbing or struggling (Armario et al, 1988). Climbing is defined as any 
energetic and vertical movement of all four limbs against the wall of the tank. Swimming 
was recorded when animals carried out horizontal movements with their forepaws, 
leading to the displacement of the body throughout the swim chamber (Armario et al, 
1988). After the test, mice were dried with a soft towel, put back in a box with absorbing 
paper under a warming light, and were monitored for 10 minutes. 
Dark and light box (DL). The DL test is based on the conflict between the tendency to 
explore a novel environment and the avoidance of a brightly lighted open area (Blumstein 
and Crawley 1983). The DL apparatus consisted of a polypropylene chamber divided in 
two compartments by a partition containing a small opening (5 cm H x 5 cm W). The 
light compartment (25 cm W x 25 cm H x 25 cm L) was open, painted in white and 
illuminated with an intense light (335 lx), while the dark compartment (25 cm W x 25 cm 
H x 18 cm L) was painted in black and had a removable ceiling to close it (Kulesskaya 
and Voikar, 2014). To start the test session, mice were individually placed in the dark 
chamber facing one corner. Test sessions were videotaped. Total number of crosses 
between compartments as an index of locomotion, and total time spent in the lit chamber, 
as an index of anxiogenesis were recorded for 5 min (procedure is based on López-Cruz 
et al., 2014). 
Elevated plus maze (EPM). After being in the DL box for 5 minutes, animals were 
placed in the EPM for 5 more minutes. The EPM consists of two open and two enclosed 
arms (65 cm L x 5 cm W) arranged in a plus configuration with an intersection in a central 
platform. It was made of black polypropylene and is elevated 50 cm above the floor. The 
open arms had a 1 cm border around their perimeter and the closed arms had a 20 cm 
translucent wall. This anxiety paradigm measures the avoidance that rodents show to 
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elevated open spaces (Lister 1987; Walf and Frye 2007). Under normal conditions, mice 
spend more time and make more entries into the closed arms of the maze. Animals were 
placed in the central platform with their head pointing at one enclosed arm, and they were 
assessed during 5 minutes. Sessions were videotaped and a trained observer registered 
total time spent in the open arms, and total entries in the 4 arms as an index of locomotion. 
An entry into an arm was recorded when the animal crossed with all four legs the line that 
connected that arm with the central platform (procedure is based on López-Cruz et al., 
2014). 
Experiments. 
Table 1 summarizes the experiments conducted, the experimental design and 
number of mice used in each experiment.  
Pharmacological or 
Behavioral manipulation Experimental design Control condition 
TBZ effect:  
T-maze 
FST. 
DL, EPM 
 
 
 
N=13. Within groups 
N=47. Between groups  
N=41. Between groups 
 
 
 
Vehicle day 
Vehicle group 
Vehicle group 
Change in relative value of 
sweet pellets: 
Standard food restriction 
Binge-eating 
 
 
N=8.  Within groups 
N=25. Between groups  
 
 
BL with no food restriction 
Group exposed to standard 
food 
Change in the relative value 
of the odor:  Social odors 
 
 
N=10. Within groups 
 
 
BL with non-social odor 
Change in the relative value 
of the RW: 
 
 
 
BL with no extra weight 
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Table 1. Experimental design and number of mice used in each experiment. (FST, Forced 
swim test; DL box, Dark/Light box; EPM: elevated plus maze). 
Experiment 1. Effect of TBZ on preference for active reinforcers as measured in the 
3-choice-T-maze task. After reaching a stable baseline level of performance in the T-
maze, animals (n=13) received vehicle or the DA depleting agent TBZ (vehicle, 4.0, 6.0 
and 8.0 mg/kg) 120 min before the test began. Animals received one dose of the drug 
every week in a randomly varied order. In previous work from our laboratory using rats 
and mice, we have observed that TBZ does not produce sensitization or tolerance when 
administered once a week; animals recover their behavioral baseline performance after 
few hours of the acute intraperitoneal injection. The T-maze paradigm requires a baseline 
performance of two weeks before tests start, and that performance is maintained across 
weeks, thus allowing a repeated measures design. 
Experiment 2. Manipulations that change the relative value of the sweet pellets. 
Experiment 2.1. Effect of standard food restriction in the home cage. Animals (n=8) 
were trained and, after reaching stable levels, they were food restricted to 4.0 mg of 
standard chow the night before the test, in order to increase their appetite for the sucrose 
pellets. This amount of standard food was selected based on previous studies using food 
restriction (Pardo et al, 2012; Yang et al, 2019). Baseline with ad libitum food was used 
as the control condition.  
Experiment 2.2. Binge-eating like consumption of sweet pellets. Before the T-maze 
testing took place, during 4 weeks, at intermittent random days (3 days a week in 
average), non-food restricted mice (n=12) were placed individually in standard home 
cages with free ad libitum access to sweet pellets (50% sucrose) and water for one hour 
during the light cycle (based on Murphy et al., 2018). The control group (n=13) was also 
placed in the same type of cages for an hour with standard food and water. After these 4 
weeks, mice were trained in the T-maze.  
Increase in RW resistance 
Light over the RW 
 
N=8. Within groups 
N=14. Within groups 
 
BL with no light over RW 
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Experiment 2.3. Effect of TBZ and of increasing food value on the amount of sweet 
pellets consumed in the T-maze. The effect of the highest dose of TBZ (8.0 mg/kg) vs. 
vehicle from experiment 3 was used in order to make comparisons with the effects of 
food restriction and binge-like eating exposure on milligrams of sucrose pellets consumed 
on the test day. The effects of food restriction and binge-like eating exposure were 
compared to their respective control groups. Thus, all these data were obtained from 
experiments 3, 5.1, and 5.2. 
Experiment 3. Manipulations that change the relative value of the odor: effect of 
social odors. Animals (n=10) were trained as in previous experiments and on the test day, 
a social odor (bedding from male or from female conspecifics) replaced the strawberry 
odor during two consecutive days: in the first session, male conspecific odor was used 
and, the following day, female mice odor replaced the male odor. Estrous cycle of the 
females was not controlled. Baseline was taken with the non-social odor and was used as 
the control condition.  
Experiment 4. Manipulations that change the relative value of the RW. 
Experiment 4.1. Effect of increasing RW resistance. Mice (n=8) were trained as in 
previous experiments. The test was performed during 2 consecutive days: in the first day 
weights were attached to the wheel so that the resistance increased 75%, and for the 
second day additional weights increased resistance to 95%. Before increasing the 
resistance of the wheel, behavior of animals in the T-maze was established as baseline 
and used as control condition.  
Experiment 4.2. Effect of an intense light over the RW. Mice (n=14) were trained 
normally in the T-maze and for the test day a bright light; like the one used in the DL 
box) was placed over the RW in order to add an aversive component. Baseline with 
standard test lighting conditions was used as the control condition.  
Experiment 5. Effect of TBZ on depressive-like behaviors assessed in the FST. Naïve 
animals (n=47) received one dose of TBZ or vehicle (vehicle, 4.0, 6.0 or 8.0 mg/kg) and 
120 min after the injection were placed in the FST. Mice were exposed only once to the 
FST since behavioral habituation develops in one session. 
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Experiment 6. Effect of TBZ on anxiety parameters as measured in the DL and EPM 
paradigms. Mice (n=41) received one dose of TBZ (0, 4, 6 or 8 mg/kg) 120 min before 
the test began. Animals were first place in the DL box for 5 minutes, and immediately 
after this test, they were placed in the EPM for 5 more minutes. Mice were exposed only 
once to both paradigms, since behavioral habituation develops in one session.  
 
Statistical Analyses 
Normally distributed and homogenous data (according to Kolmogorov-Smirnov test) for 
the FST, DL, and EPM experiments employed a between groups design and data were 
analyzed by one-way repeated measures ANOVA. Data for the key dependent variable in 
the T-maze experiments; time with the three reinforcers, was analyzed by a MANOVA 
in previous work (Correa et a., 2016). Because the three-way interaction was significant, 
univariate ANOVAs were conducted for each reinforcer in all the dependent 
variables. Since, in the present work baselines are consistent among the 3 stimuli and they 
are also consistent across experiments, we performed univariate ANOVAs. Thus, 
normally distributed data in the T-maze experiments followed a within groups design with 
the exception of the binge-eating experiment, which used two different groups of animals. 
Thus, when more than 2 experimental conditions were used such as in the TBZ 
experiment, the experiment with increasing RW resistance, and the social odors 
experiments, data were analyzed by repeated measures ANOVA. When the overall 
ANOVA was significant, non-orthogonal planned comparisons using the overall error 
term were used to compare each treatment with the vehicle control group (Keppel, 1991). 
For these comparisons,  level was kept at 0.05 because the number of comparisons was 
restricted to the number of treatments minus one. The effects of intense light over the RW, 
and food restriction, were evaluated by Student’s t-test for dependent samples. Binge-like 
eating of sweet food was analyzed by Student’s t-test for independent samples. All data 
were expressed as mean ± SEM, and significance was set at p<0.05. STATISTICA 7 
software was used.  
Results 
Experiment 1. Effect of TBZ on preference for active reinforcers as measured in the 
3-choice-T-maze task. Repeated measures ANOVA showed that total time spent sniffing 
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the neutral odor was not significant (F(3,36)=0.29, p=0.83). However, TBZ produced a 
significant effect on time spent eating (F(3,36)=3.46, p<0.05), and time spent running in 
the RW (F(3,36)=2.99, p<0.05) (Figures 2A-C). Planned comparisons revealed that all 
doses of TBZ produced a significant increase in time consuming sucrose pellets in 
comparison with the vehicle group (p<0.05 for 4.0 and 6.0 mg/kg, and p<0.01 for 8.0 
mg/kg). Planned comparisons also showed that mice treated with 8.0 mg/kg TBZ spent 
significantly less time running in the RW compared to vehicle group (p<0.01). Repeated 
measures ANOVA showed that total time spent in the RW compartment (F(3,36)=0.98, 
p=0.40), the food compartment (F(3,36)=1.11, p=0.35), and the neutral odor compartment 
(F(3,36)=0.89, p=0.45) were not significant (Figure 2D). Finally, TBZ did not produce 
significant differences in the number of entries into the RW compartment (F(3,36)=0.98, 
p=0.40), food compartment (F(3,36)=0.70, p=0.55), and neutral odor compartment 
(F(3,36)=0.46, p=0.71) (data shown in Figure 2E). 
Figure 2. Effect of tetrabenazine (TBZ) (Vehicle, 4, 6 and 8 mg/kg) on time eating (A), time 
running (B), time sniffing (C), time spent in each compartment (D) and entries into compartments 
(E) in the T-maze task assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated 
seconds or number of entries. *p<0.05, **p<0.01 significantly different from vehicle. 
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Experiment 2. Manipulations that change the relative value of the sweet pellets. 
Experiment 2.1. Effect of standard food restriction in the home cage. Food restriction 
significantly decreased time in RW, and significantly increased time eating compared 
with BL condition as showed by Student’s t-test for dependent samples (t=4.95, p<0.01 
and t=-4.24, p<0.01 respectively). However, there was no significant difference between 
conditions on time spent sniffing the neutral odor (t=-0.42, p=0.68) (Figures 3A-C). 
Student’s t-tests for time in each compartment showed significant differences between 
both conditions in time spent in food compartment (t=-3.10, p<0.01), and RW 
compartment (t=3.22, p<0.01), but no significant effect on time in the odor compartment 
(t=1.50, p=0.17) (Figure 3D). Finally, there were no significant differences in total entries 
to the food compartment (t=-0.84, p=0.42), to the RW compartment (t=0.30, p=0.76), and 
to the odor compartment (t=2.19, p=0.06) (Figure 3E). 
 
Figure 3. Effect of home food restriction in mice behavior in the T-maze task. Bars represent 
mean (±SEM) of time (seconds) spent eating (A), running (B), and sniffing the neutral odor (C), 
time in different compartments (D) and entries (E) during a 15 minutes session. Bars represent 
mean ± S.E.M. of accumulated seconds or number of entries. **p<0.01 significantly different 
from baseline (BL). 
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Experiment 2.2. Binge-like consumption of sweet pellets. A Student’s t-test for 
independent samples showed a significant increase in time eating sucrose pellets (t=-5.60, 
p<0.01), and time sniffing the neutral odor (t=-4.68, p<0.01), but a significant decrease 
in time running in the RW (t=3.92, p<0.05) compared with the BL condition (Figures 4A-
C). Moreover, Student’s t-test for time in each compartment showed significant 
differences between both conditions for time spent in the food compartment (t=5.60, 
p<0.01), the RW compartment (t=5.99, p<0.01) and the odor compartment (t=4.68, 
p<0.01) (Figure 4D). Finally, there were no significant differences in total entries to the 
food compartment (t-1.88, p=0.08), and the RW compartment (t=1.06, p=0.30), but there 
was a significant increase in total entries to the odor compartment (t=-2.75, p<0.01) 
(Figure 4E).  
 
Figure 4. Effect of binge eating pattern for sucrose pellets on time eating (A), time running (B), 
time sniffing (C), time spent in each compartment (D) and compartment entries (E) in the T-maze 
task assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated seconds or number 
of entries. *p<0.05, **p<0.01 significantly different from control group. 
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Experiment 2.3. Effect of TBZ and changes in food value on the amount of sweet 
pellets consumed in the T-maze.  The Student’s t-test for dependent samples did not 
show significant differences between the vehicle condition and the TBZ 8.0 mg/kg 
condition (t=-0.75, p=0.46). However, Student’s t-test for dependent samples showed that 
there were significant differences among conditions in the experiment in which animals 
were food deprived (t=3.05, p<0.01). Similarly, the Student’s t test for independent 
samples showed significant differences between the control group and the binge-like 
eating group (t=-3.84, p<0.01). Data are shown in Table 2.  
Pellet intake (mg) 
 
Table 2. Effect of tetrabenazine (TBZ) and behavioral manipulations that increased food value 
on pellets consumed in the T-maze. Mean (± SEM) of milligrams consumed. **p<0.01 
significantly different from their corresponding control condition. 
 
Experiment 3. Manipulations that change the relative value of the odor: effect of 
social odors. Repeated measures ANOVA showed an overall effect of odor type on time 
sniffing (F(2,18)=85.98, p<0.01). Planned comparisons revealed a significant increase in 
time sniffing the same-sex conspecific and female odors (both p<0.01) (Figure 5C). The 
ANOVA also yielded an overall effect on time running in the RW (F(2,18)=7.34, p<0.01), 
and the planned comparisons showed a significant difference between BL and the female 
odor condition (p<0.01) (Figure 5B). However, there was not an effect of type of odor on 
time spent eating (F(2,18)=0.61, p=0.55) (Figure 5A). For the time spent in the various 
compartments, the repeated measures ANOVA showed an overall effect on time in the 
odor compartment (F(2,18)=23.45, p<0.01), and time in the RW compartment 
(F(2,18)=8.99, p<0.01). Planned comparisons demonstrated a significant increase in time 
spent in the odor compartment when the odor was male or female (p<0.05, and p<0.01 
respectively), and there was a significant decrease in time spent in the RW compartment 
 
Control 
Experimental 
condition 
TBZ (Vehicle and 8.0 mg/kg) 169.6 ± 48.1 228.4 ± 50.5 
Food restriction 157.7 ± 32.9 736.1 ± 235.8** 
Binge-eating 301.1 ± 61.4 684.6 ± 82.5** 
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only when the odor was female (p<0.01). There was not an effect of odor type on time 
spent in the food compartment (F(2,18)=2.08, p=0.15) (Figure 5D). Finally, repeated 
measures ANOVA showed an overall effect of social odors on entries to the RW 
compartment (F(2,18)=4.31, p<0.05), entries to the food compartment (F(2,18)=4.50, 
p<0.05), and entries to the odor compartment (F(2,18)=6.35, p<0.01). Planned 
comparisons showed an increase in entries to the food compartment when the male or the 
female odors were used as compared with the BL (p<0.05), and the same was observed 
for the compartment where the odor was present (p<0.05 for the male odor, and p<0.01 
for the female odor both compared to BL). However, the increase in total entries to the 
RW compartment increased only when the female odor was present in comparison with 
the neutral odor condition (p<0.05) (Figure 5E).  
 
Figure 5.  Effect of changing from fruit odor to social odors in the odor compartment of the T-
maze task on; time eating (A), time running (B), time sniffing (C), time spent in each compartment 
(D) and entries into compartments (E) in the T-maze task assessed during 15 minutes. Bars 
represent mean ± S.E.M. of accumulated seconds or number of entries. *p<0.05, **p<0.01 
significantly different from baseline (BL). 
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Experiment 4. Manipulations that changed the relative value of the RW. 
Experiment 4.1. Effect of increasing RW resistance. Repeated measures ANOVA did 
not show a significant effect of increasing RW resistance on time eating (F(2,10)=1.03, 
p=0.38), or time sniffing the neutral odor (F(2,10)=0.40, p=0.68). However, RW 
resistance produced a significant effect on time running in the RW (F(2,10)=5.12, 
p<0.05). Planned comparison showed a decrease in time running in the RW when the 
resistance was the highest (95%) in comparison with BL condition (p<0.01) (Figure 6A-
C). Increasing the RW resistance did not yield a significant effect on time spent in the 
food compartment (F(2,10)=3.71, p=0.06), time spent in the RW compartment 
(F(2,10)=2.12, p=0.17), or time spent in the odor compartment (F(2,10)=2.64, p=0.11) 
(Figure 6D). Although repeated measures ANOVA did not show an overall effect of 
increasing RW resistance on total entries to the RW compartment (F(2,10)=0.96, p=0.40), 
it did yield a significant effect on entries to the food compartment (F(2,10)=4.89, p<0.05), 
and to the odor compartment (F(2,10)=10.88, p<0.01). Planned comparisons showed a 
decrease in total entries after applying 75% more resistance to the RW in comparison 
with the BL condition in the odor compartment (Figure 6E). 
Figure 6. Effect of increasing RW resistance on mice behavior in the T-maze task. Bars represent 
mean (±SEM) of time (seconds) eating (A), running (B), and sniffing the neutral odor (C), time 
spent in each compartment (D) and compartment entries (E) during a 15 minutes session. Bars 
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represent mean ± S.E.M. of accumulated seconds or number of entries. *p<0.05, **p<0.01 
significant different from baseline (BL). 
Experiment 4.2. Effect of an intense light over the RW. The bright light condition 
significantly decreased time that animals spent running in the RW (t=2.98, p<0.01), and 
increased time eating the sucrose pellets compared with the BL condition (t=-2.38, 
p<0.05) as shown by the Student’s t-test for dependent samples. However, the increase in 
sniffing time did not reach statistical significance (t=-1.37, p=0.19) (Figures 7A-C). 
Student’s t-test for time in these compartments showed a significant decrease in time 
spent in the RW compartment (t=3.44, p<0.01), and a significant increase in time spent 
in the food (t=-2.89, p<0.01), and in the odor (t=-3.60, p<0.01) compartments (Figure 
7D). Finally, the t-tests for dependent samples showed an increase on entries to the food 
compartment (t=-4.03, p<0.01), and to the odor compartment (t=-3.14, p<0.01), although 
there were no significant differences in entries to the RW compartment compared with 
the BL condition (t=-0.83, p=0.41) (Figure 7E). 
 
Figures 7. Effect of placing an intense light over the RW on time eating (A), time running (B), 
time sniffing (C), time spent in each compartment (D) and entries into compartments (E) in the 
T-maze task assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated seconds 
or number of entries. *p<0.05, **p<0.01 significantly different from baseline (BL).  
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Experiment 5. Effect of TBZ on depressive-like behaviors assessed in the FST. The 
ANOVA for time spent swimming did not show significance (F(3,43)=1.90, p=0.14). 
However, TBZ produced a significant effect on immobility (F(3,43)=4.02, p<0.01), and 
on climbing (F(3,43)=3.86, p<0.01). Planned comparisons revealed that the groups that 
received the two highest doses of TBZ (6.0 and 8.0 mg/kg) displayed significantly more 
time immobile (p<0.05 and p<0.01, respectively) and less climbing (p<0.01) in 
comparison with the vehicle group (Figure 8). 
 
Figure 8. Effect of tetrabenazine (TBZ) (Vehicle, 4, 6 or 8 mg/kg) on duration of immobility, 
swimming and climbing behavior in the FST assessed during 6 minutes. Bars represent mean ± 
S.E.M. of accumulated seconds. *p<0.05, **p<0.01 significantly different from vehicle.  
 
Experiment 6. Effect of TBZ on anxiety parameters as measured in the DL and EPM 
paradigms. The ANOVAs did not show any significant effects on time spent in the 
illuminated arena of the DL box (F(3,37)=2.22, p=0.10), or time spent in the open arms 
(F(3,38)=0.68, p=0.56) of the EPM, both of which are indices of anxiety. However, TBZ 
did have a significant effect on the total number of crosses between compartments in the 
DL box (F(3,37)=5.69, p<0.01), and total number of crosses to all arms in the EPM 
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(F(3,38)=6.38, p<0.01). Planned comparisons revealed that the groups that received TBZ 
6.0 and 8.0 mg/kg displayed significantly fewer crosses than vehicle group (p<0.01) in 
the DL box, but only the group that received the highest dose of TBZ (8.0 mg/kg) 
displayed fewer crosses (p<0.01) than vehicle group in the EPM. The total number of 
crosses assessed in the DL box and EPM can be considered as an index of locomotion. 
Data are shown in Table 3. 
TBZ (mg/kg) 
 
Table 3. Effect of tetrabenazine (TBZ) on mice behavior in the Dark and Light (DL) Box and 
Elevated Plus Maze (EPM). Every test lasted 5 minutes. Mean (± SEM) seconds or frequency. ** 
p<0.01 significantly different from vehicle. 
 
 
 
  
 Vehicle 4 6 8 
DL     
Time in light 
compartment (sec) 
125.6 ± 6.1 116.8 ± 8.9 84.5 ± 13.5 117.1 ± 11.4 
Crosses between 
compartments 
23.6 ± 1.6 20.2 ± 1.8 17.2 ± 4.1** 12.6 ± 1.4** 
 
EPM 
    
Time in open arms 
(sec) 
79.2 ± 13.7 75.2 ± 13.9 82.2 ± 8.5 95.9 ± 12.6 
Crosses between arms 19.1 ± 1.0 15.2 ± 2.1 18.9 ± 1.5 11.2 ± 1.4** 
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Discussion 
 
The present group of studies evaluated the impact of the VMAT-2 inhibitor TBZ on 
behavioral activation as assessed in a 3-choice-T-maze task that evaluates preference for 
vigorous physical activity vs. other sources of reinforcement that could be obtained with 
little effort. These experiments also studied how TBZ can affect behavioral activation 
induced by stressful conditions such as the non-escapable FST.  
In the 3-choice-T-maze task, mice freely distribute their time performing an effortful 
activity (running in a RW) or doing more sedentary activities (eating sucrose pellets or 
sniffing a fruit odor). Under basal conditions, mice spent a large part of the time running, 
some time consuming sucrose, and very little time sniffing a non-social odor. Consistent 
with this finding, previous studies have shown that running has a high motivational value, 
because animals work to unlock a RW (Belke et al., 2005, 2014; Collier et al., 1990). 
Also, the RW can be used as a motivational stimulus for inducing conditioned place 
preference (Lett et al., 2000; Trost and Hauber, 2014; Basso and Morrell 2015). In our 
study, TBZ decreased time spent running but increased time eating, with no change in 
time interacting with the neutral odor. These results are consistent with previous studies 
in our laboratory using lower doses of TBZ (López-Cruz et al, 2018), and also using 
haloperidol (D2 receptor antagonist), in a simpler version of the T-maze (Correa et al, 
2016). In addition, in the present study we further analyzed other behavioral variables 
such as time spent in the different compartments or total number of entries into each 
compartment. TBZ produced no significant change in these measures of place preference 
and exploration, indicating that mice did not avoid being in close proximity to the RW 
and showed normal motor exploration of the T-maze. A further statistical comparison of 
vehicle versus the highest dose of TBZ with a Student t-test for related samples did not 
show a significant effect on these two variables either. Thus, by depleting DA (López-
Cruz et al, 2018), these doses of TBZ seem to be producing anergia or reduced behavioral 
activation rather than affecting the primary reinforcing effects of sucrose, since time spent 
eating sucrose actually increased.  
However, in order to test potential alternative explanations, we manipulated the 
reinforcing value of these 3 reinforcers. Thus, we addressed potential factors that could 
be increasing food value. In one of the experiments, animals were exposed to the T-maze 
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after having gone through home food restriction, in order to increase homeostatic value 
for food and food seeking. In this experiment, time spent eating was significantly 
increased almost ten times, and time running decreased by half the baseline values. Thus, 
this manipulation profoundly changed baseline preferences, and it was the only 
manipulation that made RW and food equally preferred (mice spent around 200 seconds 
interacting with each one of them). In a different experiment, animals exposed daily to an 
unlimited amount of sweet food for a limited time demonstrated a binge eating pattern 
increasing about ten times their time eating in the T-maze compared to control animals, 
almost to the level of animals in the previous experiment restricted of standard food. In 
addition, binge eating animals not only showed reduced time spent running, but they also 
showed increased time sniffing the strawberry odor. This pattern of results was parallel 
to results for the variable time in the compartment, and for entries in the compartments, 
although only entries in the odor compartment increased significantly. These results 
indicate that a binge-like-eating pattern produces a shift in relative preferences towards 
sedentary stimuli (odor and food). However, when we analyzed the amount of pellets 
consumed after DA depletion and after food manipulations (Table 2), we observed that 
animals significantly consumed more grams of sucrose pellets only after food restriction 
and after stablishing a binge-like pattern of intake compared to their respective control 
conditions. Although TBZ did not significantly change total grams of pellets consumed, 
it did significantly increase time spent eating at the highest dose. This is important 
because previous behavioral studies indicate that time allocated to a particular activity is 
a fundamental marker of reinforcement value (Baum and Rachlin, 1969). Previous studies 
have shown that administration of TBZ had no significant effect on free food intake both 
in mice and rats (Correa et al, 2018; López-Cruz et al, 2018; Pardo et al, 2015; Nunes et 
al, 2013), and did not induce changes in hedonic taste reactivity to sucrose (Pardo et al, 
2015). In rats, responding on effort-based choice tasks involving lever pressing, TBZ-
induced decreases in lever pressing are actually accompanied by increased intake of the 
concurrently available chow (Nunes et al, 2013; Yohn et al, 2016a). Taken together, these 
data are consistent with other studies indicating that the TBZ-induced relative shifts in 
choice behavior do not appear to be due to changes in primary food motivation (Nunes et 
al, 2013; Randall et al, 2012, 2014). Moreover, considerable evidence indicates that 
nucleus accumbens DA depletions do not impair the unconditioned reinforcing properties 
of food (Koob et al, 1978; Salamone et al, 1991; Kelley et al, 2005; Salamone and Correa, 
2002, 2012; Salamone et al, 2016).  Thus, the T-maze choice paradigm appears to be 
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useful for exploring changes in patterns of food consumption (rather than total food 
consumed), as well as changes in preferences after conditions that impair voluntary 
exercise. 
We also tried to alter the value of the least preferred reinforcer, the fruit odor. There is 
considerable evidence showing an increase in sexual motivation of male rodents when a 
female odor is present (Trezza et al., 2011; Portillo and Paredes, 2004). In 
rodents, olfactory stimuli from conspecific estrous females can be conditional cues that 
induce incentive motivation and seeking behavior parallel to a significant increase in 
accumbens DA (Fujiwara and Chiba, 2018). Thus, we increased the value of the odor by 
using social odors (conspecific male and conspecific female). All the subjects were male, 
and the male odor significantly increased time sniffing the cotton ball, but did not produce 
a significant reduction in time running. However, when the cotton contained a female 
odor, male mice increased sniffing time almost ten-fold, and this increase was paralleled 
by a significant reduction in time spent running, but not time eating. These results were 
parallel for the time-in-compartment variable. However, the presence of these social 
odors made animals more active in exploring the T-maze: mice increased entries in all 
the compartments when conspecific odors substituted the fruit odor. Thus, in the present 
results, male mice showed a decrease in the relative preference for the running wheel 
when a female odor was present, making food and opposite sex odor equally preferred 
(around 30 seconds of interaction with each stimuli). 
Finally, in order to reduce time in the RW, we tried to devalue the RW stimulus in 
different ways. Devaluing the RW by making it more resistant to turn and thus, increasing 
muscular effort, produced a very different pattern of effects compared to TBZ. Animals 
reduced time running but there was no compensatory increase in time eating. In fact, 
animals tended to increase time spent in the RW compartment indicating no avoidance of 
the RW, and no increased interest in the other stimuli. Thus, force requirement does not 
seem to be the key factor underlying the effects of TBZ on RW preference in the present 
experiments. This result is similar to previous experiments using weights attached to a 
lever to increase resistance in an operant setting (Ishiwari et al., 2004). In that experiment, 
rats with a local Nacb DA depletion were relatively insensitive to different force 
requirements, but were very sensitive to temporal or rate components of work 
requirements as compared to controls.  
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The term fatigue has been used for many different aspects of human performance. Fatigue 
includes a range of effects that can vary between reductions in physical and cognitive 
function that extend from an exercise-induced impairment of motor performance, to the 
sensations of tiredness and weakness that accompany some clinical conditions (Enoka 
and Duchateau 2016). In order to assess all these components, most authors have 
stablished a dichotomy between central and peripheral fatigue or perceived fatigability 
and performance fatigability (Enoka and Stuart 1992; Enoka and Duchateau 2016). 
Among perceived fatigability, psychological factors, and in particular motivational 
factors, play a role in healthy individuals (McCormick et al., 2015), but they play an even 
more prominent role in the type of fatigue reported in various clinical conditions, such as 
in Parkinson's disease (Kluger et al., 2013), and in depressed patients (Caligiuri and 
Ellwanger, 2000; Demyttenaere et al., 2005; Fava et al., 2014). Interestingly, this type of 
fatigue in Parkinson's disease is significantly correlated with level of depression (Kluger 
et al., 2013). In summary, it seems that the type of fatigue generated by DA depletion, 
rather than a decline in muscle force, is more likely to reduce the capacity to sustain high 
levels of voluntary activation.  
The FST, is the classical animal test to evaluate antidepressant actions of different type 
of drugs (Armario et al., 1988; Lucki 1997). This test, traditionally, provides information 
about passive behaviors such as immobility (Porsolt et al, 1977), as a measure of 
behavioral despair or “giving up”, but it also can provide information about behaviors 
directed to the maintenance of vigorous and persistent active responding in order to 
escape (Gil and Armario, 1998). In fact, this test provides information about different 
parameters of behavioral activation such as climbing and swimming (Armario et al., 
1988; Gil and Armario, 1998; Slattery and Cryan, 2012). In the present setting, the 
administration of a broad range of TBZ doses that has previously been shown to reduce 
DA levels in ventral striatum of mice (López-Cruz et al, 2018), dose dependently 
produced a significant decrease in climbing (active behavior), and also increased time 
spent immobile, in the FST (Figure 8). Previous studies have shown that after chronic 
oral administration of TBZ by putting it in the food, the immobility of mice in the FST 
increased significantly (Wang et al, 2010). Moreover, D2 receptor antagonists not only 
increased immobility in rats, but also concurrently decreased active climbing (Gil and 
Armario, 1998; Li et al, 2005). Thus, DA depletion in the T-maze RW test (a test of 
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preference for rewarding stimuli with different vigor requirements), and also in the FST 
(a test of unescapable stress) (Armario and Nadal 2013), reduced behavioral activation.  
In addition, because aversive states such as stress and anxiety could be factors that play a 
role in T-maze procedures, and since it has been previously demonstrated that, in operant 
paradigms of effort-based choice in rats, acute stress decreased preference for the high-
effort reward (Shafiei et al., 2012), we performed a T-maze experiment in which we 
reduced the value of the RW by placing over it an intense light, like the one used in 
anxiety paradigms, thus making it more aversive. Indeed, animals spent less time running, 
and tended to spend more time engaging with the other two stimuli, although only eating 
was statistically significant. However, the pattern of results for the other two variables 
was quite different from the results found with TBZ: animals significantly reduced time 
spent in the RW compartment, and increased time spent in the other two compartments. 
They also increased entries into those other two compartments. Thus, animals not only 
reduced significantly the act of running, they also spent less time in close proximity of 
the RW, and explored the other two stimuli (not only the food) more.  Moreover, TBZ 
did not produce any significant effect on anxiety-related parameters, such as time spent 
in the lit chamber of the DL box, or time spent in the open arms of the EPM paradigm 
(Table 3). These results are in accordance with previous studies in which the 
administration of a high dose of TBZ (8.0 mg/kg) did not affect anxiety in the DL box 
(Correa et al, 2018), and administration of the D2 antagonist haloperidol did not produce 
any anxiogenic effect in mice assessed in the EPM paradigm (Pail et al, 2015). However, 
in the present studies, the administration of the two highest doses of TBZ (6.0 and 8.0 
mg/kg) significantly decreased the total number of crosses between compartments in the 
DL box, and total arm entries in the EMP paradigm. These are parameters that, while 
affected by the aversive nature of some areas in the paradigm, are considered to be more 
related to spontaneous locomotion.  
In summary, the present work confirms that the 3-choice T-maze task, in which rodents 
show a high preference for exercise, is sensitive to pharmacological and motivational 
manipulations, and that mice allocate their behavior from one stimulus to another 
depending on a number of different conditions. TBZ administration induces changes in 
preferences based on effort requirements, and those effects do not closely resemble 
changes in preference produced by altering the force requirements or enhancing the 
reinforcing value of food. While making the RW more aversive by shining a light on it 
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produced some effects that are similar to TBZ (e.g. reducing time spent running and 
increasing eating), these manipulations do not produce the same effects on other measures 
(e.g. time in RW compartment). TBZ also reduced climbing in the FST, indicating that 
TBZ generally reduces highly active behaviors. Numerous studies have reported that TBZ 
and DA antagonists affect effortful behaviors in rodents when animals have to work (lever 
pressing or climbing a barrier) in order to obtain a high-value reinforcer when they 
concurrently have a free low-value reinforcer (Nunes et al, 2013; Randall et al, 2014; 
Pardo et al, 2012, 2015; Yohn et al, 2015a,b, 2016a,b; Contreras-Mora et al, 2018; Correa 
et al, 2018; Rotolo et al, 2019; Yang et al, 2019). In conclusion, the 3-choice-T-maze task 
can evaluate preference for exercise and anergia induced by DA impaired function, and 
this task could have potential clinical relevance for modeling the psychomotor 
retardation, anergia, fatigue and the low effort bias seen in some human 
psychopathologies.  
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Abstract  
 
Nucleus Accumbens (Nacb) dopamine (DA) depletion induces anergia and fatigue in 
effort-based decision tasks in humans and animals. These motivational symptoms are 
seen in depression and are highly resistant to treatment. In these studies, we evaluated the 
effect of the catecholamine uptake blocker bupropion on its own, and after the 
administration of tetrabenazine (TBZ), a VMAT2 blocker that depletes DA, and induces 
depression in humans. These drugs were evaluated in male CD1 mice on a 3-choice-T-
maze task developed to assess preference between a reinforcer that requires voluntary 
behavioral activation (running wheel, RW) or other more sedentary reinforcers (sweet 
food pellets and a neutral non-social odor), and also in the forced swim test (FST), which 
measures behavioral activation in a stressful setting. Anxiety was also evaluated in the 
dark-light box (DL), and in the elevated plus maze (EPM). Bupropion increased selection 
of RW activity on the T-maze. TBZ reduced time running, but increased time-consuming 
sucrose, indicating an induction of fatigue but not an effect on primary sucrose 
motivation. In the FST, bupropion reduced immobility, increasing swimming and 
climbing, and TBZ produced the opposite effects. Bupropion reversed the effects of TBZ 
on the T-maze, on the FST, as well as the effects on pDARPP32-Thr34 and pDARPP32-
Thr75 in Nacb core as assessed with immunohistochemistry and western blotting. None 
of these manipulations affected anxiety-related parameters. Thus, bupropion shows 
antidepressant properties in traditional animal models like the FST, but also in the T-maze 
task, which could be useful for assessing preferences based on effort requirements. 
 
Bupropion, dopamine, motivation, effort, depression, nucleus accumbens, rodent 
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Introduction 
Psychiatric pathologies such as depression are characterized not only by emotional and 
cognitive symptoms, but also by motivational deficiencies that lead to manifestations 
such as psychomotor symptomatology including anergia, psychomotor slowing, fatigue 
and lassitude (Stahl, 2002; Demyttenaere et al, 2005; Treadway and Zald, 2011; Fava et 
al, 2014; Barch et al, 2016; Salamone et al, 2016c). Many times, these symptoms are not 
considered central for depression, but clinical data shows how their severity limits long 
term functional outcomes, producing problems with employment and social functions 
(Fava et al, 2014; Rostchild et al, 2014; Salamone et al, 2007; Chong et al, 2016). People 
with major depression have deficits in the exertion of effort, reward seeking and effort-
related decision making that do not change the experience of pleasure in response to 
primary stimuli (Treadway and Zald, 2011; Argyropoulos and Nutt, 2013; Pizzagalli, 
2014; Knowland and Lim, 2018).  
There are many evidences pointing to the implication of the mesolimbic dopamine (DA) 
circuit, in particular nucleus accumbens (Nacb), as the neural basis of effort-related 
dysfunctions in depression (Caligiuri and Ellwagner, 2000; Schmidt et al, 2001; Volkow 
et al, 2001; Salamone et al, 2007, 2016c, 2018). In animal models, the administration of 
the vesicular monoamine transporter type-2 (VMAT-2) blocker and DA depleting agent 
tetrabenazine (TBZ) produces motivational anergia, which shifts behavior from high 
demanding options to obtain highly preferred reinforcers, towards low-effort ones, 
obtaining in consequence, less valued reinforcers (Nunes et al, 2013; Randall et al, 2012; 
Pardo et al., 2015a; Yohn et al, 2015a, 2016a; Correa et al., 2018; López-Cruz et al, 2018; 
Rotolo et al, 2019). Moreover, TBZ has been reported to induce depressive symptoms in 
humans (Frank, 2009; Guay et al, 2010), and has also been used in classical animal 
models of depression (Jang et al, 2009; Wang et al, 2010; Carratalá-Ros et al, 2020).  
Moreover, it has been shown that blockade of the DA transporter (DAT), that leads to the 
increase of extracellular DA, can improve motivational symptoms in depressed patients 
(Patkar et al, 2006; Goss et al, 2013; Malhi et al, 2016). Thus, the catecholamine uptake 
inhibitor bupropion has demonstrated efficacy to treat depression (Feighner et al, 1986; 
Kiev et al, 1994; Weihs et al, 2000; Pae et al., 2007; Papakostas et al, 2006; Cooper et al, 
2014). Its main mechanism of action is to block DAT, and it shows low potential to 
produce abuse in humans (Nutt et al 2007; Learned-Coughlin et al, 2003; Sthal et al, 
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2004), and in rodents (Mori et al, 2013). In addition, it has been shown that this DAT 
blocker increases extracellular DA and DA-singal transduction in Nacb (Randall et al, 
2014a). The enhancement of DA transmission can reverse effort-decision making 
impairments (Salamone et al, 2007; Floresco et al, 2008; Mai et al, 2012; Hosking et al, 
2015; Salamone et al, 2016b; Salamone et al, 2016c; Yohn et al, 2015a,b; Yohn et al, 
2016a,b; Rotolo et al, 2019). Thus, in PROG/chow or FR5/chow feeding tasks, bupropion 
was able to alleviate and reverse the effects produced by TBZ, increasing the effort to 
work in order to obtain a preferred food (Randall et al, 2014a; Yohn et al, 2015a,b, 2016a). 
Moreover, this DAT inhibitor has been also used in classical paradigms to assess 
antidepressant effects of drugs, such as the forced swim test (FST; Porsolt et al., 1977). 
This paradigm requires a stressful and non-escapable setting in which naïve rodents at 
first try to actively scape, but after a while they give up and remain immobile, mainly 
flouting. All these behaviors can be improved by different categories of antidepressants 
drugs (Porsolt et al, 1977; Armario et al, 1988; Lucki, 1997). It seems that active 
behaviors are more likely to be affected by DA manipulations than the traditional 
immobility measure (Gil and Armario, 1998; Costa et al, 2013). Thus, bupropion has anti-
immobility effects in mice and rats (Yamada et al, 2004; Kitamura et al, 2010; Yuen et 
al, 2017), and also increases swimming and climbing (Yuen et al, 2017; Hayashi et al, 
2011; Rénéric and Lucki, 1998). 
In evaluating effort-based decision-making processes in humans and in rodent models, 
lever pressing is the most commonly used work requirement (Treadway et al, 2012; 
Randall et al, 2014b; Yohn et al, 2015; 2016a). However, more hole-body physical 
behaviors such as rearing, barrier climbing or wheel running can be used as the 
requirement to get access to the most preferred reinforcer, or even as the more preferred 
activity (Correa et al, 2016). Physical activities can require high levels of performance 
and endurance, but they also can have intrinsic motivational properties (Belke et al, 2005; 
Belke and Pierce, 2014). One of the most commonly studied voluntary physical activities 
in rodent models is wheel running, which can be performed under non-stressed 
conditions, and according to the rhythmicity of the animal. Mice run spontaneously when 
given access to running wheels and, depending on the strain, they can run for a total 
distance of up to 20 km per day and a total activity time of around 3 to 7 hours a day 
(Manzanares et al, 2018). Thus, wheel running can be used as the highly preferred and 
highly demanding choice in relation to other less preferred but less effort demanding 
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alternatives, such as consumption of palatable food or drugs of abuse (Premack and 
Premack, 1963; McMillan et al, 1995; Mueller et al, 1997; Cosgrove et al, 2002; Correa 
et al, 2016; López-Cruz et al, 2018; Carratalá-Ros et al, 2020; Presby et al, 2020). 
However, little is known about the neural mechanisms involved in the decision-making 
processes that establish those preferences for vigorous physically demanding behaviors.  
In view of these premises, the present study explores the impact of the DAT inhibitor, 
bupropion, administered alone or in combination with the DA depleting agent TBZ, in 
the 3-choice T-maze task which uses voluntary exercise in a running wheel as the most 
preferred but high effort demanding option in competition with less preferred but more 
sedentary options such as consumption of high-sucrose containing food or sniffing floral 
odors (Correa et al, 2016; López-Cruz et al, 2018; Carratalá-Ros et al, 2020). We compare 
the impact of bupropion alone or after TBZ administration, on spontaneous preference in 
non-deprived animals and under non-stressful conditions, with the impact of the same 
doses of bupropion on the FST. Moreover, we assess if the present pharmacological 
manipulations have an impact on anxiety-related behaviors in classical rodent models 
(dark and light box; DL box and the elevated plus maze: EPM). Finally, an additional 
experiment studies how the most effective dose of bupropion on these behaviors, affects 
DA receptor dependent metabotropic markers in one of the main sub-regions of Nacb 
(core) using immunochemistry and western blotting methods.  
 
Materials and Methods 
 
Animals. CD1 adult male mice (N=102) purchased from Janvier, France S.A. were 8-14 
weeks old (40-50 g) at the beginning of the study. Mice were housed in groups of three 
or four per cage, with standard laboratory rodent chow and tap water available ad libitum. 
The colony was kept at a temperature of 22 +  2 ºC with lights on from 08:00 to 20:00 h. 
All animals were under a protocol approved by the Institutional Animal Care and Use 
committee of Universitat Jaume I. All experimental procedures complied with directive 
2010/63/EU of the European Parliament and of the Council, and with the “Guidelines for 
the Care and Use of Mammals in Neuroscience and Behavioral Research”, National 
Research Council 2003, USA. All efforts were made to minimize animal suffering, and 
to reduce the number of animals used. 
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Pharmacological agents. The catecholamine uptake inhibitor bupropion hydrochloride 
(Alfa Aesar, Spain) was dissolved in 0.9% saline, which also served as the vehicle control 
for these studies. Bupropion was administered 30 minutes before the test started. Doses 
and times were selected from previous work in our laboratory (Randall et al, 2014a,b; 
Yohn et al, 2015a) and from studies with the forced swim test  (Yamada et al, 2004; 
Kitamura et al, 2010). The VMAT-2 inhibitor tetrabenazine (TBZ, CIMYT Quimica SL, 
Spain) was dissolved in a solution of 0.9% saline (80%) plus dimethylsulfoxide (DMSO 
20%, final pH 5.5) and administered 120 min before testing. The vehicle solution of 20% 
DMSO and saline was used as the vehicle control for TBZ. Time and doses were selected 
based on previous work (López-Cruz et al, 2018; Correa et al, 2018; Carratalá-Ros et al, 
2020). All drugs were administered intraperitoneally (IP). 
 
Testing procedures 
All behavioral procedures started two hours after light period onset. The behavioral test 
room was illuminated with a soft light, and external noise was attenuated. 
T-maze RW-sucrose-odor choice task. The T-maze apparatus (25 cm L x 11 cm W x 
30 cm H) consisted of a central area that lead to 3 arms (based on Correa et al, 2016). 
Each arm provided of different type of stimuli. In one of them, sweet pellets (TestDietTM, 
50% sucrose, 45 mg each) were available, in another arm there was a RW, and in the third 
arm there was a hole with a cotton ball socked with a neutral non-social odor (López-
Cruz et al, 2018; Carratalá-Ros et al, 2020). Training as well as test sessions lasted 15 
minutes. Mice were trained 5 days a week. Training phase 1: to avoid neophobia to the 
sweet tasting pellets, animals were enclosed in that arm with the food during 5 sessions. 
Training phase 2: during 2 more weeks animals were exposed, one 15 min session a day 
to the T-maze with free access to the three stimuli. Test phase: This phase lasted during 
4 or 5 more weeks depending on the experiment. For each week there were 4 baseline 
days plus a testing session in which animals received drug injections. Test sessions were 
videotaped and a trained observer manually registered several parameters. Time 
interacting with each of the stimulus was selected as the main dependent measure because 
it allowed for the evaluation of the three stimuli with the same units. Time allocation is a 
useful measure of preference, relative reinforcement value, and response choice (Baum 
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and Rachlin, 1969). Entries into the arms and time spent in the arms of the T-maze were 
simultaneously recorded. All these measures were taken based on previous studies 
(Correa et al., 2016; López-Cruz et al, 2018; Carratalá-Ros et al, 2020). 
Forced swim test (FST). This paradigm is considered to be a model of behavioral despair 
and is used as a test for assessing depressive-like states and for evaluating drugs with 
potential as antidepressants (Porsolt et al, 1977). Immobility was defined when the animal 
remained motionless, making only minor movements to balance the body and keep the 
head above the water. In addition, we also assessed escape related mobility behavior such 
climbing or struggling (Armario et al, 1988). Climbing is defined as any energetic and 
vertical movement of all four limbs against the wall of the tank. Mild swimming was 
recorded when animals carried out horizontal movements with their forepaws, leading to 
the displacement of the body throughout the swim chamber (Armario et al, 1988). Naïve 
mice were placed in a transparent cylindrical glass tank (26 cm high and 18 cm diameter) 
filled with water (14 cm) and maintained at a temperature of 25ºC. Water was changed 
between animals. During the 6 minutes test, mice were videotaped from the side, and 
climbing, immobility and mild swimming were later measured by an observer unaware 
of the experimental condition. After the test, mice were dried with a soft towel, put back 
in a box with absorbing paper under a warming light, and were monitored for 10 minutes.  
Dark and light box (DL). The DL test is based on the conflict between the tendency to 
explore a novel environment and the avoidance of a brightly lighted open area (Blumstein 
and Crawley 1983). The DL apparatus consisted of a polypropylene chamber divided in 
two compartments by a partition containing a small opening (5 cm H x 5 cm W). The 
light compartment (25 cm W x 25 cm H x 25 cm L) was open, painted in white and 
illuminated (335 lx), while the dark compartment (25 cm W x 25 cm H x 18 cm L) was 
painted in black and had a removable ceiling to close it. To start the test session, mice 
were individually placed in the dark chamber facing one corner. Test sessions were 
videotaped, and the total number of crosses and the total time spent in the lit chamber 
were recorded for 5 min (procedure is based on López-Cruz et al, 2017). 
Elevated plus maze (EPM). After being in the DL box for 5 minutes, animals were 
placed in the EPM for 5 more minutes. The EPM consists of two open and two enclosed 
arms (65 cm L x 5 cm W) arranged in a plus configuration and intersecting in a central 
platform. It is made of black polypropylene and is elevated 50 cm above the floor. The 
open arms have a 1 cm border around their perimeter and the closed arms have a 20 cm 
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translucent wall. This anxiety paradigm measures the avoidance that rodents show to high 
open spaces. Under normal conditions, mice spend more time, and make more entries into 
the closed arms of the maze (Lister, 1987). Animals were placed in the central platform 
with their head pointing at one enclosed arm, and they were assessed during 5 minutes. 
Sessions were videotaped and a trained observer registered total time spent in the open 
arms and total number of entries in the four arms as an index of locomotion. An entry into 
an arm was recorded when the animal crossed with all four legs the line that connected 
that arm with the central platform (procedure is based on López-Cruz et al, 2017). 
Immunohistochemistry for phosphorylated DA and c-AMP related phosphoprotein-
32 kDaltons (pDARPP-32). After drug treatments, animals were anesthetized with CO2 
and transcardially perfused with 0.9% physiological saline for 5 min, followed by 
perfusion with 3.7% formaldehyde for 5 min and brains were extracted. Tissue was fixed 
in 3.7% formaldehyde overnight and moved to 30% sucrose cryo-protectant. Then 40-um 
sections were cut using a cryostat. To measure the immunoreactivity to phosphorylated 
DA and c-AMP-regulated phosphoprotein 32kDa (pDARPP-32) nonspecific binding 
sites were blocked with a solution of 3% H202 for 30 min at room temperature following 
then with 1% bovine serum albumin and 0.1% Triton X-100 in PBS for 1 hour at room 
temperature. Phosphorilated DARPP-32 immunoreactivity was visualized with a 
polyclonal rabbit antibody for pDARPP-32 phosphorilated at threonine 34 residue 
(Thr34, 1:1000; Santa Cruz Biotechnology) or polyclonal rabbit antibody for pDARPP-
32 phosphorilated at threonine 75 residue (Thr75, 1:500, Santa Cruz Biotechnology). 
These antibodies were dissolved in solutions that also contained 0.1% bovine serum 
albumin and 0.1 Triton X-100 in PBS for 24 h incubation on a rotating shaker at 4ºC. 
After the primary antibody treatment, the sections were rinsed in PBS (3 times for 5 min) 
and incubated in the secondary antibody, anti-rabbit HRP conjugate envision plus 
(DAKO) for 1hour and 30 minutes on a rotating shaker at room temperature. Finally, 
sections were washed and rinsed for 3-5 min in 3,3’ diaminobenzidine chromagen. The 
sections were then mounted to gelatin-coated slides, air dried and coverslipped using 
Eukitt quick-hardening (Sigma-Aldrich) as a mounting medium. The tissue was then 
examined by light microscopy.  
 
Quantification of the number of cells that express immunoreactivity for pDARPP-32 
(Thr34) and pDARPP-32 (Thr75) in the Nacb was performed by photographing the 
73 
 
sections with a 20X (0.125 mm2 / field) objective (Eclipse E600; Nikon) upright 
microscope equipped with a Leica DFC 450C camera (Leica Microsystems) and captured 
digitally using LASX software. Cells that were positively labeled for pDARPP-32 
(Thr34) and pDARPP-32 (Thr75) were quantified with ImageJ software (version 1.51) 
and a macro written to automate particle counting within the region of interest. The size 
of the region of interest was 1000 x 1000 um. For each animal, cell counts were at levels 
that correspond to 0.70-1.70 mm anterior to bregma (Paxinos and Watson, 1997) 
bilaterally from at least three sections and counts were averaged across slides and 
sections.  
Immunofluorescence double-labeling studies for pDARPP-32(Thr75) and 
enkephalin. Free floating coronal sections of brains (40 um) were serially cut using a 
cryostat and rinsed in 0.01M PB. To measure the immunoreactivity to pDARPP-32, 
nonspecific binding sites were blocked and cells were permeabilized in a solution 
containing 0.3% T.X and 5% of goat serum in PBS for 30 min at room temperature on a 
rotating platform before primary antibody incubation. pDARPP-32 immunoreactivity 
was visualized with a polyclonal rabbit antibody for pDARPP-32(Thr75) (1:200; Aviva 
Systems). pDARPP-32(Thr75) was double labeled with a primary antibody for 
enkephalin (goat polyclonal, 1:800; Origene). These antibodies were dissolved in 
solutions that also contained 5% goat serum and 0.3% T.X in PBS for 24h incubation on 
a rotating shaker at 4ºC. After the primary antibody treatment, the sections were rinsed in 
PBST (6 times for 10 min) and incubated in the secondary antibody solution containing 
donkey anti-rabbit Alexa Fluor 488 (1:350, Life Technologies) or donkey anti-guinea pig 
Alexa 647 (1:350, Abcam). These antibodies were dissolved in solutions that also 
contained 5% goat serum and 0.3% T.X in PBS for 2h incubation on a rotating shaker at 
room temperature. The sections were then mounted to gelatin-coated slides, dried and 
coverslipped using Mowiol (Abcam). Immunofluorescence staining was visualized for 
high-resolution observation on a confocal microscope (Leica DMI8, Leica Microsystems 
CMS GmbH, Wetlar Germany). 
Western Blotting for phosphorylated DA and c-AMP related phosphoprotein-32 
kDaltons (pDARPP-32). After drug treatments, animals were anesthetized with CO2, 
decapitated and brains were extracted. Fresh striatal tissue samples were homogenized in 
ice-cold lysis buffer (130Mm NaCl, 20Mm Tris-Hcl at Ph 8.0, and 1% Nonidet P40), 
containing protease inhibitors (10 ug/ml of aprotinin, 20ug/ml of leupetine, and 1Mm 
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PMSF) as well as phosphatase inhibitors (10 Mm NaF, 1Mm sodium orthovanade and 
10Mm DTT). Homogenates were centrifuged at 13000 rpm for 15 min at 4ºC. Aliquots 
of supernatants were collected and used Bradford quantification of total protein. Every 
sample was boiled for 3 min for protein denaturation. Equal amounts (30ug) of striatum 
protein samples were separated by 12.5% SDS-PAGE and transferred to nitrocellulose 
membrane (Bio-rad) for 90 min at 30V. Filtering membranes were incubated in 5% of 
Bovine Serum Albumin (BSA, Sigma-Aldrich) dissolved in TBS-T (Tris Base 200Mm 
and 5M NaCl) containing 0.1% Tween 20, and then incubated overnight at 4ºC with 
polyclonal rabbit anti-DARPP32-Thr75 antibody (1:500, Cell Signaling). Membranes 
were probed with Anti-actin polyclonal antibody (1:500, Abcam), as an internal standard 
for protein quantification. After rinses with TBS-T buffer, membranes were incubated 
with goat anti-rabbit IG secondary antibody coupled to HRP (1:20000, Bio-rad) during 
1h and developed by enhanced chemiluminescence system (1:40, ThermoFisher 
Scientific). The membranes were exposed to Image Quant LAS 4000 (Leica). The relative 
densities of brands were analyzed using ImageJ software. Every sample was replicated at 
least twice to ensure the reproducibility of the method.  
 
Experiments 
Experiment 1. Effect of bupropion on preference for reinforcers as measured in the 
3-choice-T-maze task. After reaching stable baseline level of performance in the T-maze 
task, animals (N=14) received a dose of BUP (0, 5, 10 and 15mg/kg) and were placed to 
the paradigm during 15 minutes. Animals received one dose of the drug every week in a 
randomly varied order. The T-maze paradigm requires a baseline performance of two 
weeks before tests start, and that performance is maintained across weeks, thus allowing 
a repeated measures design. 
Experiment 2. Effect of bupropion in combination with TBZ on preference for 
reinforcers as measured in the 3-chgoice-T-maze task. A new group of mice (N=13) 
received TBZ (veh, 8 mg/kg) and 90 minutes later (30 minutes before they were placed 
in the T-maze during 15 minutes), they received a dose of bupropion (5, 10 and 15 mg/kg).  
Animals received one drug combination (veh-veh, TBZ-veh, TBZ-5, TBZ-10 and TBZ-
15 mg/kg) every week during 5 weeks in a random varied order.  
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Experiment 3. Effect of bupropion on FST performance. Animals (N=40) received 
one dose of bupropion (vehicle, 5, 10 or 15 mg/kg) and 30 min after the injection were 
placed in the FST during 6 minutes. Mice were exposed only once to the FST since 
behavioral habituation develops in one session. 
Experiment 4. Effect of bupropion in combination with TBZ on FST performance. 
Three groups of naïve mice (N=35) received a combination of TBZ (8 mg/kg, a dose that 
had demonstrated to be effective in the FST) (Carratalá-Ros et al, 2020) plus vehicle or 
the most effective dose of bupropion (10 mg/kg) or the combination of both vehicles. 
Bupropion was given 90 minutes after TBZ and 30 minutes before animals were placed 
in the FST. 
Experiment 5. Effect of bupropion on anxiety parameters as measured in the DL 
and EPM paradigms. Mice (N=40) received one dose of bupropion (vehicle, 5, 10 or 15 
mg/kg) and 30 min after injection were first placed in the DL box for 5 minutes. 
Immediately after this test, they were placed in the EPM for 5 more minutes. Mice were 
exposed only once to both paradigms, since behavioral habituation develops in one 
session. 
Experiment 6. Effect of bupropion in combination with TBZ on anxiety parameters 
as measured in the DL and EPM paradigms. Three groups of naïve mice (N=35) 
received a combination of TBZ (8 mg/kg) plus vehicle or the most effective dose of 
bupropion (10 mg/kg) or the combination of both vehicles. Bupropion was given 90 
minutes after TBZ and 30 minutes before animals were placed in the DL box for 5 
minutes, and immediately after this test, they were placed in the EPM for 5 more minutes.  
Experiment 7. Effect of bupropion in combination with TBZ on DARPP-32 
phosphorylation patters in Nacb as measured by immunohistochemistry. Mice 
(N=16) received veh-veh, TBZ-veh, or TBZ-10 mg/kg, 2 hours before perfusion. Coronal 
sections were analyzed by immunochemistry for pDARPP-32 (Thr34) and pDARPP-32 
(Thr75).  
 
Experiment 8.  Effect of TBZ on pDARPP-32(Thr75) levels in ventral striatum as 
measured by western blot. Mice (N=18) received DMSO or 8 mg/kg TBZ 120 min 
76 
 
before brain extraction. Striatum samples were analyzed by western blotting for 
pDARPP-32(Thr75).  
 
Statistical Analyses. Normally distributed data (according to Kolmogorov-Smirnov test) 
in the T-maze experiment followed a within groups design. Thus, in the bupropion 
experiment, data were analyzed by repeated measures ANOVA. Normally distributed and 
homogenous data for the FST, DL, and EPM experiments employed a between groups 
design and data were analyzed by one-way ANOVA. Immunohistochemical studies were 
analyzed by one-way ANOVA. When the overall ANOVA was significant, non-
orthogonal planned comparisons using the overall error term were used to compare each 
treatment with the vehicle control group (Keppel, 1991). For these comparisons, α level 
was kept at 0.05 because the number of comparisons was restricted to the number of 
treatments minus one. Western blotting data were analyzed by a Student t-test analysis 
for independent samples. All data were expressed as mean ± SEM, and significance was 
set at p<0.05. STATISTICA 7 software was used. 
 
Results 
Experiment 1. Effect of bupropion on preference for reinforcers as measured in the 
3-choice-T-maze task. The repeated measures ANOVA showed that bupropion did not 
produce any significant effect on time spent eating the sucrose pellets (F(3,39)=2.38, 
p=0.08), or time sniffing the neutral odor  (F(3,39)=0.45, p=0.71) (Fig 1A and 1C). 
However, bupropion produced a significant effect on time running in the RW 
(F(3,39)=3.26, p<0.05). Planned comparisons revealed that all doses of bupropion (5, 10 
and 15 mg/kg) significantly increased time running in the RW (p<0.05 for the two lower 
doses and p<0.01 for the highest one) compared to the vehicle group (Figure 1B). 
Moreover, repeated measures ANOVA also showed a significant effect of bupropion on 
time spent in the RW compartment (F(3,39)=4.35, p<0.01), and time spent in the food 
compartment (F(3,39)=3.92, p<0.01). However, there was no significant effect of 
bupropion on time spent in the neutral odor compartment (F(3,39)=1.78, p=0.16) (Figure 
2E). Planned comparisons showed that all doses of bupropion increased time spent in the 
RW compartment in comparison with the vehicle group (10 mg/kg p<0.05, and 5 and 15 
mg/kg p<0.01). Similarly, bupropion-treated mice spent less time in the sucrose pellets 
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compartment in comparison with the vehicle group (10 mg/kg p<0.05, and 5 and 15 
mg/kg p<0.01). Finally, the catecholamine blocker did not produce significant differences 
in the number of entries into the food compartment (F(3,39)=1.39, p=0.42), entries to the 
RW compartment (F(3,39)=1.39, p=0.25), or entries to the neutral odor compartment 
(F(3,39)=0.13, p=0.93) (Figure 1D). 
 
 
Figure 1. Effect of bupropion (vehicle, 5, 10 and 15 mg/kg) on time eating (A), time running (B), 
time sniffing (C), entries into compartments (D), and time spent in each compartment (E) of the 
T-maze task assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated seconds 
or number of entries. *p<0.05, **p<0.01 significantly different from vehicle.  
 
Experiment 2. Effect of bupropion in combination with TBZ on preference for 
reinforcers as measured in the 3-choice-T-maze task. Repeated measures ANOVA 
resulted in a significant effect of treatment on time spent eating the sucrose pellets 
(F(4,48)=4.60, p<0.01). Planned comparisons revealed the TBZ plus vehicle increased 
the time animals spent eating sucrose pellets (p<0.05) compared to vehicle, and all doses 
of bupropion were able to decrease significantly time consuming the food (p<0.01) in 
comparison with the TBZ-vehicle condition (Figure 2A). In addition, repeated measures 
ANOVA also show a significant effect of treatment on time running in the RW 
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(F(4,48)=3.06, p<0.05). Planned comparisons revealed that the TBZ-vehicle condition 
significantly reduced time running in the RW (p<0.05) in comparison with the vehicle-
vehicle condition, but 10 mg/kg of bupropion reversed that effect, increasing time running 
in the RW when compared to the TBZ-treated condition (p<0.01) (Figure 2B). However, 
the repeated measures ANOVA did not produced a significant effect on sniffing the 
neutral odor F(4,48)=0.54, p=0.70) (Figure 2C).  
Repeated measures ANOVA did not show a significant effect of treatment on time spent 
in the RW compartment (F(4,48)=1.93, p=0.11), or time spent in the neutral odor 
compartment (F(4,48)=0.91, p=0.46) (Data are shown in figure 2E). However, there was 
a significant effect on time spent in the food compartment (F(4,48)=4.04, p<0.01). 
Planned comparisons showed TBZ-vehicle treated mice spent more time in the food 
compartment in comparison with the vehicle-vehicle group (p<0.05), and all doses of 
bupropion (5, 10 and 15 mg/kg) reversed this effect when compared with the TBZ-vehicle 
treatment (p<0.01). Finally, repeated measures ANOVA analyzing the dependent variable 
entries in compartment did not show a significant effect of treatment on total number of 
entries to the food compartment (F(4,48)=1.48, p=0.22), or to the neutral odor 
compartment (F(4,48)=2.48, p=0.06) (Figure 2D). However, there was a significant effect 
of bupropion and TBZ combination on total entries to the RW compartment 
(F(4,48)=2.92, p<0.05), and planned comparisons showed that TBZ-10 mg/kg of 
bupropion treated mice decreased number of entries to the RW compartment in 
comparison with the vehicle-vehicle treatment (p<0.01).  
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Figure 2. Effect of TBZ (vehicle or 8 mg/kg) plus bupropion (vehicle, 5, 10 and 15 mg/kg) 
combination on time eating (A), time running (B), time sniffing (C), entries into compartments 
(D), and time spent in each compartment (E) of the T-maze task assessed during 15 minutes. Bars 
represent mean ± S.E.M. of accumulated seconds or number of entries. *p<0.05, **p<0.01 
significantly different from Vehicle-Vehicle. ##p<0.01 significantly different from TBZ-Veh. 
 
 
Experiment 3. Effect of bupropion on FST performance. The one-way ANOVA’s for 
the different dependent variables showed a significant effect on time spent immobile 
(F(3,36)=7.27, p<0.01), time spent swimming (F(3,36)=5.47, p<0.01), and time spent 
climbing (F(3,36)=2.77, p<0.05) in the FST. Planned comparisons revealed that all the 
groups that received bupropion (5, 10 and 15 mg/kg) displayed significantly less time 
immobile (p<0.01), and spent more time swimming (p<0.05 for 10 mg/kg and p<0.01 for 
5 and 15 mg/kg) in comparison with the vehicle group. However, only the group that 
received 10 mg/kg of bupropion displayed more time climbing than the vehicle group 
(p<0.01) (Fig. 3A).  
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Experiment 4. Effect of bupropion in combination with TBZ on FST performance. 
A series of one-way ANOVA’s showed a significant effect of bupropion on immobility 
(F(2,32)=13.98, p<0.01), swimming (F(2,32)=7.65, p<0.01), and climbing 
(F(2,32)=4.56, p<0.01). Planned comparisons revealed that TBZ-treated mice spent more 
time immobile (p<0.01), and less time swimming and climbing (p<0.05) in comparison 
with the vehicle group. Moreover, bupropion was able to reverse these effects, and mice 
that received the combination of TBZ (8 mg/kg) and bupropion (10 mg/kg) spent less 
time immobile, increased time swimming and climbing (all p<0.01) in comparison with 
TBZ-treated mice (Fig. 3B).  
 
Figure 3. Effect of bupropion (vehicle, 5, 10 or 15 mg/kg) (A) and TBZ plus bupropion 
combination (Vehicle+Vehicle, 8 mg/kg TBZ+Vehicle, or 8 mg/kg TBZ and 10 mg/kg 
bupropion) (B) on duration of immobility, swimming and climbing behavior in the FST assessed 
during 6 minutes. Bars represent mean ± S.E.M. of accumulated seconds. *p<0.05, **p<0.01 
significantly different from vehicle or vehicle-vehicle. ##p<0.01 significantly different from 
TBZ-Veh. 
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Experiment 5. Effect of bupropion on anxiety parameters as measured in the DL 
and EPM paradigms. The one-way ANOVA’s for the different dependent variables in 
the anxiety paradigms did not show significant effects of bupropion on time spent in the 
illuminated arena (F(3,37)=0.74, p=0.53) or total of entries between the lit chamber and 
the dark chamber (F(3,37)=0.27, p=0.84) of the DL box (Table 1). Moreover, bupropion 
did not affect significantly time spent in the open arms of the EPM paradigm 
(F(3,33)=2.34, p=0.09), although there was a significant effect on total number of entries 
to all arms (F(3,33)=6.23, p<0.01) in the EPM. Planned comparisons showed that the 
highest dose of bupropion (15 mg/kg) increased significantly total of entries to all arms 
of the EPM (p<0.01) in comparison with the vehicle group. 
 
 Bupropion (mg/kg) 
DL box Vehicle 5 10 15 
Time in the lit 
chamber (sec) 
128.8 ± 8.6 117.8 ± 13.1 116.9 ± 10.1 106.3 ± 12.8 
Crosses between 
compartments 
27.0 ± 2.3 25.4 ± 2.8 24.8 ± 4.0 28.9 ± 4.5 
 
EPM 
    
Time in open 
arms (sec) 
83.6 ± 11.8 49.3 ± 10.8 82.8 ± 9.8 60.5 ± 7.4 
Entries to all arms 17.6 ± 2.3 13.0 ± 2.2 17.5 ± 2.5 27.0 ± 1.1** 
 
Table 1. Effect of bupropion on mice behavior in the Dark and Light Box (DL) and Elevated 
Plus Maze (EPM). Every test lasted 5 minutes. Mean (± SEM) seconds or frequency. **p<0.01 
significantly different from vehicle.  
 
Experiment 6. Effect of bupropion in combination with TBZ on anxiety parameters 
as measured in the DL and EPM paradigms. The one-way ANOVA’s did not show 
any significant effect of the treatment on time spent in the lit chamber of the DL box 
(F(2,28)=0.35, p=0.70), but the treatment produced a significant effect on the total of 
crosses between compartments (F(2,28)=5.57, p<0.01) of the DL box. Planned 
comparisons revealed that TBZ treatment decreased significantly the total of entries 
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between compartments in the DL box both in the TBZ-vehicle (p<0.01) and in the TBZ-
bupropion (10 mg/kg) condition (p<0.05) in comparison with the vehicle-vehicle group 
(Table 2).  
The one-way ANOVA’s for the variables evaluated in the EPM showed that the treatment 
produced no significant effect on time spent in the open arms (F(2,26)=2.70, p=0.08), 
although it produced a significant effect on the total number of entries to all arms 
(F(2,26)=6.67, p<0.01). Planned comparisons indicated that both groups treated with 
TBZ showed reduced locomotion; TBZ plus vehicle (p<0.01) and TBZ plus10 mg/kg 
bupropion (p<0.05) in comparison with the vehicle-vehicle group.  
 
DL box Vehicle/Vehicle TBZ/ Vehicle 
TBZ/ Bupropion 
10 mg/kg 
Time in the lit 
chamber (sec) 
125.6 ± 6.2 117.1 ± 11.5 111.3 ± 13.8 
Crosses between 
compartments 
23.6 ± 1.7 12.6 ± 1.5** 17.2 ± 2.2* 
 
EPM 
   
Time in open arms 
(sec) 
73.3 ± 17.4 100.5 ± 14.3 61.0 ± 8.7 
Entries to all arms 19.0 ± 1.4 10.6 ± 1.6** 13.9 ± 1.3* 
 
Table 2. Effect of TBZ and BUP combination on mice behavior in the Dark and Light Box and 
Elevated Plus Maze. Every test lasted 5 minutes. Mean (± SEM) seconds or frequency. *p<0.05, 
**p<0.01 significantly different from vehicle. 
 
Experiment 7. Effect of bupropion in combination with TBZ on DARPP-32 
phosphorylation patters in Nacb as measured by immunohistochemistry. One way 
ANOVA’s showed an overall effect of treatment on pDARPP-32(Thr34) in Nacb core 
(F(2,11)=18.35, p<0.01). Planned comparisons revealed that the administration of 8 
mg/kg TBZ increased significantly phosphorylation of DARPP-32(Thr34) in Nacb core 
(p<0.01) in comparison with the vehicle-vehicle group. TBZ plus bupropion (10 mg/kg) 
was significantly different from the TBZ-vehicle group (p<0.05) (Figure 4). However, 
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there was no significant effect of treatment on pDARPP-32(Thr75) (F(2,12)=1.31, 
p=0.30) (Figure 4).  
 
Figure 4. Effect of TBZ and bupropion combination (Vehicle+Vehicle, 8 mg/kg TBZ+Vehicle, 
8 mg/kg TBZ+10 mg/kg bupropion) on number of cells counts positive for pDARPP-32(Thr34) 
and pDARPP-32(Thr75) immunoreactivity on Nacb core. Left: photomicrographs of individual 
representative brains. Right: mean ± S.E.M of number of pDARPP-32-(Thr34) counts in a 
100um2 ROI. **p<0.01 significantly different from Vehicle+Vehicle. ##p<0.01 significant 
difference from TBZ-Vehicle. 
 
Experiment 8. Effect of TBZ on pDARPP-32(Thr75) levels in ventral striatum as 
measured by western blot. The Student t-test for independent samples did not show a 
significant effect of treatment on pDARPP-32(Thr75) when analyzed by western blotting 
(t(16)=1.27, p=0.22) (Figure 6). 
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Figure 6. Effect of TBZ (Vehicle+Vehicle and 8 mg/kg TBZ+Vehicle) on pDARPP-32 (Thr75) 
protein level in ventral striatum. Data are expressed as mean ± S.E.M of density units of pDARPP-
32 (Thr75). Lower part: representative western blots showing two bands corresponding to actin 
(molecular weight of 42 kDa), and pDARPP-32(Thr75) (molecular weight of 32kDa). Each line 
contains 30ug of ventral striatum homogenates taken as tissue punctures represented in the 
coronal brain sections. 
 
 
Figure 5.  Top: Photomicrographs of pDARPP-32(Thr75) staining in nucleus accumbens core, 
showing representative mice treated with 8 mg/kg TBZ. Images were taken at 20x magnification. 
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Figure 6.  Top: Photomicrographs of pDARPP-32(Thr75) staining in nucleus accumbens core, 
showing representative mice after administration of different treatments. Images were taken at 
20x.  Scale bar: 200um.  
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Figure 7. pDARPP-32(Thr75) is colocalized with enkephalin immunofluorescence activity. 
Images were taken at 40x.  Scale bar: 20um.  
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Discussion 
The current studies examined the ability of the DAT inhibitor bupropion to produce an 
effect on selection of active reinforcers assessed in a novel 3-choice-T-maze-task that 
provides information about the choice between highly and active physical activity vs. 
other sources of reinforcement that could be obtained with little effort. Those studies were 
compared with additional experiments that examined how bupropion was able to 
modulate behavioral activation in the FST, a classical paradigm that evaluates how 
antidepressant drugs potentiate behaviors to scape a stressful unescapable environment, 
interpreted as depression-like behaviors. Moreover, we also assessed if the same 
pharmacological manipulations have an impact on emotional parameters assessed in the 
DL box and EPM paradigm, used to evaluate anxiety-like behaviors. In addition, in order 
to know the ability of bupropion to alleviate fatigue and behavioral activation 
impairments we used TBZ (8 mg/kg), since this drug has been reported to induce 
motivational symptoms such as anergia or fatigue in people (Frank et al, 2009; Guay et 
al, 2010; Chen et al, 2012), as well as behavioral activation impairments in classical 
animal models of depression (Jang et al, 2009; Wang et al, 2010; Carratalá-Ros et al, 
2020), and in effort-related decision making tasks (Nunes et al, 2013; Randall et al, 2014a; 
Yohn et al, 2016a, López-Cruz et al, 2018; Rotolo et al, 2019).  
Bupropion is a catecholamine uptake inhibitor mostly prescribed in the clinical field as 
an antidepressant (Dwoskin et al, 2006; Papakostas et al, 2006; Nutt et al, 2007). By 
blocking DAT and increasing extracellular DA levels (Hudson et al, 2012; Randall et al, 
2014a), bupropion is able to alleviate motivational symptoms such as anergia, fatigue and 
psychomotor retardation commonly seen in depression (Rampello et al, 1991; Sthal et al, 
2002; Demyttenaere et al, 2005; Pae et al, 2007).  
In our experiments, mice were introduced to the T-maze task, a paradigm that allows 
animals to freely choose between non-aversive stimuli; animals can choose between a 
highly preferred reinforcer that requires a high degree of vigor (running in a RW), or a 
palatable reinforcer (50% sucrose pellets) that is also preferred in contrast to other types 
of foods (Nunes et al, 2013), or doing more sedentary activities such as sniffing a fruit 
odor (López-Cruz et al, 2018; Carratalá-Ros et al, 2020). Under basal conditions, mice 
usually spent most of the time in the preferred reinforcer which is the RW, secondly spent 
their time eating the sucrose pellets, and the least preferred reinforcer is always the non-
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social odor (López-Cruz et al, 2018; Carratalá-Ros et al, 2020). In the present studies, 
although the baseline of preference for the RW was already high, the administration of 
bupropion was able to increase significantly time spent running in comparison with the 
vehicle group, and also time spent in the RW compartment. This effect was paralleled by 
a mild reduction in preference for sucrose that was significant for the variable time spent 
in the food compartment (figure 1E), but there was no impact on the least preferred 
reinforcer; the odor. These doses of bupropion did not seem to affect general ambulation 
in the T-maze as there was no change in number of crosses between compartments. Our 
results are similar to previous studies where the administration of different doses of this 
DAT inhibitor in rats shifted behavior increasing the tendency to work by lever pressing 
for food in a highly demanding task; progresive ratio (Randall et al, 2014b; Bruijnzeel 
and Markou, 2003). Rats increase work output in order to obtain the same type of 
palatable food used in our T-maze, and they decreased the consumption of concurrently 
available chow that is much less preferred (Randall et al, 2014a,b). Other more selectively 
DAT inhibitors such as GBR12909, PRX-14040, lisdexamfetamine, MRZ-9547 and S-
CE-123 also produced a significant increase on lever pressing in PROG/chow tasks and 
decreased free, but less preferred, chow (Sommer et al, 2014; Yohn et al, 2016a,b,c,d; 
Rotolo et al, 2019). In addition, mice lacking DAT, also increased the tendency to work 
for a food reward in a concurrent task (Cagniard et al, 2006). 
Bupropion also decreased passive behaviors and increased active behaviors such as 
swimming and climbing assessed in the FST. Previous studies have reported similar 
effects of bupropion in mice and rats on traditional paradigms for the assessment of 
antidepressant drugs such as the tail suspension test and the FST (Bourin et al, 2005; 
Kitamura et al, 2008, 2010; Yamada et al, 2004; Hufgard et al, 2017). However, in very 
few of them climbing (or struggling to do so in order to scape a stressful and unescapable 
situation) has been assessed for bupropion previously (Hayashi et al, 2011; Rénéric and 
Lucki, 1998). The maintenance of vigorous and persistent active responding (Gil and 
Armario, 1998) in order to escape is related with DA transmission, and studies that use 
DA antagonists or DA reuptake inhibitors show a decrease or increase respectively on the 
output of active behaviors in the FST (Li et al, 2015; Kitamura et al, 2010; Yamada et al, 
2004).  
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Previous studies from our laboratory have demonstrated the anergia inducing effects of 
the DA depleting agent TBZ in effort-based decision-making tasks such as the present T-
maze RW-choice task (López-Cruz, 2018; Carratalá-Ros et al, 2020), the T-maze barrier-
choice task (Yohn et al, 2015a,b; Correa et al, 2018), and also in operant procedures with 
different ratio requirements (PROG/chow tasks and FR5/chow) (Nunes et al, 2013; 
Randall et al, 2014a,b; Yohn et al, 2015a, 2016b, Rotolo, 2019). Those effects were not 
due to changes in appetite, food preference or food reactivity (Nunes et al, 2013; Randall 
et al, 2014a; Pardo et al, 2015a,b; Yang et al, 2019; Correa et al, 2018, Carratalá-Ros et 
al, 2020).  
In the present study, we used a dose of TBZ (8 mg/kg) that had demonstrated to be 
effective in mice for depleting ventral striatum DA (López-Cruz, 2018) and shifted 
behavior towards sedentary sources of reinforcement (Carratalá-Ros et al, 2020). TBZ-
treated mice reduced significantly time running in the RW and shifted their behavior 
towards spending more time doing sedentary activities (consuming sucrose pellets) than 
under the vehicle condition. Bupropion, was able to reverse TBZ-induced anergia. In fact, 
co-administration of 10 mg/kg of bupropion to TBZ-treated animals produced a 
significant reversal of the effects of the DA depleting agent, as indicated by an increase, 
equal to control levels, on time running in the RW, and a decrease on time consuming 
sucrose. These results are in accordance with previous studies done in our laboratory in 
which the administration of different doses of bupropion to rats alleviated TBZ-induced 
anergia in operant procedures such as PROG/chow tasks and FR5/chow tasks (Yohn et 
al, 2015a, 2016a; Randall et al, 2014a; Nunes et al, 2013).  
In addition, the most effective dose of bupropion (10 mg/kg) in the T-maze task, and the 
one that had improved climbing in the FST, also reversed immobility induced by TBZ, 
and restored swimming and climbing to normal levels in TBZ treated mice. According 
with the present results, bupropion was able to decrease immobility time in VMAT-2 
mutant mice evaluated in the FST (Fukui et al, 2007).  
None of these “therapeutic” effects of bupropion on its own or in TBZ treated animals, 
seem to be due to anxiolytic actions, since there were no changes in anxiety measures in 
the DL box or in the EPM (Table 1 and 2). Similar doses of bupropion in adult mice had 
previously demonstrated not to have an impact on emotional parameters evaluated in the 
EPM paradigm (Carrasco et al, 2013, 2004; Redolat et al, 2005a), but these doses do have 
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effects on motor activity in mice (Redolat et al, 2005b), and because the EPM has 
demonstrated to be sensitive to the motor actions of bupropion (Carrasco et al, 2004), we 
also analyzed crosses between compartments in the DL box and entries to all arms in the 
EPM, as indices of changes in locomotion. Thus, the highest dose of bupropion used in 
the present experiments (15 mg/kg), did increased locomotion assessed as total of entries 
to all arms in the EPM paradigm, and TBZ decreased total crosses between compartments 
in the DL box and total of entries to the EPM paradigm. Bupropion at 10 mg/kg was not 
able to reverse this effect in TBZ-treated animals. Thus, none of the doses used in the 
present experiments seem to modulate anxiety although some of them can affect 
locomotion in these paradigms, an effect that was not seen as total number of crosses in 
the T-maze. Thus, behavioral activation seems to be slightly affected by these two drugs 
as seen in parameters such as locomotion and exploration but also as the more active 
behaviors in the FST. 
All these results seem coherent with the well know functions of Nacb DA which has 
demonstrated to have a key role in the regulation of voluntary locomotion and effort 
related aspects of motivated behavior (Salamone and Correa 2002, 2012). Bupropion, 
which acts as a DAT blocker, increases extracellular DA levels in Nacb as measured by 
microdialysis (Randall et al, 2014b), and also a high increase on immunoreativity of the 
postsynaptic marker DARPP-32 phosphorilated at different sites depending on the type 
of DA receptor that is activated (Randall et al, 2014b; Svenningson et al, 2004; Bateup et 
al, 2008). On the contrary, TBZ reduces DA levels (Nunes et al., 2013; López-Cruz et al., 
2018), and produces the opposite pattern of DARPP-32 phosphorilation than bupropion 
(Nunes et al, 2013; Randall et al, 2014b; López-Cruz et al, 2018). In the present results, 
in mice we demonstrate using immunoreactivity methods that TBZ significantly 
increased pDARPP-32(Thr34) compared to vehicle treated mice, and this effect of TBZ 
was reversed by bupropion (10 mg/kg) in Nacb core, but not shell (data not shown), 
indicating the core subregion of Nacb is a more critical site for regulating persistent and 
sustained vigor in effort-choice tasks that have already been learned (Sokolowski et al., 
1998; Segovia et al., 2011, 2012). Interestingly for the present results, Randall and 
colleagues (2012) showed an increase of pDARPP-32(Thr34) in Nacb core in high lever 
pressing responder rats compared with low responders in the PROG/chow task that is the 
most work requiring operant task. In addition, the administration of S-CE-123, an atypical 
and selective DAT inhibitor, which has demonstrated to reverse TBZ-induced shift on an 
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FR5/choice task, also produced an increase on extracellular DA levels in Nacb core 
(Rotolo et al, 2019).  
However, it seems that in mice TBZ tends to suppress phosphorylation of DARPP-32 at 
threonine 75 (pDARPP-32(Thr75)) in Nacb core. Thus, using different antibodies and 
using two different techniques (immunoblotting and immunohistochemistry) pDARPP-
32(Thr75) in TBZ treated mice seems to be reduced, although results are not significant, 
probably because it is difficult to see lower levels of phosphorilation than in the vehicle 
group. Using immunofluorescence techniques could be a more sensitive way to be able 
to account for the reduction, as it is suggested by the sample pictures shown in figure 5. 
These results seem to differ from previous studies using immunohistochemical techniques 
in rats, in which TBZ demonstrated an increase in both phosphorylated forms of DARPP-
32 (Thr34 and Thr75) in Nacb core and shell (Nunes et al, 2013), but they seem in line 
with previous results in mice using western blotting in which TBZ only produced an 
increase on pDARPP-32(Thr34), but not on pDARPP-32(Thr75) in ventral striatum 
(López-Cruz et al, 2018). Moreover, as suggested by the literature and the co-localization 
images presented here (lower part of figure 5), it seems that in mice TBZ induced changes 
are mainly occurring in D2 containing neurons (Nunes et al, 2013; Svenningsson et al, 
2000; Bateup et al, 2008; Bonito-Oliva et al, 2011). D2 receptors are co-localized on 
enkephalin-containg medium spiny neurons (MSNs), while D1 receptors are co-localized 
on substance-P containing MSNs (Svenningsson et al, 2000; Bateup et al, 2008). In 
addition, in the present studies bupropion was able to reverse the induction of pDARPP-
32(Thr34) produced by TBZ, pointing to a predominant effect of both drugs in D2 
receptors situated in striatal enkephalin-containing MSNs. However, further work should 
assess if this cells also contain D1 receptors, and also if there is co-localization with 
pDARPP-32(Thr34) positive cells. 
In summary, our results show how bupropion increases the motivation to choose and to 
keep active under different type of behavioral settings (stressful or rewarding). Together 
with previous studies using different rodent and behavioral models (Randall et al, 2012, 
2014a,b; Yohn et al,2015a, 2016a), our results also show how bupropion improves 
impaired behavior after DA depletion but also baseline responding, specially, in low 
responders (Randall et al., 2012, 2014a).These results are supported by other studies in 
which this DAT blocker exerts great behavioral effects at doses that augment pre- and 
post- synaptic markers of DA transmission (Nunes et al, 2013; Randall et al, 2014b, Yohn 
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et al, 2015a). Moreover, bupropion also has demonstrated to have therapeutical effects on 
motivational symptoms in humans (Pae et al, 2007; Papakostas et al, 2006; Argyropoulos 
and Nutt, 2013; Soskin et al, 2013), and the rank order of clinical effectiveness in 
depressed patients with psychomotor retardation, paralleled the specificity of 
antidepressants as dopaminomimetic agents (Rampello et al, 1991; Brown and Gershon, 
1993; Treadway and Zald, 2011; Treadway and Pizzigali, 2014). These motivational 
symptoms are not alleviated by classical antidepressant treatments such as serotonin 
uptake inhibitors (Fava et al, 2014; Sthal et al, 2002), which seem more effective in 
patients affected by anxious depression (Rampello et al, 1995). The present results 
support the idea that alterations in dopaminergic transmission could contribute to the 
pathophysiology of motivational impairments in depression (Salamone et al, 2016b,c; 
Sthal et al, 2002; Treadway and Zald, 2011), and they emphasize the recent therapeutical 
approach that considers necessary to take into consideration the cluster of symptoms that 
patients with depression show to create a more effective pharmacological and 
individualized approach (Cuthbert and Insel, 2013). 
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CHAPTER III 
  
Fluoxetine has antidepressant effects in the forced swim 
test, but anergic effects in the T-maze three-choice 
task: potentiation of dopamine depletion induced 
impairments. 
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Abstract  
Impairments in behavioral activation and effort-related motivational functions like 
fatigue, anergia and apathy are treatment resistant symptoms of depression. Depressed 
people show a decision bias towards selection of low effort alternatives. Objectives. In 
studies with male CD1 mice, we evaluated the ability of fluoxetine to modulate behavioral 
activation in different models. Fluoxetine was assessed using a classical depression model 
(forced swim test (FST)), and an effort-based choice task (running wheel (RW) T-maze 
task). We also studied the ability of fluoxetine to reverse the effects of the dopamine 
depleting agent tetrabenazine, which reduces activity in both tasks. In the FST 
experiment, fluoxetine increased active behaviors (swimming, climbing) while reducing 
passive behaviors (immobility). Fluoxetine did not reverse tetrabenazine-induced anergia, 
in fact exacerbating it. With the T-maze task, fluoxetine produced the same pattern of 
effects as tetrabenazine, reducing time running, but increasing time consuming sucrose. 
Fluoxetine did not reverse tetrabenazine-induced suppression of RW activity, but did 
suppress time consuming sucrose in tetrabenazine-treated mice. The pattern of effects 
produced by fluoxetine in tetrabenazine-treated mice was dissimilar from that seen after 
reducing food value by prefeeding or making the food bitter tasting, since in both cases, 
time in the RW increased. The suppressive effect of tetrabenazine+fluoxetine in the RW 
was consistent with the decrease in locomotion seen under anxiogenic conditions, and the 
reduced crossing between compartments in the T-maze. These treatments reduced 
pDARPP32 at both phosphorylating sites in Nacb. These results have implications for the 
use of fluoxetine in the treatment of depressive symptoms such as fatigue and anergia in 
humans.  
 
 
Fluoxetine, serotonin, dopamine, depression, motivation, effort, anxiety, sedentarism. 
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Introduction 
Motivational symptoms such as psychomotor retardation, anergia, lack of energy, 
lassitude, fatigue and reduced exertion of effort are common and critical in major 
depressive disorder (Stahl, 2002; Demyttenaere et al, 2005; Salamone et al, 2007; 
Treadway et al, 2011; Fava, 2014). These highly debilitating symptoms in depression are 
highly correlated with problems in social function, and employment (Tylee, 1999; Stahl, 
2002, 2017; Hodgetts et al, 2017). They are also highly resistant to treatment, and remain 
as residual symptoms after remission (Stahl, 2002; Nutt et al. 2007; Fava et al. 2014). Many 
common antidepressants including serotonin (5-HT) transporter (SERT) inhibitors such 
as fluoxetine and citalopram are useful for treating mood symptoms in depression 
(Hieronymus et al., 2016; Rizvi et al., 2013; Rosenblau et al, 2012), but they are relatively 
ineffective for treating motivational dysfunctions, and, in fact, it has been suggested that 
SERT inhibitors can exacerbate or induce these symptoms in some patients (Nutt et al, 
2007; Targum and Fava, 2011; Padala et al., 2012; Stenman and Lilja, 2013; Rothschild 
et al, 2014; Fava, 2014).  
Because of the clinical significance of motivational dysfunctions, it is critical to develop 
animal models that allow researchers to study a broad range of impairments, and also to 
assess the ability of different drugs to reverse them. Thus, some studies have focused 
upon different tasks involving effort-based decision making that offer rodents the 
possibility of choosing between high effort instrumental actions leading to more valued 
reinforcers or to choose the low effort options leading to less valued reinforcers. 
Conditions associated with depression, including stress (Shafiei et al, 2012; Bryce and 
Floresco, 2019, 2016), pro-inflammatory cytokines (Nunes et al, 2014; Yohn et al, 2016c; 
Goldsmith et al, 2016), and dopamine (DA) receptor antagonism (Yang et al, 2019; Pardo 
et al, 2012; 2015; Yohn et al, 2015b; Correa et al, 2016) or DA depletion (Nunes et al, 
2013; Randall et al, 2014; Pardo et al, 2015; Yohn et al, 2015a; López-Cruz et al, 2018; 
Rotolo et al, 2019; Carratalá-Ros et al, 2020) can affect effort-related decision making 
and bias animals towards the low effort options. These results obtained from animal 
studies are consistent with clinical data showing a reduced selection of high effort 
alternatives in depressed people tested on tasks of effort-based choice (Treadway et al, 
2012; Chong et al, 2016). Administration of the vesicular monoamine transporter 
(VMAT-2) inhibitor tetrabenazine (TBZ), which blocks the monoamine storage and leads 
to a striatal DA depletion at low doses in primates (Pettibone et al, 1984), rats (Nunes et 
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al, 2013; Podurgiel et al, 2015, 2016; Yohn et al, 2016b), and mice (López-Cruz et al, 
2018; Carratalá-Ros et al, 2020), has been used to induce effort-related motivational 
impairments in rodents (Nunes et al, 2014; Yohn et al, 2015a,b; Yohn et al, 2016a,b; 
López-Cruz et al, 2018; Correa et al, 2018; Rotolo et al, 2019; Carratalá-Ros et al, 2020). 
This drug is used in the treatment of Huntington’s disease and has been reported to 
produce depressive symptoms including fatigue in people (Frank et al, 2009; Guay et al, 
2010).  
Voluntary physical activity is important for phenomena as varied as motivational 
performance in laboratory experiments, and workplace activity in humans. It has been 
observed that a lack of activity can contribute to the development of depression (Lambert 
2006), and in depressed people, symptoms such as loss of interest, motivation and energy, 
and generalized fatigue problems interfere with participation in exercise (Knapen et al, 
2015). Of course, the choice to engage in voluntary physical activity is always undertaken 
in relation to the possible selection of other alternatives, such as sedentary behaviors or 
food consumption. Voluntary running wheel was used in a recent T-maze choice task as 
the high effort/highly preferred option (Correa et al, 2016; López-Cruz et al, 2018; 
Carratalá-Ros et al, 2020). This paradigm assesses the impact of drugs, homeostatic or 
environmental manipulations on behavioral activation and effort-related choice. This task 
allows the animal to freely choose between running on a running wheel (RW), consuming 
sucrose pellets, or sniffing a neutral non-social odor. It has been demonstrated that TBZ 
produced a dose dependent shift in response selection, reducing preference for the energy 
requiring reinforcer (wheel running), but concurrently increasing time with the second 
preferred reinforcer (palatable food) that required little effort to obtain (López-Cruz et al, 
2018; Carratalá-Ros et al, 2020). 
The ability of monoamine uptake inhibitors to reverse the effects of TBZ on effort-based 
choice in rodents differs depending upon their specific mechanism of action. For example, 
SERT inhibitors such as fluoxetine or s-citalopram failed to reverse the low-effort bias 
induced by TBZ in rats tested in operant paradigms in which animals had to work (lever 
press) to get access to more palatable food or could choose to approach and consume a 
less preferred but freely available chow (Yohn et al, 2016a,b,c). However, DAT inhibitors 
reverse TBZ effects (Randall et al, 2014; Yohn et al, 2016a,b,c). In classical animal 
paradigms that evaluate the therapeutic actions of antidepressant drugs such as the forced 
swim test (FST), TBZ suppressed active behaviors (swimming and climbing), while 
increasing passive ones (immobility) (Carratalá-Ros et al, 2020). Some studies have 
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shown that fluoxetine effectively enhances active behaviors and reduces passive ones in 
the FST (Jang et al, 2009; Castagné et al, 2010; Petit-Demouliere et al, 2005). 
The present study explored the effect of fluoxetine administered alone or in combination 
with the DA depleting agent TBZ in the preference for active reinforcers in the 3-choice 
RW T-maze task, comparing those results with actions in classic paradigms that evaluate 
depressive-like behaviors such as the FST, which involves a stressful test setting. We also 
evaluate the effect of these drugs and their combination on anxiety paradigms (dark and 
light box; DL box and the elevated plus maze; EPM). Finally, we also assess the effect of 
behavioral manipulations that change the emotional or homeostatic value of food in this 
novel task. The proposed work was not presenting a global model of depression per se, or 
providing a general screening of antidepressant drugs, but rather focused on a behavioral 
component (active exertion of physical effort) that is particularly important for the 
motivational symptoms of depression, and potentially other disorders as well.  
 
Materials and Methods 
Animals. CD1 adult male mice (N=106) purchased from Janvier, France S.A. were 8-14 
weeks old (40-50 g) at the beginning of the study. Mice were housed in groups of three 
or four per cage, with standard laboratory rodent chow and tap water available ad libitum. 
The colony was kept at a temperature of 22 +  2 ºC with lights on from 08:00 to 20:00 h. 
All animals were under a protocol approved by the Institutional Animal Care and Use 
committee of Universitat Jaume I. All experimental procedures complied with directive 
2010/63/EU of the European Parliament and of the Council, and with the “Guidelines for 
the Care and Use of Mammals in Neuroscience and Behavioral Research”, National 
Research Council 2003, USA. All efforts were made to minimize animal suffering, and 
to reduce the number of animals used. 
Pharmacological agents. Fluoxetine (CIMYT Quimica SL, Spain) was dissolved in 
0.9% saline and administered 30 minutes before testing. The range of doses of fluoxetine 
was based on studies involving classical mice antidepressant screening tests (Lucki et al, 
2001) and effort-related behavioral tests (Yohn et al, 2016a,b). In order to conduct the 
reversal behavioral experiments, the VMAT-2 blocker tetrabenazine (TBZ; CIMYT 
Quimica SL, Spain) was used. TBZ was dissolved in a vehicle solution of 0.9% saline 
(80%) plus dimethylsulfoxide (DMSO 20%, final pH 5.5) and administered 120 minutes 
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before testing. Time elapsed after injection and the dose of 8.0 mg/kg TBZ were selected 
based on previous behavioral work (López-Cruz et al, 2018; Correa et al, 2018; Carratalá-
Ros et al, 2020) and neurochemical studies (López-Cruz et al, 2018) demonstrating that 
in mice this is an optimal dose and time lead to deplete DA. DMSO (20% v/v) and saline 
was used as the control group. All the substances were administered intraperitoneally (IP). 
 
Testing procedures 
All behavioral procedures started two hours after the light period started. The behavioral 
test room was illuminated with a soft light, and external noise was attenuated. 
Forced swim test (FST). This paradigm is considered to be a model of behavioral despair 
and is used as a test for assessing depressive-like states and for evaluating drugs with 
potential as antidepressants (Porsolt et al, 1977). Immobility was defined as the animal 
remaining motionless, making only minor movements to balance the body and keep the 
head above the water. In addition, we also assessed escape-related mobility such as 
climbing or struggling (Armario et al, 1988). Climbing is defined as any energetic and 
vertical movement of all four limbs against the wall of the tank. Mild swimming was 
recorded when animals carried out horizontal movements with their forepaws, leading to 
the displacement of the body throughout the swim chamber (Armario et al, 1988). Naïve 
mice were placed in a transparent cylindrical glass tank (26 cm high and 18 cm diameter) 
filled with water (14 cm) and maintained at a temperature of 25ºC. Water was changed 
between animals. During the 6-minute test, mice were videotaped from the side, and 
climbing, immobility and swimming were later measured by an observer unaware of the 
experimental condition. After the test, mice were dried with a soft towel, put back in a 
box with absorbing paper under a warming light, and were monitored for 10 minutes.  
Dark and light box (DL). The DL test is based on the conflict between the tendency to 
explore a novel environment and the avoidance of a brightly lit open area (Blumstein and 
Crawley 1983). The DL apparatus consisted of a polypropylene chamber divided in two 
compartments by a partition containing a small opening (5 cm H x 5 cm W). The light 
compartment (25 cmW x 25 cm H x 25 cm L) was open, painted in white and illuminated 
(335 lx), while the dark compartment (25 cm W x 25 cm H x 18 cm L) was painted in 
black and had a removable ceiling to close it (Kulesskaya and Voikar, 2014). To start the 
test session, mice were individually placed in the dark chamber facing one corner. Test 
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sessions were videotaped, and the latency of the first entry into the lit chamber, the total 
number of crosses and the total time spent in the lit chamber were recorded for 5 min 
(López-Cruz et al, 2014; Carratalá-Ros et al, 2020). 
Elevated plus maze (EPM). The EPM consists of two open and two enclosed arms (65 
cm L x 5 cm W) arranged in a plus configuration and intersecting in a central platform. It 
is made of black polypropylene and is elevated 50 cm above the floor. The open arms 
have a 1 cm border around their perimeter and the closed arms have a 20 cm translucent 
wall. This anxiety paradigm measures the avoidance that rodents show to high open 
spaces. Under normal conditions, mice spend more time in and make more entries into 
the closed arms of the maze (Lister 1987). Animals were placed in the central platform 
with their head pointing at one enclosed arm, and they were assessed during 5 minutes. 
Sessions were videotaped and a trained observer registered total time spent in the open 
arms, ratio of entries into the open arms compared to total arm entries, and total entries 
in the 4 arms as an index of locomotion. An entry into an arm was recorded when the 
animal crossed with all four legs the line that connected that arm with the central platform 
(procedure is based on López-Cruz et al, 2014). 
T-maze RW-sucrose-odor choice task. The T-maze apparatus consisted of a central area 
that lead to 3 arms (based on López-Cruz et al, 2018). In one of them, sucrose pellets 
(TestDietTM, 50% sucrose, 45 mg each) were available, in another arm there was a RW, 
and in the third arm there was a hole with a cotton ball socked with a fruit odor. Training 
as well as test sessions lasted 15 minutes. Mice were trained in one session, 5 days a week. 
Training phase 1: to avoid neophobia to the sweet tasting pellets, animals were enclosed 
in that arm with the food during 5 sessions. Training phase 2: during 2 more weeks 
animals were exposed, one 15 min session a day to the T-maze with free access to the 
three stimuli. Test phase: This phase lasted between 2 or 5 more weeks depending on the 
experiment. For each week, there were 4 training sessions plus a testing session in which 
animals received drug injections or were exposed to the food manipulations. The day 
before the manipulation was considered as the baseline (BL). Entries into the arms of the 
T-maze and time spent in the reinforcer compartment of the arms were simultaneously 
recorded. All these measures were used based on previous studies (Correa et al, 2016; 
López-Cruz et al, 2018; Carratalá-Ros et al, 2020). Time was selected as the main 
dependent measure because it allowed for the evaluation of the three different stimuli 
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with the same units. Time allocation is a useful measure of preference, relative 
reinforcement value, and response choice (Baum and Rachlin, 1969).  
Immunohistochemistry for phosphorylated DA and c-AMP related phosphoprotein-
32 kDaltons (pDARPP-32). After drug treatments, animals were anesthetized with CO2 
and transcardially perfused with 0.9% physiological saline for 5 minutes, followed by 
perfusion with 3.7% formaldehyde for 5 minutes and brains were extracted. Tissue was 
fixed in 3.7% formaldehyde overnight and moved to 30% sucrose cryo-protectant. Then 
40-um sections were cut using a cryostat. To measure the immunoreactivity to 
phosphorylated DA and c-AMP-regulated phosphoprotein 32kDa (pDARPP-32) 
nonspecific binding sites were blocked with a solution of 3% H202 for 30 minutes at 
room temperature following then with 1% bovine serum albumin and 0.1% Triton X-100 
in PBS for 1 hour at room temperature. Phosphorilated DARPP-32 immunoreactivity was 
visualized with a polyclonal rabbit antibody for DARPP-32 phosphorilated at threonine 
34 residue (Thr34, 1:1000; Santa Cruz Biotechnology) or polyclonal rabbit antibody for 
DARPP-32 phosphorilated at threonine 75 residue (Thr75, 1:500, Santa Cruz 
Biotechnology). These antibodies were dissolved in solutions that also contained 0.1% 
bovine serum albumin and 0.1 Triton X-100 in PBS for 24 h incubation on a rotating 
shaker at 4ºC. After the primary antibody treatment, the sections were rinsed in PBS (3 
times for 5 minutes) and incubated in the secondary antibody, anti-rabbit HRP conjugate 
envision plus (DAKO) for 1 hour and 30 minutes on a rotating shaker at room 
temperature. Finally, sections were washed and rinsed for 3-5 minutes in 3,3’ 
diaminobenzidine chromagen. The sections were then mounted to gelatin-coated slides, 
air dried and coverslipped using Eukitt quick-hardening (Sigma-Aldrich) as a mounting 
medium. The tissue was then examined by light microscopy.  
Quantification of the number of cells that express immunoreactivity for pDARPP-32 
(Thr34) and pDARPP-32 (Thr75) in the Nacb was performed by photographing the 
sections with a 20X (0.125 mm2 / field) objective (Eclipse E600; Nikon) upright 
microscope equipped with a Leica DFC 450C camera (Leica Microsystems) and captured 
digitally using LASX software. Cells that were positively labeled for pDARPP-32 
(Thr34) and pDARPP-32 (Thr75) were quantified with ImageJ software (version 1.51) 
and a macro written to automate particle counting within the region of interest. The size 
of the region of interest was 1000 x 1000 um. For each animal, cell counts were at levels 
that correspond to 0.70-1.70 mm anterior to bregma (Paxinos and Watson, 1997) 
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bilaterally from at least three sections and counts were averaged across slides and 
sections.  
 
Experiments 
Experiment 1. Effect of fluoxetine on depressive-like behaviors measured in the 
FST. Animals (N=31) received one dose of fluoxetine (vehicle, 10.0, 15.0 or 20.0 mg/kg) 
and 30 min after the injection were placed in the FST during 6 minutes. Mice were 
exposed only once to the FST since behavioral habituation develops in one session. 
Experiment 2. Effect of TBZ and fluoxetine combination on depressive-like 
behaviors measured in the FST. Three groups of naïve mice (N=38) received a 
combination of TBZ (8.0 mg/kg, a dose that was shown to be effective in the FST) 
(Carratalá-Ros et al, 2020) plus vehicle or the highest dose of fluoxetine (20 mg/kg) or 
the combination of both vehicles. Fluoxetine was given 90 minutes after TBZ and 30 
minutes before animals were placed in the FST. 
Experiment 3. Effect of fluoxetine on anxiety parameters as measured in the DL and 
EPM paradigms. Mice (N=35) received one dose of fluoxetine (vehicle, 10.0, 15.0 or 
20.0 mg/kg) and 30 min after injection were first place in the DL box for 5 minutes. 
Immediately after this test, they were placed in the EPM for 5 more minutes. Mice were 
exposed only once to both paradigms, since behavioral habituation develops in one 
session. 
Experiment 4. Effect of TBZ and fluoxetine combination on anxiety parameters as 
measured in the DL and EPM paradigms. Three groups of naïve mice (N=32) received 
a combination of TBZ (8.0 mg/kg) plus vehicle or the highest dose of fluoxetine (20.0 
mg/kg) or the combination of both vehicles. Fluoxetine was given 90 minutes after TBZ 
and 30 minutes before animals were placed in the DL box for 5 minutes, and immediately 
after this test, they were placed in the EPM for 5 more minutes.  
Experiment 5. Effect of fluoxetine on preference for active reinforcers as measured 
in the 3-choice-T-maze task. After reaching a stable baseline level of performance in the 
T-maze, animals (N=10) received fluoxetine (vehicle, 10.0, 15.0 and 20.0 mg/kg) and, 
after 30 minutes, were placed in the T-maze for 15 minutes. Animals received one dose 
of the drug every week in a randomly varied order. The T-maze paradigm requires a 
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baseline performance of two weeks before tests starts, and that performance is maintained 
across weeks, thus allowing a repeated measures design. We have observed that 
fluoxetine does not produce sensitization or tolerance when administered once per week. 
Experiment 6. Effect of TBZ and fluoxetine combination on preference for active 
reinforcers as measured in the 3-choice-T-maze task. A new group of mice (N=9) 
received TBZ (veh, 8.0 mg/kg) and, 90 minutes later, a dose of fluoxetine (veh, 10.0, 
15.0, 20.0 mg/kg), and 30 minutes later they were placed in the T-maze during 15 
minutes. Animals received one drug combination (veh-veh, TBZ-veh, TBZ-10, TBZ-15 
and TBZ20 mg/kg) every week during 5 weeks in a random varied order.  
Experiment 7. Manipulations that change the relative value of the sucrose pellets: 
Change in taste with bitter pellets. Animals (N=8) were trained as described before, 
and after reaching stable levels of interaction with the three different reinforcers, a drop 
of quinine (1.0 g/L) was added to the sweet pellets in order to make them bitter. BL 
behavior was assessed the day before the bitter pellets substituted the regular ones. 
Experiment 8. Manipulations that change the relative value of the sucrose pellets: 
change in appetite by pre-feeding. After training, BL performance of mice (N=12) was 
recorded. Overnight animals were pre-exposed to sweet pellets ad libitum, and the 
following day, the test session started.  
Experiments 9 and 10. Effect of pharmacological and food manipulations on amount 
of sucrose consumption, or locomotion in the T-maze. Data on pellets consumed (in 
milligrams) or crosses between compartments in the T-maze from experiments 5, 6, 7, 
and 8 were analyzed comparing each experimental condition with its respective control 
condition (vehicle or BL).  
Experiment 11. Effect of fluoxetine alone and in combination with TBZ on DARPP-
32 phosphorylation patters in Nacb as measured by immunohistochemistry. Mice 
(N=16) received (veh-veh, veh-fluoxetine 20 mg/kg, or TBZ 8 mg/kg-fluoxetine 20 
mg/kg) at the same time leads used for the behavioral studies before perfusion. Coronal 
sections were analyzed by immunohistochemistry for pDARPP-32 (Thr34) and 
pDARPP-32 (Thr75).  
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Statistical Analyses. Normally distributed and homogenous data (according to 
Kolmogorov-Smirnov test) for the FST, DL, and EPM as well as pDARPP-32 
immunoreactivity experiments employed a between groups design and data were 
analyzed by one-way ANOVA. Normally distributed data in the T-maze experiment 
followed a within groups design. Thus, when more than 2 experimental conditions were 
used, such as in the fluoxetine or the TBZ plus fluoxetine experiments, data were analyzed 
by repeated measures ANOVA. When the overall ANOVA was significant, non-
orthogonal planned comparisons using the overall error term were used to compare each 
treatment with the vehicle control group (Keppel, 1991). For these comparisons, α level 
was kept at 0.05 because the number of comparisons was restricted to the number of 
treatments minus one. The effects of changing the taste of the pellets and pre-feeding 
animals were evaluated by Student’s t-test for dependent samples. All data were 
expressed as mean ± SEM, and significance was set at p<0.05. STATISTICA 7 software 
was used. 
 
Results 
Experiment 1. Effect of fluoxetine on depressive-like behaviors measured in the 
FST. The one-way ANOVAs showed a significant effect on immobility time 
(F(3,27)=5.0, p<0.01), time swimming (F(3,27)=3.41, p<0.05), and time climbing 
(F(3,27)=5.68, p<0.01). Planned comparisons revealed that the groups that received 10.0 
and 20.0 mg/kg displayed significantly less time been immobile (p<0.05, p<0.01 
respectively) in comparison with the vehicle group. The two highest doses of fluoxetine 
(15.0 and 20.0 mg/kg) produced an increase on time spent swimming (p<0.01 and p<0.05 
respectively), and only 20.0 mg/kg of fluoxetine increased time climbing in the FST 
(p<0.01) in comparison with the vehicle group (Figure 1A). 
Experiment 2. Effect of TBZ and fluoxetine combination on depressive-like 
behaviors measured in the FST. The one-way ANOVA for time spent swimming 
(F(2,35)=0.34; p=0.70) was not significant. However, the ANOVAs for immobility and 
climbing were significant (F(2,35)=3.76, p<0.05; F(2,35)=9.10, p<0.01 respectively). 
Planned comparisons revealed that the group that received TBZ 8.0 mg/kg plus vehicle, 
and also the group that received TBZ 8.0 + fluoxetine 20.0 mg/kg displayed significantly 
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less climbing than the vehicle group (p<0.01). Finally, TBZ+ fluoxetine at 20.0 mg/kg 
increased time of immobility compared with the vehicle group (p<0.01) (Figure 1B).  
 
Figure 1. Effect of fluoxetine (Vehicle, 10, 15 or 20 mg/kg) (A) and TBZ plus fluoxetine 
combination (Vehicle+Vehicle, TBZ 8 mg/kg +Vehicle, or TBZ8 mg/kg and fluoxetine 20 mg/kg 
(B) on duration of immobility, swimming and climbing behavior in the FST assessed during 6 
minutes. Bars represent mean ± S.E.M. of accumulated seconds. * p<0.05, **p<0.01 significantly 
different from the control group. 
 
Experiment 3. Effect of fluoxetine on anxiety parameters as measured in the DL and 
EPM paradigms. The one-way ANOVA showed a significant effect on time spent in the 
illuminated arena (F(3,31)=5.11, p<0.01) of the DL box. Moreover, the one-way ANOVA 
also revealed a significant effect on the total number of entries into both compartments 
of the DL box (F(3,31)=2.99, p<0.05). Planned comparisons indicated that mice treated 
with fluoxetine at 15.0 and at 20.0 mg/kg spent less time in the lit chamber (p<0.01) in 
comparison with the vehicle group. Moreover, the highest dose of fluoxetine produced a 
decrease in total number of entries into both compartments (p<0.01) in comparison with 
the vehicle group (Figures 2A, B).  
The one-way ANOVA for the effect of fluoxetine in the EPM showed a significant effect 
on the ratio of entries into the open arms (F(3,31)=7.49, p<0.01).  Planned comparisons 
showed that all doses of fluoxetine reduced ratio of entries compared to vehicle (p<0.01). 
However, the one-way ANOVA did not show any significant effect on time spent in the 
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open arms (F(3,31)=1.91, p=0.14). The ANOVA for the total number of entries into all 
arms of the EPM was not significant either (F(3,31)=0.25, p=0.85) (Figures 2C-E). 
 
Figure 2. Effect of fluoxetine (Vehicle, 10, 15 or 20 mg/kg) on time spent in the lit chamber (A) 
and total of entries between the two compartments (B) of the DL box, and on time spent in the 
open arms (C), ratio to the open arms (D), and total of entries to the four arms (E) of the EMP 
during 5 minutes each test. Bars represent mean ± S.E.M. of accumulated seconds. **p<0.01 
significantly different from the vehicle group. 
 
Experiment 4. Effect of TBZ and fluoxetine combination on anxiety parameters as 
measured in the DL and EPM paradigms. The one-way ANOVAs did not show any 
significant effect of the treatment on anxiety parameters such as time spent in the lit 
chamber of the DL box (F(2,27)=1.23, p=0.30), time spent in the open arms 
(F(2,27)=2.27, p=0.80) or ratio of entries (F(2,27)=1.69, p=0.20) evaluated in the EPM 
paradigm (Figure 3). However, the one-way ANOVAs did show significant effects on 
locomotion seen in the total of entries between the two compartments of the DL box 
(F(2,27)=16.93, p<0.01), and total of entries into all arms of the EPM (F(2,27)=6.64, 
p<0.01). Planned comparisons revealed that the groups treated with 8.0 mg/kg of TBZ 
plus vehicle and the combination of TBZ plus fluoxetine both decreased the total number 
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of entries in comparison with the vehicle group (p<0.01) in the DL box (Figure 3B). The 
same effect was observed in the EPM: the groups treated with TBZ plus vehicle, and TBZ 
plus fluoxetine were different from the vehicle treated group (p<0.01) (Figure 3E). 
Figure 3. Effect of TBZ plus fluoxetine combination (Vehicle+Vehicle, TBZ 8 mg/kg +Vehicle, 
or TBZ8 mg/kg and fluoxetine 20 mg/kg) on time spent in the lit chamber (A) and total of entries 
between the two compartments (B) of the DL box, and on time spent in the open arms (C), ratio 
to the open arms (D), and total of entries to the four arms (E) of the EMP during 5 minutes each 
test. Bars represent mean ± S.E.M. of accumulated seconds. **p<0.01 significantly different from 
vehicle-vehicle group. 
 
Experiment 5. Effect of fluoxetine on preference for active reinforcers as measured 
in the 3-choice-T-maze task. Repeated measures ANOVA showed fluoxetine did not 
produce any significant effect on time spent sniffing the neutral odor (F(3,27)=0.90, 
p=0.45). However, fluoxetine produced a significant effect on time spent eating 
(F(3,27)=6.26, p<0.01), and time spent running in the RW (F(3,27)=15.13, p<0.01). 
Planned comparisons revealed that fluoxetine 20 mg/kg treated-mice spent significantly 
more time consuming sucrose pellets (p<0.01), and less time running in the RW (p<0.01) 
compared to the vehicle group (Figures 4A-C).  As for the other dependent variables, the 
repeated measures ANOVA showed that total time spent in the neutral odor compartment 
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was not significant (F(3,27)=1.21, p=0.32). However, fluoxetine showed a significant 
effect on time spent in the RW compartment (F(3,27)=9.69, p<0.01) and food 
compartment (F(3,27)=6.15, p<0.01). Planned comparisons revealed that when mice 
received the highest dose of fluoxetine (20.0 mg/kg) they spent less time in the RW 
compartment (p<0.01), and more time spent in the food compartment (p<0.01), in 
comparison with their respective vehicle conditions (Figure 4D).  Finally, repeated 
measures ANOVAs indicated that fluoxetine did not produce significant effects on the 
number of entries into the food compartment (F(3,27)=0.97, p=0.42), and into neutral 
odor compartment (F(3,27)=1.98, p=0.14). However, the SERT inhibitor did produce a 
significant effect on total number of entries into the RW compartment (F(3,27)=5.43, 
p<0.01). Planned comparisons revealed that all doses of fluoxetine produced a decrease 
on total of entries to the RW compartment in comparison with the vehicle group (p<0.01) 
(data shown in Figure 4E).  
 
Figure 4. Effect of fluoxetine (Vehicle, 10, 15 and 20 mg/kg) on time eating (A), time running 
(B), time sniffing (C), entries into compartments (D), and time spent in each compartment (E) in 
the T-maze task assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated 
seconds or number of entries. * p<0.05, **p<0.01 significantly different from vehicle.  
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Experiment 6. Effect of TBZ and fluoxetine combination on preference for active 
reinforcers as measured in the 3-choice-T-maze task. Repeated measures ANOVA 
showed a significant effect of treatment on time spent eating sucrose pellets 
(F(4,32)=3.33, p<0.05) and time spent running in the RW (F(4,32)=3.86, p<0.01), but no 
significant effect on time sniffing the neutral odor (F(4,32)=0.77, p=0.54). Planned 
comparisons showed that mice treated with TBZ 8.0 mg/kg plus vehicle spent less time 
running (p<0.05) than the vehicle-vehicle control condition. Also, fluoxetine suppressed 
time running in the RW in TBZ- treated mice at doses of 15.0 and 20.0 mg/kg in 
comparison with the vehicle-vehicle condition (p<0.05 and p<0.01 respectively). Planned 
comparisons for the time consuming sucrose measure revealed that mice treated with TBZ 
plus vehicle increased time consuming sucrose pellets (p<0.01) in comparison with the 
vehicle-vehicle group, and all doses of fluoxetine in combination with TBZ suppressed 
time consuming sucrose pellets (for TBZ+ 10.0 and TBZ+15.0 mg/kg p<0.05 and for 
TBZ+20 mg/kg p<0.01) in comparison with the TBZ plus vehicle condition (Figures 5A-
C).  
Repeated measures ANOVA did not show any significant effect of treatment on time 
spent in the RW compartment (F(4,32)=0.77, p=0.54), food compartment (F(4,32)=1.58, 
p=0.20), or odor compartment (F(4,32)=1.86, p=0.14) (Figure 5D, E). Finally, repeated 
measures ANOVAs showed a significant effect of treatment on total number of entries to 
the RW compartment (F(4,32)=2.89, p<0.05), total entries into the food compartment 
(F(4,32)=5.46, p<0.01), and total entries into the odor compartment (F(4,32)=3.46, 
p<0.01). Planned comparisons showed that TBZ+ fluoxetine at 15.0 and 20.0 mg/kg 
produced a decrease in entries into the RW compartment (p<0.05), and into the food 
compartment (p<0.05 and p<0.01 respectively) compared with their respective vehicle 
condition. Only the highest dose of fluoxetine (20.0 mg/kg) in combination with TBZ 
decreased entries to the odor compartment (p<0.01) in comparison with the vehicle 
condition. 
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Figure 5. Effect of TBZ (Vehicle or 8 mg/kg) plus fluoxetine (Vehicle, 10, 15 and 20 mg/kg) 
combination on time eating (A), time running (B), time sniffing (C), entries into compartments 
(D), and time spent in each compartment (E) in the T-maze task assessed during 15 minutes. Bars 
represent mean ± S.E.M. of accumulated seconds or number of entries. *p<0.05, **p<0.01 
significantly different from vehicle-vehicle.  #p<0.05, ##p<0.01 significantly different from 
TBZ-Vehicle. 
 
Experiment 7. Manipulations that change the relative value of the sucrose pellets: 
Change in taste with bitter pellets. A series of Student`s t-tests for dependent samples 
for each variable showed a significant effect of bitter pellets (t(5)=4.56, p<0.01) on time 
running and on time spent eating compared with the control condition (t(5)=-2.53, 
p<0.01). However, there was no significant effect of bitter food on time sniffing the 
neutral odor (t=2.0, p=0.10) (Figures 6A-C). The t-tests for dependent samples comparing 
time in compartments between both conditions (BL vs. bitter food) did not reveal 
differences in time spent in RW compartment (t(5)=-1.13, p=0.30), food compartment 
(t(5)=1.39, p=0.22) or neutral odor compartment (t(5)=1.81, p=0.12) (Fig 6E). Finally, t-
tests for dependent samples failed to demonstrate significant differences between both 
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conditions on any of the following variables: total entries to the food compartment (t(5)=-
0.09, p=0.92), total entries to the RW compartment (t(5)=-2.23, p=0.07), and total entries 
to the odor compartment (t(5)=-0.58, p=0.58) (Figures 6D).  
 
Figure 6. Effect of bittering the sucrose pellets on time eating (A), time running (B), time sniffing 
(C), entries into compartments (D), and time spent in each compartment (E), in the T-maze task 
assessed during 15 minutes. Bars represent mean ± S.E.M. of accumulated seconds or number of 
entries. **p<0.01 significantly different from baseline condition.  
Experiment 8. Manipulations that change the relative value of the sucrose pellets: 
change in appetite by pre-feeding. The Student’s t-test for dependent samples showed 
a significant increase in time running in the RW (t(11)=-3.87, p<0.01), and a decrease in 
time eating sucrose pellets (t(11)=2.95, p<0.01) in the pre-feed condition compared with 
the control condition (Fig 7A, B). However, there was no significant effect of pre-feeding 
on time spent sniffing the neutral odor (t(11)=-0.82, p=0.42) (Fig 7C). Student’s t-tests 
for dependent samples for the variable time in compartments did not show significant 
differences between conditions on time spent in RW compartment (t(11)=-2.06, p=0.06), 
and neutral odor compartment (t(11)=-0.22, p=0.82) (Fig 7E). However, Student’s t-test 
analyses did show that there was a significantly decreased in time spent in the food 
compartment in the pre-feed condition compared with BL (t(11)=3.07, p<0.01). The t-
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tests revealed no statistical differences in total entries into the food compartment 
(t(11)=1.51, p=0.15), total entries into the RW compartment (t=-1.02, p=0.32) and total 
entries into the odor compartment (t(11)=-1.42, p=0.18) (Fig 7D). 
 
Figure 7. Effect of pre-feeding on time eating (A), time running (B), time sniffing (C), entries 
into compartments (D), and time spent in each compartment (E), in the T-maze task assessed 
during 15 minutes. Bars represent mean ± S.E.M. of accumulated seconds or number of entries. 
**p<0.01 significantly different from BL condition. 
 
Experiment 9. Effect of pharmacological and food manipulations on amount of 
sucrose consumption in the T-maze. The Student’s t-test for dependent samples showed 
significant differences in the amount of pellets consumed when animals received 
fluoxetine 20.0 mg/kg in comparison with the vehicle condition (t(9)=-3.13, p<0.01). 
However, the t-test comparison of vehicle-vehicle with TBZ-vehicle did not show a 
significant effect (t(7)=-0.67, p=0.52), and a separate t-test between vehicle-vehicle and 
TBZ-fluoxetine 20.0 mg/kg was not significant either (t(7)=0.88, p=0.40). There were 
significant differences in the amount of pellets consumed when animals were pre-feed 
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(t(11)=2.62, p<0.05), or had access to bitter food (t(5)=3.43, p<0.05) compared to their 
respective controls (Table 1).  
 
 Control condition  Experimental condition 
Exp. 5. Fluoxetine 112.5 ± 40.4 306.0 ± 74.9** 
Exp. 6. TBZ 129.4 ± 54.1 196.9 ± 64.7 
   
Exp. 6. TBZ+ Fluoxetine 129.4 ± 54.1 61.9 ± 35.0 
Exp. 7. Bitter food 345.0 ± 104.4 41.3 ± 28.7* 
Exp. 8. Pre-feeding 240.0 ± 50.7 60.0 ± 15.0* 
 
Table 1. Effect of tetrabenazine (TBZ) and fluoxetine alone or in combination and food 
manipulations on pellets intake. Mean (± SEM) of milligrams consumed during the T-maze test. 
*p<0.05, **p<0.01 significantly different from its respective control condition.  
 
Experiment 10. Effect of pharmacological and food manipulations on locomotion in 
the T-maze. The Student’s t-test for dependent samples showed significant differences 
in spontaneous locomotion in the T-maze when mice received fluoxetine 20.0 mg/kg in 
comparison with the vehicle condition (t(9)=2.53, p<0.05). However, the t-test 
comparison of vehicle-vehicle with TBZ-vehicle did not show a significant effect (t(7)=-
3.11, p=0.35) although a separate t-test between vehicle-vehicle and TBZ-fluoxetine 20.0 
mg/kg was significant (t(7)=2.83, p<0.05). Finally, there were no significant differences 
in spontaneous locomotion in the T-maze when animals were pre-feed (t(11)=-0.43, 
p=0.67) or had access to bitter pellets (t(5)=-1.01, p=0.35) (Data are shown in Table 2). 
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 Control condition  Experimental condition 
Exp. 5. Fluoxetine 41.5 ± 8.8 24.5 ± 4* 
Exp. 6. TBZ 19.4 ± 2.4 22.5 ± 2.3 
   
Exp. 6. TBZ+ Fluoxetine 19.4 ± 2.4 9.1 ± 2.1* 
Exp. 7. Bitter food 27.6 ± 2.8 33.0 ± 1.5 
Exp. 8. Pre-feeding 49.0 ± 10.0 50.8 ± 9.7 
 
Table 2. Effect of tetrabenazine (TBZ) and fluoxetine alone or in combination, and food 
manipulations on general locomotion. Mean (± SEM) of total entries to the three compartments 
of the T-maze test. **p<0.01 significantly different from its respective control condition.  
 
Experiment 11. Effect of fluoxetine alone and in combination with TBZ on DARPP-
32 phosphorylation patters in Nacb as measured by immunohistochemistry. One 
way ANOVAs showed an overall effect of treatment on pDARPP-32(Thr34) in Nacb 
(F(2,13)=4.64, p<0.05). Planned comparisons revealed that the administration of 20 
mg/kg of fluoxetine decreased significantly phosphorylation of DARPP-32(Thr34) in 
Nacb core (p<0.05) in comparison with the vehicle-vehicle group. Moreover, TBZ (8 
mg/kg) plus fluoxetine (20 mg/kg) was also significantly different from the vehicle-
vehicle group (p<0.01). There was a significant effect of treatment on pDARPP-
32(Thr75) in Nacb core (F(2,12)=4.46, p<0.05). Planned comparisons revealed that both 
the administration of 20 mg/kg of fluoxetine and the combination of 8 mg/kg TBZ plus 
20 mg/kg fluoxetine significantly decreased phosphorylation of DARPP-32(Thr75) in 
comparison with the vehicle-vehicle group (p<0.05 and p<0.01 respectively). Data are 
also shown in figure 8.  
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Figure 8. Effect of TBZ and fluoxetine combination (Vehicle+Vehicle, 8 mg/kg TBZ+Vehicle 
or 8 mg/kg TBZ+20 mg/kg fluoxetine) on number of positive cell counts for pDARPP-32(Thr34) 
and pDARPP-32(Thr75) immunoreactivity in Nacb core. Left: photomicrographs of individual 
representative brains. Right: mean ± S.E.M of number of pDARPP-32-(Thr34) and pDARPP-32-
(Thr75) counts in a 100um2 ROI. *p<0.05, **p<0.01 significantly different from 
Vehicle+Vehicle. 
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Discussion  
The present experiments evaluated the ability of the 5-HT uptake inhibitor fluoxetine to 
produce antidepressant effects on the classical rodent paradigm, the FST, and also its 
potential to reverse the depression-like effects of the DA depleting agent TBZ in this 
paradigm (Carratalá-Ros et al, 2020). We confirmed that administration of a range of 
doses of fluoxetine increased significantly the time mice spent climbing and swimming, 
consequently reducing the time animals spent immobile in the FST (Fig 1). Previous 
studies have shown the same pattern; fluoxetine increases active behaviors (swimming 
and climbing) and decreases passive ones (immobility) in different strains of mice after 
acute or chronic IP administration of this SERT blocker (Costa et al, 2013; Sanmukhani 
et al, 2011; Lucki et al, 2001; Dulawa et al, 2004). However, when we evaluated the 
ability of the highest dose of fluoxetine (20.0 mg/kg) to reverse the depression-like effects 
produced by the DA depleting agent TBZ (8.0 mg/kg) in the FST (Carratalá-Ros et al, 
2020), we observed that fluoxetine not only failed to reverse the effects of TBZ, but, in 
fact, it exacerbated them. Thus, animals that received the combination of TBZ and 
fluoxetine significantly increased time spent immobile and decreased time spent 
climbing, suggesting that fluoxetine is not able to alleviate motivational deficits in 
escaping behavior induced by DA depletion. TBZ was used in this study as a tool for 
altering behavioral activation and effort-related choice since this drug has been reported 
to induce depressive symptoms including fatigue in people (Frank et al, 2009; Chen et al, 
2012) and behavioral impairments in traditional rodent depression models (Wang et al, 
2010; Carratalá-Ros et al, 2020), and effort-based tasks (Nunes et al, 2013; Yohn et al, 
2016a, López-Cruz et al, 2018; Rotolo et al, 2019). 
The antidepressant-like effect of fluoxetine alone in the FST cannot be explained by 
anxiolytic actions since the same doses of fluoxetine that had an antidepressant effect in 
the FST, also increased anxiety-related parameters evaluated in the DL box and EPM 
paradigms. Thus, mice that received the two highest doses of fluoxetine (15.0 and 20.0 
mg/kg) spent significantly less time in the lit chamber of the DL box, and in the open 
arms of the EPM paradigm (Fig 2). Some animal studies have shown that acute 
administration of doses of fluoxetine like the ones used in the present study (20.0 mg/kg) 
produce anxiogenic effects in rats (Greenwood et al, 2008), and mice (Kurt et al, 2000; 
Belzung et al, 2001). Moreover, it has been shown that null-SERT mutant mice usually 
display anxious behaviors (Holmes et al, 2003). In the present and previous experiments, 
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TBZ showed no anxiogenic effects at a broad range of doses (Correa et al, 2018; 
Carratalá-Ros et al, 2020). Interestingly, unlike fluoxetine alone, the combination of 
fluoxetine (20.0 mg/kg) plus TBZ (8.0 mg/kg) did not produce anxiety-related effects in 
any of the paradigms (Fig 3).  
The FST provides some information about behaviors related to the maintenance of 
vigorous and persistent active responding (Gil and Armario, 1998; Slattery and Cryan, 
2012) in order to escape a stressful unescapable situation. Based on this, we decided to 
evaluate the effects of fluoxetine in the 3-choice-T-maze-task, a rodent model that 
evaluates preference for vigorous physical activity vs. other sources of reinforcement that 
could be obtained with little effort (Correa et al., 2016; López-Cruz et al, 2018; Carratalá-
Ros et al, 2020). In the standard version of this paradigm, no stressor is used, and mice 
can freely distribute their time performing an effortful and highly preferred activity 
(running in a RW) or engaging in more sedentary activities (eating sucrose pellets or 
sniffing a fruit odor). Under basal conditions, mice spent most of their time running in 
the RW, some of the time eating sucrose pellets and very little time sniffing the neutral 
odor. In this experiment, the highest dose of fluoxetine (20.0 mg/kg) decreased 
significantly time mice spent running and partially shifted their behavior, increasing time 
consuming sucrose pellets in comparison with the vehicle condition (Fig 4). This increase 
in time consuming sucrose is also seen in terms of amount of food consumed; the highest 
dose of fluoxetine significantly increased intake of sucrose in milligrams (around 170%, 
table 1). This pattern of effects is surprisingly similar to the pattern previously observed 
for TBZ alone in this paradigm (López-Cruz et al, 2018; Carratalá-Ros et al, 2020). The 
administration of different doses of TBZ produced a partial shift; mice spent less time 
running and increased time-consuming sucrose pellets in comparison with the vehicle 
condition. TBZ alone also tends to increase total milligrams consumed, but the increase 
is milder (around 35-50%), and never reaches significance (Carratalá-Ros et al, 2020). 
This increase in food consumption has not been observed in rats in operant choice 
procedures (Yohn et al, 2016a), in which animals tend to reduce palatable food as well as 
chow intake. It is possible that this discrepancy is due to differences between these two 
species. Rats tend to consume proportionally more food and are less active than mice in 
T-maze paradigms (Rotolo et al., in preparation). Thus, it is possible than mice are more 
sensitive to the anergic effects of fluoxetine, and much less to its appetite suppressant 
effects. Moreover, although previous clinical studies have shown how that this SERT 
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blocker decreases appetite (Silverstone et al, 1992; Michelson et al, 1999), a recent 
metanalysis study (Serralde-Zúñiga et al, 2019) comparing different categories of anti-
obesity drugs indicates that, unlike other drugs, fluoxetine treatment does not 
conclusively decrease weight, but there is a clear increase in the risk for drowsiness and 
fatigue. In addition, unlike TBZ alone, mice treated with 20.0 mg/kg of fluoxetine showed 
avoidance for the RW in general; they spent significantly more time in the food 
compartment, reducing the time spent and the total number of entries into the RW 
compartment. This is a pattern of effects that is similar after introducing aversive 
conditions in the T-maze (Carratalá-Ros et al, 2020). Thus, placing an intense light over 
the RW that is known to induce anxiogenic effects in the DL shifts behavior from RW to 
food consumption, but animals also show place avoidance for the RW compared to 
baseline (Carratalá-Ros et al, 2020). Those results are different from the pattern observed 
for TBZ, which did not change any of these parameters; mice still highly preferred to 
spent time in the compartment with the active reinforcer (the RW compartment) after 
TBZ administration, although they did not run as much (Carratalá-Ros et al, 2020). 
In the next experiment, different doses of fluoxetine were unable to reverse the partial 
shift from RW towards food induced by TBZ (Fig 5). However, fluoxetine at all doses 
suppressed the TBZ-induced increase in time consuming sucrose, making the combined 
administration of the two drugs no different from control conditions. In previous studies 
in rats, fluoxetine consistently failed to reverse the lever pressing suppression induced by 
TBZ. But when animals were tested on fluoxetine alone, the did not shift their behavior 
from high effort/highly palatable food to free chow available in the operant chamber, as 
is typical for TBZ (Yohn et al, 2016b). In fact, in these experiments animals also showed 
reduced chow consumption (Yohn et al, 2016b). Thus, it seems that fluoxetine in 
combination with TBZ produces both anergic effects and a suppresses food consumption 
in rats and mice. For that reason, we wanted to evaluate the effects of conditions related 
to appetite and food reinforcement on T-maze choice task performance, to compare those 
actions with the effects of fluoxetine plus TBZ. We altered the reinforcing value of the 
sucrose pellets that were available in this paradigm by pre-feeding the mice with the same 
type of sucrose pellets the night before the test, or by adding quinine to the sucrose pellets 
in order to make them bitter. Both manipulations produced a significant shift, reducing 
almost to zero the time mice spent consuming sucrose pellets in comparison with the 
baseline condition, but significantly increasing time running (figures 6 and 7), which was 
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not observed in the pharmacological interaction experiment. Moreover, pre-feeding or 
making the pellets bitter led to a robust and significant reduction of milligrams consumed, 
which is the did not occur either with TBZ alone, and did not reach significance with TBZ 
plus fluoxetine (Table 1).  
The disruptive effects on time running produced by fluoxetine or fluoxetine in 
combination with TBZ in the T-maze could be explained by general effects of locomotor 
activity. Thus, in the anxiety paradigms, fluoxetine (15.0 and 20.0 mg/kg), or fluoxetine 
(20.0 mg/kg) plus TBZ reduced locomotion, as measured by total number of entries into 
compartments and crosses between arms (figures 2B, 3B and 3E). Moreover, in all the 
experiments, the number of overall crosses between compartments in the T-maze was 
only significantly reduced after fluoxetine (20.0 mg/kg) or fluoxetine plus TBZ (table 2). 
Previous studies have reported that SERT blockade or deletion in mice reduced 
locomotion (Sanders et al, 2007; Holmes et al, 2002), and fluoxetine in rats that had 
received TBZ showed further decreased locomotor activity compared with administration 
of TBZ alone (Podurgiel et al, 2015). 
The inability of fluoxetine to alleviate motivational impairments induced by a DA 
depleting agent, and to induce psychomotor deficits, could be due to actions of fluoxetine 
on the mesolimbic DA system (Cameron and Williams, 1995; Daw et al, 2002). 
Fluoxetine alone decreased DA levels in nucleus accumbens (Nacb) as measure by 
microdyalisis (Yohn et al, 2016a), and coadministration of TBZ and fluoxetine further 
decreased DA tissue levels in the rat ventrolateral neostriatum compared with TBZ alone 
(Podurgiel et al, 2015). Nacb receives projections from dorsal raphe nuclei 5-HT neurons, 
and the stimulation of this neurons decreases DA mesolimbic activity (Browne et al, 
2019; Di Giovani et al, 2000; Di Matteo et al, 2008; Ichiwaka and Meltzer, 1995; Di 
Mascio et al, 1998). Thus, the combination of fluoxetine with TBZ, which also has been 
demonstrated to reduce DA tissue content and release (López-Cruz et al, 2018; Nunes et 
al, 2013), suggests that these impairments in behavioral activation assessed in the 3-
choice-T-maze task and in the FST could be produced by an overall reduction of 
mesolimbic DA activity.  Thus, in the present experiments, the reduction in both forms 
of phosphorylated DARPP32 induced by fluoxetine and also by fluoxetine combined with 
TBZ in Nacb core, suggests that there is a reduction in D1 and D2 dopamine receptor 
activation by DA as compared to the control condition.  
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In summary, fluoxetine, which is the SERT inhibitor most prescribed for treating 
depression (Hieronymus et al, 2016; Rizvi et al, 2013; Rosenblau et al, 2012), produced 
a antidepressant-like effect under stressful conditions in the FST, but induced an anergic 
effect on its own, and did not reverse the anergic effects produced by TBZ in either the 
FST or the 3-choice-T-maze task. Several clinical studies have reported that fluoxetine is 
relatively ineffective for treating psychomotor and motivational symptoms seen in 
depression and, in fact, it can exacerbate or induce these effects (Katz et al., 2004; Nutt 
et al, 2007; Padala et al, 2012; Rostchild et al, 2014). However, it should be pointed out 
that drugs that facilitate 5-HT can treat other aspects of depression such as mood 
dysfunction, rumination and cognitive arousal (Carr and Lucki, 2011; Bell et al, 2013) 
and, as seen in the present study as well as previous studies, fluoxetine administered alone 
produces an effective response in classical antidepressant tests such as the FST (Armario 
et al., 1988; Cryan et al, 2005a,b; Jang et al, 2009).  Thus, the present studies are 
consistent with the idea that not all antidepressants are adequate for the treatment of 
psychomotor slowing and anergia symptoms commonly seen in depression. This idea of 
different therapeutic drugs having positive actions for some symptoms, but no effect or 
even negative actions on other symptoms, is consistent with the research domain criterion 
(RDoC) approach that highlights the importance of describing the neural circuits that 
mediate specific symptoms in psychopathology, and not simply the traditional diagnostic 
categories (Cuthbert and Insel, 2013).  
 
 
 
  
134 
 
 
References 
Armario A, Gavaldà A, Martí O (1988) Forced swimming test in rats: effect of 
desipramine administration and the period of exposure to the test on struggling 
behavior, swimming, immobility and defecation rate. Eur J Pharmacol 158: 207-212. 
Baum WM, Rachlin HC. (1969). Choice as time allocation. J Exp Anal Behav 12: 861-
874. 
Belzung C, Le Guisquet AM, Barreau S, Calatayud F (2001) An Investigation of the 
mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. 
Behav Pharmacol, 12(3) 151-62.  
Bell DS, Shipman WM, Cleves MA, Siegelman J (2013) Which drug for which patient? 
Is there a fluoxetine responding versus a bupropion responding personality profile? Clin 
Pract Epidemiol Ment Health 9, 142-47. 
Blumstein LK, Crawley JN. (1983). Further characterization of a simple, automated 
exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem 
Behav 18: 37-40. 
Bogdanova OV, Kanekar S, D’Anci KE, Renshaw PF (2013) Factors influencing 
behavior in the forced swim test. Physiol Behav, 118 227-39. 
Browne CJ, Abela AR, Chu D, Li Z, Ji X, Lambe EK, Fletcher PJ (2019) Dorsal raphe 
serotonin neurons inhibit operant responding for reward via inputs to the ventral 
tegmental area but not the nucleus accumbens: evidence from studies combining 
optogenetic stimulation and serotonin reuptake inhibition. Neuropsychopharmacology, 
44(4) 793-804. 
Bryce CA, Floresco SB (2016) Perturbations in effort-related decision-making driven by 
acute stress and corticotropin-releasing factor. Neuropsychopharmacology, 41(8) 2147-
59.ry 
Bryce CA, Floresco SB (2019) Alterations in effort-related decision-making induced by 
stimulation of dopamine D1, D2, D3 and corticotropin-releasing factor receptors in 
nucleus accumbens subregions. Psychopharmacology (Berl), 236(9), 2699-2712. 
135 
 
Cameron DL, Williams JT. (1995). Opposing roles for dopamine and serotonin at 
presynaptic receptors in the ventral tegmental area. Clin Exp Pharmacol Physiol. 22: 841-
845. 
Carlini VP, Gaydou RC, Schiöth HB, Barioglio SR (2007) Selective serotonin reuptake 
inhibitor (fluoxetine) decreases the effect of ghrelin on memory retention and food intake. 
Regul Pept, 140(1-2) 65-73. 
Carr GV, Lucki I (2011) The role of serotonin receptor subtypes in treating depression: a 
review of animal studies. Psychopharmacology (Berl), 213(2-3) 265-87. 
Castagné V, Moser P, Roux S, Porsolt RD (2010) Rodent models of depression: forced 
swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Pharmacol, 
Chapter 5, Unit5.8 
Carratalá-Ros C, López-Cruz L, SanMiguel N, Ibañez-Marín P, Martínez-Verdú A, 
Salamone JD, Correa M. (2020). Preference for exercise versus more sedentary 
reinforcers: validation of an animal model of tetrabenazine-induced anergia. Front Behav 
Neurosc. In press 
Chen JJ, Ondo WG, Dashtipour K, Swope DM (2012) Tetrabenazine for the treatment of 
hyperkinetic movement disorders: a review of the literature. Clin Ther 34: 1487-1504. 
doi: 10.1016/j.clinthera.2012.06.010 
Chong TT, Bonnelle V, Husain M (2016) Quantifiying motivation with effort-based 
decision-making paradigms in health and disesase. Prog Brain Res, 229 71-100. 
Correa M, Pardo M, Bayarri P, López-Cruz L, SanMiguel N, Valverde O, Ledent C, 
Salamone JD (2016) Choosing voluntary exercise over sucrose consumption depends 
upon dopamine transmission: effects of haloperidol in wild type and adenosine A2KO 
mice. Psychopharmacol (Berl), 233(3) 393-404. 
Correa M, SanMiguel N, López-Cruz L, Carratalá-Ros C, Olivares-García R, Salamone 
JD. (2018). Caffeine modulates food intake depending on the context that gives access to 
food: Comparison with dopamine depletion. Front Psychiatry 9: 411. doi: 
10.3389/fpsyt.2018.00411 
Costa AP, Vieira C, Bohner LO, Silva CF, Santos EC, De Lima TC, Lino-de-Oliveira C. 
(2013). A proposal for refining the forced swim test in Swiss mice. Prog 
Neuropsychopharmacol Biol Psychiatry 45: 150-155.  
136 
 
Cryan JF, Page ME, Lucki I. (2005a). Differential behavioral effects of the 
antidepressants reboxetine, fluoxetine and moclobemide in a modified forced swim test 
following chronic treatment. Psychopharmacology. 182:335-344. 
Cryan JF, Valentino RJ, Lucki I (2005b). Assessing substrates underlying the behavioral 
effects of antidepressants using the modified rat forced swimming test. Neurosci 
Biobehav Rev, 29(4-5) 547,69. 
Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven 
pillars of RDoC. BMC Med, 11 126. 
Daw ND, Kakade S, Dayan P. (2002). Opponent interactions between serotonin and 
dopamine. Neural Netw. 15: 603-616. 
Demyttenaere K, Jürgen DF, Sthal SM (2005) The many faces of fatigue in major 
depressive disorder. Int. J. Neuropsychopharmacol, 8(1) 93-105. 
Den Boer JA, Westenberg HG (1995) Serotonergic compounds in panic disorder, 
obsessive-compulsive disorder and anxious depression: a concise review. Hum 
Psychopharmacol, 10 Suppl 3 S173-S183. 
Di Giovanni G, DiMatteo V, DiMascio M, Esposito E (2000) Preferential modulation of 
mesolimbic versus nigrostriatal dopaminergic function by serotonin 2C/2B receptor 
agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 35, 
53-61. 
Di Mascio M, Di Giovanni G, Di Matteo V, Prisco S, Esposito E (1998) Selective 
serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in 
the ventral tegmental area. Brain Res Bull, 46(6) 547-554 
Di Matteo V, Di Giovanni G, Pierucci M, Esposito E (2008) Serotonin control of central 
dopaminergic function: focus on in vivo microdialysis studies. Prog Brain Res, 172 7-44. 
Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in 
animal models of anxiety and depression. Neuropsychopharmacology 29(7), 1321-30. 
Fava M (2014) Assessing response to treatment and recognizing residual depressive 
symptoms. J Clin Psychiatry, 75(1) 
137 
 
Frank S (2009) Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label 
continuation study. Huntington Study Group/TETRA-HD Investigators. BMC Neurol 9: 
62. doi: 10.1186/1471-2377-9-62 
Gil M, Armario A (1998) Chronic immobilization stress appears to increase the role of 
dopamine in the control of active behaviour in the forced swimming test. Behav Brain 
Res. 9 91-97. 
Goldsmith DR, Haroon E, Woolwine BJ, Jung MY, Wommack EC, Harvey PD, 
Treadway MT, Felger JC, Miller AH. (2016). Inflammatory markers are associated with 
decreased psychomotor speed in patients with major depressive disorder. Brain Behav 
Immun. 56:281-288. doi: 10.1016/j.bbi.2016.03.025. 
Greenwood BN, Strong PV, Brooks L, Fleshner M (2008) Anxiety-like behaviors 
produced by acute fluoxetine administration in male fischer 344 rats are prevented by 
prior exercise. Psychopharmacolgy (Berl.), 199(2) 209-22.  
Guay DR (2010) Tetrabenazine, a monoamine-depleting drug used in the treatment of 
hyperkinetic movement disorders. Am J Geriatr Pharmacother 8: 331-373. doi: 
10.1016/j.amjopharm.2010.08.006  
Hodggets S, Gallagher P, Stow D, Ferrier N, O’Brien JT (2017) The impact and 
measurement of social dysfunction in late-life depression: an evaluation of current 
methods with a focus on wearable technology. Int J Geriatr Psychiatry, 32(3) 247-255. 
Holmes A, Yang RJ, Murphy DL, Crawley JN (2002) Evaluation of antidepressant-
related behavioral responses in mice lacking the serotononin transporter. 
Neuropsychopharmacology, 27(6) 914-23. 
Holmes A, Murphy DL, Crawley JN (2003) Abnormal behavioral phenotypes of 
serotonin transporter knockout mice: parallels with human anxiety and depression. Biol 
Psychiatry 54 953-959 
Hieronymus F, Emilsson JF, Nilsson S, Erikson E. (2016). Consistent superiority of 
selective serotonin reuptake inhibitors over placebo in reducing depressed mood in 
patients with major depression. Mol Psychiatry. 21: 523-530. 
Ichikawa I, Meltzer HY. (1995). Effect of antidepressants on striatal and accumbens 
extracellular dopamine levels. Eur J Pharmacol, 281(3) 255-261. 
138 
 
Jang DP, Lee SH, Park CW, Lee SY, Kim YB, Cho ZH. (2009). Effects of fluoxetine on 
the rat brain in the forced swimming test: A [F-18]FDG micro-PET imaging study. 
Neuroci Lett. 451:60-64. 
Katz, M. M., Tekell, J. L., Bowden, C. L., Brannan, S., Houston, J. P., Berman, N., & 
Frazer, A. (2004). Onset and early behavioral effects of pharmacologically different 
antidepressants and placebo in depression. Neuropsychopharmacology, 29: 566 
Keppel, G., 1991. Design and Analysis: A Researcher's Handbook. Prentice-
Hall, Englewood Cliffs, New Jersey. 
Knapen J, Vancampfort D, Moriën Y, Marchal Y. (2015). Exercise therapy improves 
both mental and physical health in patients with major depression. Disabil 
Rehabil. 37:1490-1495. doi:10.3109/09638288.2014.972579.  
Kulesskaya N, Voikar V. (2014). Assessment of mouse anxiety-like behavior in the light-
dark box and open-field arena: role of equipment and procedure. Physiol Behav. 133: 30-
38. doi: 10.1016/j.physbeh.2014.05.006.  
Kurt M, Arik AC, Celik S. (2000). The effects of sertraline and fluoxetine on anxiety in 
the elevated plus-maze in mice. J Basic Clin Physiol Pharmacol, 11: 173-180. 
Lambert KG. (2006). Rising rates of depression in today's society: Consideration of the 
roles of effort-based rewards and enhanced resilience in day-to-day functioning. Neurosci 
Biobehav Rev. 30: 497-510. 
Lister RG. (1987). The use of a plus-maze to measure anxiety in the mouse. 
Psychopharmacology (Berl). 92: 180-185. 
López-Cruz L, Pardo M, Salamone JD, Correa M. (2014). Differences between the 
nonselective adenosine receptor antagonists caffeine and theophylline in motor and mood 
effects: studies using medium to high doses in animal models. Behav Brain Res 270: 213-
222. doi: 10.1016/j.bbr.2014.05.020. 
López-Cruz L, San Miguel N, Carratalá-Ros C, Monferrer L, Salamone JD, Correa M. 
(2018). Dopamine depletion shifts behavior from activity based reinforcers to more 
sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral 
striatum DARPP32 phosphorylation patterns. Neuropharmacol 138: 349-359. doi: 
10.1016/j.neuropharm.2018.01.034.  
139 
 
Lucki I, Dalvi A, Mayorga AJ. (2001). Sensitivity to the effects of pharmacologically 
selective antidepressants in different strains of mice. Psychopharmacology (Berl). 155: 
315-322. 
Michelson D, Amsterdam JD, Quitkin FM, Reimherr FW, Rosenbaum JF, Zajecka J, 
Sundell KL, Kim Y, Beasley CM (1999). Changes in weight during a 1-year trial of 
fluoxetine. Am J Psychiatry, 156(8) 1170-6 
Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa 
M, Salamone JD. (2014). Effort-related motivational effects of the pro-inflammatory 
cytokine interleukin 1-beta: Studies with the concurrent fixed ratio 5/chow feeding choice 
task. Psychopharmacology (Berl). 231: 727-736. 
Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz 
L, Correa M, Salamone JD. (2013). Effort-related motivational effects of the VMAT-2 
inhibitor tetrabenazine: implications for animal models of the motivational symptom of 
depression. J Neurosci 33:19120-19130. doi: 10.1523/JNEUROSCI.2730-13.2013 
Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Luigi P, Carrasco JL, Sthal S. 
(2007). The other face of depression, reduced positive affect: the role of catecholamines 
in causation and cure. J Psychopharmacol. 21: 461-471. 
Padala PR, Padala KP, Monga V, Ramirez DA, Sullivan DH. (2012). Reversal of SSRI-
associated apathy syndrome by discontinuation of therapy. Ann Pharmacother. 46:e8. doi: 
10.1345/aph.1Q656. 
Pardo, M., López-Cruz, L., Valverde, O., Ledent, C., Baqi, Y., Müller, C. E., ... & Correa, 
M. (2012). Adenosine A2A receptor antagonism and genetic deletion attenuate the effects 
of dopamine D2 antagonism on effort-based decision making in 
mice. Neuropharmacology, 62(5-6), 2068-2077. 
Pardo, M., López-Cruz, L., San Miguel, N., Salamone, J. D., & Correa, M. (2015). 
Selection of sucrose concentration depends on the effort required to obtain it: studies 
using tetrabenazine, D 1, D 2, and D 3 receptor 
antagonists. Psychopharmacology, 232(13), 2377-2391. 
Pettibone DJ, Totaro JA, Pflueger AB. (1984). Tetrabenazine-induced depletion of brain 
monamines: characterization and interaction with selected antidepressants. Eur J 
Pharmacol. 102: 425-430. 
140 
 
Petit-Demouliere B; Chenu F, Bourin M. (2005). Forced swimming test in mice: a review 
of antidepressant activity. Psychopharmacology. 177:245-255. 
Podurgiel SJ, Milligan MN, Yohn SE, Purcell LJ, Contreras-Mora HM, Correa 
M, Salamone JD. (2015). Fluoxetine Administration Exacerbates Oral Tremor and 
Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. 
Neuropsychopharmacology. 40:2240-2247. doi: 10.1038/npp.2015.69. 
Podurgiel SJ, Yohn SE, Dortche K, Correa M, Salamone JD. (2016). The MAO-B 
inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the 
VMAT-2 inhibitor tetrabenazine. Behavioural brain research, 298, 188-191. 
Porsolt RD, Bertin, A, Jalfre M. (1977). Behavioral despair in mice: a primary screening 
test for antidepressants. Arch Int Pharmacodynam Therap, 229: 327-336. 
Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P1, Pandit 
S1, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. (2014). 
The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a 
progressive ratio/chow feeding choice task: reversal with antidepressant drugs. PLoS 
One, 9(6), e99320. 
Rostchild AJ, Raskin J, Wang CN, Marangell LB, Fava M. (2014). The relationship 
between change in apathy and changes in cognition and functional outcomes in currently 
non-depressed-SSRI-treated patients with major depressive disorder. Compr Psychiatry. 
55: 1-10.  
Rotolo RA, Dragacevic V, Kalaba P, Urban E, Zehl M, Roller A, Wackerlig J, Langer T, 
Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, Correa M, 
Lubec G, Salamone JD (2019) The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-
123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting 
Agent Tetrabenazine and Increases Progressive Ratio Responding. Front Pharmacol 
10:682. doi: 10.3389/fphar.2019.00682. 
Rizvi SJ, Salomons TV, Konarski JZ, Downar J, Giacobbe P, McIntyre RS, Kennedy SH. 
(2013). Neural response to emotional stimuli associated with successful antidepressant 
treatment and behavioral activation. J Affect Disord. 151: 573-581. 
Rosenblau G, Sterzer P, Stoy M, Park S, Friedel E, Heinz A, Pilhastch M, Bauer M, 
Ströhle A. (2012). Functional neuroanatomy of emotion processing in major depressive 
141 
 
disorders is altered after successful antidepressant therapy. J Psychopharmacol. 26: 1424-
1433. 
Sanmukhani J, Anovadiya A, Tripathi CB (2011) Evaluation of antidepressant like 
activity of curcumin and its combination with fluoxetine and imipramine: an acute and 
chronic study. Acta Pol Pharm, 68(5) 769-75. 
Salamone JD (2007) Functions of mesolimbic dopamine: changing concepts and shifting 
paradigms. Psychopharmacology (Berl), 191(3) 389. 
Sanders CA, Hussain AJ, Hen R, Zhuang X (2007) Chronic blockade or constitutive 
deletion of the serotonin transporter reduces operant responding for food reward. 
Neuropshychopharmacology, 32 2321-2329. 
Serralde-Zúñiga A, González-Garay AG, Rodríguez-Carmona Y, Melendez G (2019). 
Fluoxetine for adults who are overweight or obese. Cochrane Database Syst Rev, 
10:CD011688. doi: 10.1002/14651858.CD011688.pub2. 
Shafiei N, Gray M, Viau V, Floresco SB. (2012). Acute stress induces selective 
alterations in cost/benefit decision-making. Neuropsychopharmacology. 37:2194-2209. 
Silverstone T. (1992). Appetite suppressants. A review. Drugs. 43:820-836. 
Slattery DA, Cryan JF. (2012). Using the rat forced swim test to assess antidepressant-
like activity in rodents. Nar Protoc. 7:1009-1014. doi: 10.1038/nprot.2010.044 
Stahl SM (2017) Guidelines for the recognition and management of mixed depression. 
CNS Spectr, 22(2) 203-219 
Sthal SM (2002) The psychopharmacology of energy and fatigue. J. Clin. Psychiatry, 
63(1) 7-8.  
Stenman E, Lilja A. (2013). Increased monoaminergic neurotransmission improves 
compliance with physical activity recommendations in depressed patients with fatigue. 
Med Hypotheses. 80:47-49. 
Targum SD, Fava M. (2011). Fatigue as a residual symptom of depression. Innov Clin 
Neurosci. 8:40-43. 
142 
 
Treadway MT, Bossaller NA, Shelton RC, Zald DH. (2012). Effort-based decision-
making in major depressive disorder: a translational model of motivational anhedonia. J 
Abnorm Psychol. 121:553-558. doi: 10.1037/a0028813. 
Treadway MT, Zald DH. (2011). Reconsidering anhedonia in depression: lessons from 
translational neuroscience. Neurosci Biobehav Rev. 35: 537-555. 
Tylee A. (1999). Depression in the community: physician and patient perspective. J Clin 
Psychiatry. 60:12-16. 
Wang H, Chen X, Li Y, Tang TS, Bezprozvanny I. (2010). Tetrabenazine is 
neuroprotective in Huntington's disease mice. Molecular Neurodegeneration 5:18. doi: 
10.1186/1750-1326-5-18. 
Yang J-H, Presby RE, Jarvie AA, Rotolo RA, Fitch RH, Correa M, Salamone JD. (2019). 
Pharmacological studies of effort-related decision making using mouse touchscreen 
procedures: Effects of dopamine antagonism do not resemble reinforcer devaluation by 
pre-feeding. Psychopharmacology (Berl). doi: 10.1007/s00213-019-05343-8  
Yohn SE, Thompson C, Randall PA, Lee CA, Müller CE, Baqi Y, Correa M, Salamone 
JD. (2015a). The VMAT-2 inhibitor tetrabenazine alters effort-related decision making 
as measured by the T-maze barrier choice task: reversal with the adenosine A2A 
antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacol. 
232:1313-1323. doi: 10.1007/s00213-014-3766-0. 
Yohn SE, Santerre JL, Nunes EJ, Kozak R, Podurgiel SK, Correa M, Salamone JD 
(2015b) The role of dopamine D1 receptor transmission in effort-related choice behavior: 
Effects of D1 agonists. Pharmacol Biochem Behav 135: 217-226. doi: 
10.106/j.pbb.2015.05.003 
Yohn SE, Collins SL, Contreras-Mora HM, Errante EL, Rowland MA, Correa M, 
Salamone JD. (2016a). Not all antidepressants are created equal: differential effects of 
monoamine uptake inhibitors on effort-related choice behavior. 
Neuropsychopharmacoly. 41:686-694 doi: 10.1038/npp.2015.188 
Yohn SE, Errante EE, Rosenbloom-Snow A, Somerville M, Rowland M, Tokarski K, 
Zafar N, Correa M, Salamone JD. (2016b). Blockade of uptake for dopamine, but not 
norepinephrine or 5-HT, increases selection of high effort instrumental activity: 
143 
 
Implications for treatment of effort-related motivational symptoms in psychopathology. 
Neuropharmacology. 109:270-280. doi: 10.1016/j.neuropharm.2016.06.018.  
Yohn SE, López-Cruz L, Hutson PH, Correa M, Salamone JD. (2016c). Effects of 
lisdexamfetamine and s-citalopram, alone and in combination on effort-related choice 
behavior in the rat. Psychopharmacol. 233:949-960. doi: 10.1007/s00213-015-4176-7 
 
 
 
  
144 
 
  
145 
 
  
Are there sex differences in emotional and motivational 
parameters in mice after dopamine depletion? Modulation 
by DAT and SERT blockers. 
CHAPTER IV 
146 
 
Abstract 
Disorders such as depression is twice as common in women than in men, and there are 
sex differences in the symptomatology and treatment response to this disorder. 
Mesolimbic dopamine (DA) has been implicated in effort-based decision making and in 
behavioral activation. Impairments in behavioral activation such as anergia are often seen 
in people with depression and are highly resistant to treatment. The role of DA in 
regulating behavioral activation has been extensively studied in male rodents, but little is 
known about activational processes in female rodents. In the present work, we study the 
impact of Tetrabenazine (TBZ) in male and female mice on measures of behavioral 
activation such as the Forced Swim Test (FST) and in the 3-choice-T-maze task. Social 
Interaction (SI), anxiety in the Dark and Light (DL) box and Elevated Plus Maze (EPM) 
and sucrose preference were also evaluated. TBZ reduced active behaviors in the FST 
such as climbing in male mice and increased immobility both in male and female mice. 
DA depletion reduced active behaviors (running) in the T-maze task and increased time 
doing more sedentary activities (consuming sucrose pellets) in both sexes. There were no 
major differences between sexes in SI, DL and sucrose preference even after TBZ. 
Finally, the DAT blocker bupropion, reversed the effect of DA depletion in both sexes. 
However, the SERT blocker fluoxetine, was only effective in female mice. These results 
indicate that DA is involved in behavioral activation, and thus, pro-dopaminergic 
antidepressants may be able to improve impairments related to reduce behavioral 
activation.  
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Introduction 
Preclinical studies using animal models have characterized some common symptoms seen 
in psychiatric disorders in male rodents avoiding, most of the time, performing the same 
experiments in female rodents (Zucker and Beery, 2010; Dalla et al, 2010a). This is also 
true for the study of depression, in spite of the fact that depression is twice as common in 
women than in men (Kessler, 2003; Seedat et al, 2009; Parker and Brotchie, 2010; 
Silverstein et al, 2002). Moreover, there are sex differences in the progress and the 
symptomatology of this disorder (Gorman, 2006; Marcus et al, 2005; Thiels et al, 2005). 
Clinical studies have found differences between women and men in antidepressant 
response. Thus, it seems that antidepressants that inhibits the serotonin transporter 
(SERT) such as fluoxetine or citalopram have a better outcome in women, while men are 
more likely to be more responsive for tricyclic antidepressants (Khan et al, 2005; Young 
et al, 2009; Kornstein et al, 2000). 
One of the most commonly used animal models to study differences between male and 
female rodents is the Forced Swim Test (FST). This paradigm, evaluates the attempt of 
rodents to escape in a vigorous way from a stressful non-escapable situation, being in this 
case a deep tank filled with water (Porsolt et al., 1977). Eventually, animals will cease 
the vigorous attempts to escape and will passively float in the chamber (Porsolt et al., 
1977). Thus, immobility is the classical parameter that is measured and antidepressants 
have repeatedly shown to reverse this immobility (Armario et al, 1988; Petit-Demouliere 
et al, 2005; Costa et al, 2013). Studying sex differences in the FST, few studies have 
found that female mice and rats increase the immobility time in comparison with male 
rodents (Kokras et al, 2012; Kokras et al, 2015), and this effect is alleviated in female 
rodents following the administration of SERT inhibitors. Specifically, regarding 
immobility, female rats and mice are more responsive to SERT inhibitors than male 
rodents (Kokras et al, 2015; Férnandez-Guasti et al, 2017; Dalla et al, 2010a; Jones and 
Lucki, 2005). Other behaviors that can be evaluated in the FST are swimming and 
climbing. Both behaviors are considered active behaviors that also are modified by 
antidepressants (Armario et al, 1988; Lucki, 1997), and are likely to be affected by DA 
manipulations, more than the traditional immobility measure (Gil and Armario, 1998; 
Costa et al, 2013). However, little is known about the differences between male and 
female rodent in the execution of these two behaviors. Some animal studies have found 
that, under basal conditions, female rodents display less climbing than male rodents, 
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suggesting that females are less active than males, and antidepressant drugs are able to 
enhance climbing behavior in female rodents (Kokras et al, 2015; Martínez-Mota et al, 
2011). Other studies fail to detect sex differences on climbing and swimming in the FST 
(Mourlon et al, 2010; Verma et al, 2010). Moreover, there are no studies that observed 
the effect of pro-dopaminergic drugs on modulation of climbing in female rodents 
assessed in the FST. 
DA modulation can be studied using effort-related decision-making tasks where rodents 
have to choose between exerting effort in order to obtain a higher and preferred reinforcer 
or minimizing their work and obtaining a lower and less preferred reinforcer (Salamone 
et al, 2016c, 2018; Salamone and Correa, 2012, 2002). Thus, animals with DA depletion 
or receptor antagonism seem to shift their behaviors from high value/high demanding 
options to low-effort but less valued ones (Cousins et al, 1994; Salamone et al, 2002, 
2016; Mott et al, 2009; Pardo et al, 2012, 2015; Randall et al, 2012; Mai et al, 2012; 
Sommer et al, 2014; Yohn et al, 2015a,b). Moreover, behavioral activation and effort-
based choice can be also evaluated using a novel animal paradigm: the 3-choice-T maze 
task (Correa et al, 2016; López-Cruz et al, 2018; Carratalá-Ros et al, 2020). Voluntary 
wheel running takes place in mice of all strains and in both sexes (Walker and Manson, 
2018). Mice have a high preference for engaging in physical activities (Routtenberg et al, 
1968; Correa et al, 2016; López-Cruz et al, 2018; Carratalá-Ros et al, 2020). Thus, this 
T-maze task allows mice to freely choose between doing an active behavior (running on 
a running wheel) or doing more sedentary activities (consuming sucrose pellets or sniffing 
a non-social odor). Tetrabenazine (TBZ) has been used in these kind of tasks in order to 
alter behavioral activation and decrease selection of high effort choices in rats (Nunes et 
al, 2013; Randall et al, 2014; Pardo et al, 2015; Yohn et al, 2015a,b, 2016a; Hosking et 
al, 2015; Rotolo et al, 2019) and mice (Correa et al, 2018; Carratalá-Ros et al, 2020). TBZ 
acts depleting monoamines by inhibiting the vesicular monoamine transporter-type 2 
(VMAT-2), and at low doses this drug has its greatest effects on striatal DA in rats and mice 
(Pettibone et al, 1984; Nunes et al, 2013; López-Cruz et al, 2018). Thus, TBZ produces a 
decrease in effortful activities (such as lever pressing at high ratios in FR/choice and 
PROG/choice tasks) to get palatable reinforcers, but increases the consumption of free 
chow available without affecting preference for food (Rotolo et al, 2019; Nunes et al, 
2013; Salamone et al, 2002; Cousins et al, 1996; Salamone et al, 1994b; Sink et al, 2008). 
TBZ also partially shifts choice behavior in adult male mice, reducing time running but 
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increasing time eating sucrose pellets in the T-maze task (López-Cruz et al, 2018; 
Carratalá-Ros et al, 2020).   
The effects of DA depletion in effort-related decision-making tasks using male rodents 
are well described, but there are no studies on behavioral activation impairments in female 
rodents using this kind of tasks. Thus, the aim of this study is twofold: first we explored 
the impact of an effective dose of TBZ used previously in male mice, comparing its effect 
between female and male mice in two paradigms that evaluate exertion of effort, either to 
escape a stressful situation in the FST, or by selecting a vigorous and reinforcing activity 
in the effort-based decision-making task: the 3-choice T-maze task (Correa et al, 2016; 
López-Cruz et al, 2018; Carratalá-Ros et al, 2020). We additionally assessed the impact 
of TBZ on paradigms that evaluate behaviors shaped by emotional factors, such as 
responses in anxiogenic environments (dark and light box; DL and elevated plus maze; 
EPM), or avoidance of novel social stimuli (evaluated in a social interaction task) and 
also preference and consumption of liquid sucrose that is often related to anhedonia-like 
behaviors. Secondly, we studied and compared in male and female mice the ability of two 
antidepressants with different mechanisms of action bupropion (catecholamine uptake 
blocker) and fluoxetine (SERT inhibitor) to reverse the effect produced by TBZ in the 
FST.  
 
Materials and Methods 
Animals. CD1 adult male and female mice (N=340) purchased from Janvier, France S.A. 
were 7-9 weeks old (25-50 g) at the beginning of the study. Mice were housed in groups 
of three or four per cage, with standard laboratory rodent chow and tap water available 
ad libitum. The colony was kept at a temperature of 22 +  2 ºC with lights on from 08:00 
to 20:00 h. All animals were under a protocol approved by the Institutional Animal Care 
and Use committee of Universitat Jaume I. All experimental procedures complied with 
directive 2010/63/EU of the European Parliament and of the Council, and with the 
“Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral 
Research”, National Research Council 2003, USA. All efforts were made to minimize 
animal suffering, and to reduce the number of animals used.  
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Pharmacological agents. Tetrabenazine (TBZ; CIMYT Quimica SL, Spain) was 
dissolved in a vehicle solution of 0.9% saline (80%) plus dimethylsulfoxide (DMSO 20%, 
final pH 5.5) and administered 120 minutes before testing. Time elapsed after injection 
and 8 mg/kg TBZ was selected based on previous behavioral work (López-Cruz et al, 
2018; Correa et al, 2018; Carratalá-Ros et al, 2020) and neurochemical studies (López-
Cruz et al, 2018) demonstrating that in mice this is an optimal dose and time lead to 
deplete DA. Bupropion hydrochloride (BUP; Alfa Aesar, Spain) was dissolved in 0.9% 
saline. Bupropion was administered 30 minutes before the test started. Doses and times 
were selected from previous work in our laboratory (Randall et al, 2014a,b; Yohn et al, 
2015a) and from studies with the forced swim test  (Yamada et al, 2004; Kitamura et al, 
2010). Fluoxetine (CIMYT Quimica SL, Spain) was dissolved in 0.9% saline and 
administered 30 minutes before testing. The range of doses of fluoxetine were based on 
studies involving classical mice antidepressant screening tests (Lucki et al, 2001) and 
effort-related behavioral tests (Yohn et al, 2016a,b) DMSO (20% v/v) and saline were 
used as the control group. All the substances were administered intraperitoneally (IP). 
 
Testing procedures 
All behavioral procedures started two hours after the light period started. The behavioral 
test room was illuminated with a soft light, and external noise was attenuated. 
Forced swim test (FST). This paradigm is considered to be a model of behavioral despair 
and is used as a test for assessing depressive-like states and for evaluating drugs with 
potential as antidepressants (Porsolt et al, 1977). Immobility was defined when the animal 
remained motionless, making only minor movements to balance the body and keep the 
head above the water. In addition, we also assessed escape related mobility such as 
climbing or struggling (Armario et al, 1988). Climbing is defined as any energetic and 
vertical movement of all four limbs against the wall of the tank. Mild swimming was 
recorded when animals carried out horizontal movements with their forepaws, leading to 
the displacement of the body throughout the swim chamber (Armario et al, 1988). Naïve 
male and female mice were placed in a transparent cylindrical glass tank (26 cm high and 
18 cm diameter) filled with water (14 cm) and maintained at a temperature of 25ºC. Water 
was changed between animals. During the 6 minutes test, mice were videotaped from the 
side, and climbing, immobility and swimming were later measured by an observer 
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unaware of the experimental condition. After the test, mice were dried with a soft towel, 
put back in a box with absorbing paper under a warming light, and were monitored for 10 
minutes.  
Dark and light box (DL). The DL test is based on the conflict between the tendency to 
explore a novel environment and the avoidance of a brightly lighted open area (Blumstein 
and Crawley 1983). The DL apparatus consisted of a polypropylene chamber divided in 
two compartments by a partition containing a small opening (5 cm H x 5 cm W). The 
light compartment (25 cm W x 25 cm H x 25 cm L) was open, painted in white and 
illuminated (335 lx), while the dark compartment (25 cm W x 25 cm H x 18 cm L) was 
painted in black and had a removable ceiling to close it (Kulesskaya and Voikar, 2014). 
To start the test session, mice were individually placed in the dark chamber facing one 
corner. Test sessions were videotaped, and the total number of crosses and the total time 
spent in the lit chamber were recorded for 5 min (López-Cruz et al, 2014; Carratalá-Ros 
et al, 2020). 
Elevated plus maze (EPM). The EPM consists of two open and two enclosed arms (65 
cm L x 5 cm W) arranged in a plus configuration and intersecting in a central platform. It 
is made of black polypropylene and is elevated 50 cm above the floor. The open arms 
have a 1 cm border around their perimeter and the closed arms have a 20 cm translucent 
wall. This anxiety paradigm measures the avoidance that rodents show to high open 
spaces. Under normal conditions, mice spend more time, and make more entries into the 
closed arms of the maze (Lister 1987). Animals were placed in the central platform with 
their head pointing at one enclosed arm, and they were assessed during 5 minutes. 
Sessions were videotaped and a trained observer registered total time spent in the open 
arms, and total entries in the 4 arms as an index of locomotion. An entry into an arm was 
recorded when the animal crossed with all four legs the line that connected that arm with 
the central platform (procedure is based on López-Cruz et al, 2014). 
Social preference test. Social interaction and preference was measured in a three-
chambered social box. Every mouse was placed in the center of the chamber of the social 
interaction apparatus and they freely explored the social arena during 10 minutes in the 
presence of a cage conspecific on one side-compartment, and on the other side there was 
a small wire cage containing an object. The center compartment was empty. The 
placement of the conspecific or the object was counterbalanced between animals. A 
trained experimenter who was unaware of the experimental conditions, registered 
152 
 
manually time spent sniffing each target (conspecific vs object) as a measure of social 
preference. Time spent in each compartment and crosses between compartments was also 
registered. Procedures were based on López-Cruz et al, 2016. 
Liquid sucrose consumption and preference. During 3 days, non-food restricted mice 
were place individually in standard home cages where they had ad libitum access to two 
different sucrose liquid concentrations: 10% and 5% sucrose. The amount of sucrose 
liquid consumed of both conditions was registered during the test day. All sessions lasted 
60 minutes. 
T-maze RW-sucrose-odor choice task. The T-maze apparatus consisted of a central area 
that leads to 3 arms. In one of them, sucrose pellets (TestDietTM, 50% sucrose, 45 mg 
each) were available, in another arm there was a RW, and in the third arm there was a 
hole with a cotton ball socked with a fruit odor (based on López-Cruz et al, 2018). This 
concentration of sucrose in the pellets was selected after piloting different concentrations 
(i.e. 100% sucrose pellets generate avoidance), and the non-social odor used for the 
present studies (strawberry) was the one that generated more exploration among non-
social odors in previous studies (López-Cruz et al, 2017). In general, mice were allowed 
to freely explore and interact with the stimulus during 15 minutes sessions, once a day, 5 
days a week. Training phase 1: to avoid neophobia to the sweet tasting pellets, animals 
were enclosed in that arm with the food during 5 sessions (no exploration of the other 
arms was allowed during this phase). Training phase 2: during 2 weeks animals had free 
access to the three stimuli until a stable baseline was obtained. Test phase: This phase 
lasted during 4 more weeks. For each week, there were 4 baseline drug free sessions plus 
a testing session in which animals received TBZ or were tested under different behavioral 
manipulations. The day before the test for the behavioral manipulation was considered as 
the baseline (BL) for those experiments. Sessions were videotaped and a trained observer 
manually registered several parameters. Time interacting with the stimulus was selected 
as the main dependent measure because it allowed for the evaluation of the three stimuli 
with the same units. Time allocation is a useful measure of preference, relative 
reinforcement value, and response choice (Baum and Rachlin, 1969). Entries into the 
arms and time spent in the arms of the T-maze were also simultaneously recorded. All 
these measures were taken based on previous studies (Correa et al., 2016; López-Cruz et 
al, 2018; Carratalá-Ros et al, 2020). 
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Experiments 
Experiment 1. Effect of TBZ in male and female mice on behavioral activation 
evaluated in the FST. Naïve male (n=20) and female mice (n=20) received TBZ (vehicle 
or 8 mg/kg) and their behavioral output was measured in the FST.  
Experiment 2. Effect of TBZ on anxiety parameters in male and female mice as 
measured in the DL and EPM paradigms. Male (n=26) and female (n=26) mice 
received TBZ (0, and 8 mg/kg) and after 120 minutes were first placed in the DL box for 
5 minutes, and immediately after this test, they were placed in the EPM for 5 more 
minutes. Mice were exposed only once to both paradigms, since behavioral habituation 
develops in one session. 
Experiment 3. Effect of TBZ on social motivation in male and female mice assessed 
in a three-chamber social preference test. Male and female mice (N=37; 19 males and 
18 females) received TBZ (vehicle or 8 mg/kg) and were placed in a social preference 
box during 10 minutes.  
Experiment 4. Effect of TBZ on preference for sucrose concentration and on fluid 
consumption in male and female mice. Male mice (n=25) and female mice (n=23) 
received vehicle or 8 mg/kg TBZ and were exposed concurrently to a bottle containing 
water with 5% sucrose and another bottle with 10% sucrose solution during 60 minutes.  
Experiment 5. Effect of TBZ on preference for active reinforcers assessed in the 3-
choice-T-maze task in male and female mice. Male (n=14) and female (n=13) mice 
received TBZ (vehicle and 8 mg/kg) and after 120 minutes, were placed in the T-maze 
for 15 minutes. Animals received one dose of the drug every week in a randomly varied 
order. The T-maze paradigm requires a baseline performance of two weeks before tests 
starts, and that performance is maintained across weeks, thus allowing a repeated 
measures design.  
Experiment 6. Effect of TBZ and bupropion combination on behavioral activation 
assessed in the FST in male and female mice. Three groups of naïve male mice (n=38) 
and three groups of naïve female mice (n=38) received a combination of TBZ and 
bupropion (vehicle + vehicle, 8 mg/kg TBZ + vehicle and 8 mg/kg TBZ + 10 mg/kg BUP) 
and were assessed in the FST during 6 minutes.  
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Experiment 7. Effect of TBZ and fluoxetine combination on behavioral activation 
assessed in the FST in male and female mice. Male mice (n=36) and female mice 
(n=36) received vehicle plus vehicle, 8 mg/kg TBZ plus vehicle or 8 mg/kg TBZ plus 20 
mg/kg FLX and were exposed to the FST during 6 minutes.  
 
Statistical Analyses. Normally distributed and homogenous data (according to 
Kolmogorov-Smirnov test) for the FST, DL, EPM, social interaction, and sucrose liquid 
intake were evaluated by a two-way factorial ANOVA (sex x treatment) in which both 
were between factors. For the T-maze experiments data were evaluated by two-way 
factorial ANOVAs with a between factor (sex) and a within factor (treatment). If the sex 
factor was significant, two separate Students-t test for each sex comparing the effect of 
treatment were performed. For experiments 6 and 7, additional one-way ANOVAs for the 
factor treatment in each sex were performed and when the overall ANOVA was 
significant, non-orthogonal planned comparisons using the overall error term were used 
(Keppel, 1991). For these comparisons, α level was kept at 0.05 because the number of 
comparisons was restricted to the number of treatments minus one. All data were 
expressed as mean ± SEM, and significance was set at p<0.05. STATISTICA 7 software 
was used. 
 
Results 
Experiment 1. Effect of TBZ in male and female mice on behavioral activation 
evaluated in the FST. Factorial ANOVA (sex x treatment) on time spent immobile in 
the FST showed a significant effect of treatment (F(1,1)=18.99, p<0.01), but no effect of 
sex (F(1,1)=0.75, p=0.38), and no significant interaction (F(1,36)=0.002, p=0.95) (Figure 
1A). The factorial ANOVA on time swimming showed an effect of treatment 
(F(1,1)=15.06, p<0.01), but there was no significant effect of sex (F(1,1)=0.06, p=0.80), 
and no interaction (F(1,36)=0.29, p=0.58; Figure 1B). Finally, the factorial ANOVA on 
time climbing in the FST showed an effect of sex (F(1,1)=10.41, p<0.01), and also a 
significant effect of treatment (F(1,1)=7.46, p<0.01), but there was no significant 
interaction (F(1,36)=2.89, p=0.09), (Figure 1C).  
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Figure 1. Effect of vehicle or TBZ (8 mg/kg) in male and female mice on measures of behavioral 
activation as duration of immobility (A), swimming (B) and climbing (C) in the FST assessed 
during 6 minutes. Bars represent mean ± S.E.M of accumulated seconds. **p<0.01 significantly 
different from vehicle. ##p<0.01 significant differences between male and female mice.  
 
Experiment 2. Effect of TBZ in male and female mice on anxiety as measured in the 
DL and EPM paradigms. Factorial ANOVA (sex x treatment) on time spent in the lit 
chamber of the DL box showed no effect of sex (F(1,1)=3.12, p=0.08), no effect of 
treatment (F(1,1)=0.02, p=0.94), and no interaction (F(1,30)=0.82, p=0.37) (Figure 2A). 
However, factorial ANOVA (sex x treatment) on total number of crosses between 
compartments in the DL box showed an effect of treatment (F(1,1)=13.63, p<0.01), but 
there was no effect of sex (F(1,1)=1.04, p=0.31), and no interaction (F(1,30)=3.49, 
p=0.07) (Figure 2B). 
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Factorial ANOVA (sex x treatment) on time spent in the open arms of the EPM showed 
a significant effect of sex (F(1,1)=81.40, p<0.01), but no effect of treatment 
(F(1,1)=0.002, p=0.96), and no interaction (F(1,31)=0.30, p=0.58) (Figure 2C). 
Furthermore, the factorial ANOVA (sex x treatment) on total of entries in the EPM 
showed an effect of sex (F(1,1)=152.72, p<0.01), but no effect of treatment (F(1,1)=1.75, 
p=0.19) and no interaction (F(1,31)=0.01, p=0.91) (Figure 2D) 
 
Figure 2. Effect of vehicle or TBZ (8 mg/kg) in male and female mice evaluated in the DA and 
in the EPM paradigms; time spent in the lit chamber (A), total of entries between the two 
compartments (B) of the DL box, time spent in the open arms (C), and total of entries to the four 
arms (D) of the EMP during two consecutive 5 minutes periods. Bars represent mean ± S.E.M. of 
accumulated seconds or number of crosses. **p<0.01 significantly different from vehicle, 
##p<0.01 significant differences between male and female mice.  
 
Experiment 3. Effect of TBZ on social motivation in male and female mice assessed 
in a three-chamber social preference test. Factorial ANOVA (sex x treatment) on time 
spent in the object compartment did not show an effect of sex (F(1,1)=3.03, p=0.09), or 
treatment (F(1,1)=1.55, p=0.22), and there was no significant interaction (F(1,33)=1.85, 
p=0.18). The same statistical pattern was obtained for time in the conspecific 
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compartment; no effect of sex (F(1,1)=1.99, p=0.16), or treatment (F(1,1)=0.15, p=0.70), 
and no interaction (F(1,33)=0.98, p=0.32).  
Moreover, the factorial ANOVA on time interacting with the object did not show a 
statistically significant effect of sex (F(1,1)=3.20, p=0.08), or treatment (F(1,1)=2.45, 
p=0.12), and no interaction (F(1,33)=0.03, p=0.84). Finally, the factorial ANOVA on 
time interacting with the conspecific showed no effect of sex (F(1,1)=1.00, p=0.32), or 
treatment (F(1,1)=0.09, p=0.75), and no interaction (F(1,33)=1.43, p=0.24). Data are 
shown in table 1.  
 
Table 1. Effect of TBZ (vehicle or 8 mg/kg) in male and female mice on time sniffing the 
conspecific, time sniffing the object, time spent in the conspecific compartment, and time spent 
in the object compartment in the social preference test assessed during 10 minutes. Bars represent 
mean ± S.E.M of accumulated seconds. 
 
Experiment 4. Effect of TBZ on preference for sucrose concentration and on fluid 
consumption in male and female mice. Factorial ANOVA (sex x treatment) on the 
amount of 5% liquid sucrose consumed did not show an effect of sex (F(1,1)=0.56, 
p=0.45), or treatment (F(1,1)=0.84, p=0.36), and no interaction (F(1,44)=4.14, p=0.07). 
In addition, the factorial ANOVA on the amount of 10% liquid sucrose consumed did not 
show a significant effect of sex (F(1,1)=1.78, p=0.18), no effect of treatment 
 Time sniffing Time in compartment 
 Conspecific Object Conspecific Object 
TBZ 
(mg/kg) 
Male Female Male Female Male Female Male Female 
0.0 230.2 ± 
12.5 
262.0 ± 
10.7 
263.2 ± 
11.2 
215.2 ±  
17.3 
108.6 ± 
11.8 
134.6 ± 
10.3 
127.8 ± 
10.5 
102.2 ± 
14.5 
8.0 238.2 ± 
14.1 
243.7 ± 
14.7 
261.4 ± 
15.8 
255.5 ± 
17.3 
126.4 ± 
10.1 
124.1 ± 
14.8 
145.3 ± 
14.1 
124.9 ± 
11.0 
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(F(1,1)=1.60, p=0.21), and no interaction either (F(1,44)=1.13, p=0.29). Data are shown 
in figures 3A-B.  
Figure 3. Effect of vehicle or TBZ (8 mg/kg) in male and female mice on the amount of 10% (A) 
and 5% (B) of sucrose solutions consumed during 60 minutes. Bars represent mean ± S.E.M of 
amount of ml consumed.  
 
Moreover, the factorial ANOVA (sex x treatment) on the total of liquid sucrose consumed 
(fluid containing 10% plus fluid containing 5% sucrose) did not show an effect of sex 
(F(1,1)=2.21, p=0.14), or a significant effect of treatment (F(1,1)=3.29, p=0.07), and no 
interaction (F(1,46)=2.13, p=0.15) (Data are shown in Table 2). 
Experiment 5. Effect of TBZ on preference for active reinforcers assessed in the 3-
choice-T-maze task in male and female mice. Factorial ANOVA (sex x treatment) on 
time eating the sucrose pellets showed an effect of treatment (F(1,24)=14.74, p<0.01), 
but there was no effect of sex (F(1,24)=0.64, p=0.42), and no interaction (F(1,24)=0.30, 
p=0.58) (Figure 4A). The factorial ANOVA for time running in the RW showed a 
significant effect of treatment (F(1,24)=4.68, p<0.05), but there was no significant effect 
of sex (F(1,24)=3.41, p=0.07), and no interaction (F(1,24)=1.07, p=0.31) (Figure 4B). 
Finally, the ANOVA on time sniffing the neutral odor in the third arm of the T-maze did 
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not show an effect of sex (F(1,24)=1.32, p=0.26), or treatment (F(1,24)=1.01, p=0.32), 
and no significant interaction (F(1,24)=3.49, p=0.07) (Figure 4C).  
 
Figure 4. Effect of vehicle or TBZ (8 mg/kg) on male and female mice preferences in the 3-
choice-T-maze task on time eating (A), time running (B), and time sniffing (C). Bars represent 
mean S.E.M of accumulated seconds. *p<0.05, **p<0.01 significantly different from vehicle.  
 
A series of independent factorial ANOVAs (sex x treatment) on time spent in each one 
of the T-maze compartments showed that for the food compartment there was an effects 
of sex (F(1,24)=3.88, p<0.05), but not of treatment (F(1,24)=2.91, p=0.10), and no 
significant interaction (F(1,24)=3.89, p=0.35), (figure 5A). The factorial ANOVA on 
time spent in the RW compartment also showed a significant effect of sex (F(1,24)=8.70, 
p<0.01), but no effect of treatment (F(1,24)=1.06, p=0.31), and no interaction 
(F(1,24)=2.40, p=0.13) (Figure 5B). Finally, the ANOVA on time spent in the odor 
compartment did not show an effect of sex (F(1,24)=0.54, p=0.46), or treatment 
(F(1,24)=0.05, p=0.80), and no interaction (F(1,24)=1.89, p=0.18) (Figure 5C) 
The independent factorial ANOVAs on total number of entries to the different 
compartments showed that, for the food compartment, there was a significant effect of 
sex (F(1,24)=27.56, p<0.01) and a significant interaction (F(1,24)=5.39, p<0.05), but 
there was no significant effect of treatment (F(1,24)=2.93, p=0.10). Planned comparisons 
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revealed that female mice that received vehicle significantly entered more times in the 
food compartment in comparison with male mice that received vehicle (p<0.01). 
Moreover, planned comparisons also revealed that TBZ produced different effects on 
male and female mice (p<0.01) TBZ did not produce any significant effect on total of 
entries to male mice in comparison with the vehicle but TBZ-treated female mice 
significantly reduced the total of entries to the food compartment in comparison with the 
vehicle group (Figure 5E). 
The factorial ANOVA on entries to the RW compartment showed a statistically 
significant effect of sex (F(1,24)=19.86, p<0.01), but no effect of treatment 
(F(1,24)=1.84, p=0.18), and no interaction (F(1,24)=1.35, p=0.25) (Figure 5D). Finally, 
a factorial ANOVA (sex x treatment) on entries into the odor compartment showed an 
effect of sex (F(1,24)=5.51, p<0.05), but there was no effect of treatment (F(1,24)=0.12, 
p=0.72), and no interaction (F(1,24)=0.29, p=0.59) (Figure 5F)  
 
Figure 5. Effect of vehicle or TBZ (8 mg/kg) on male and female mice in the T-maze task on 
time spent in each compartment (A-C) and entries into compartments (D-F) assessed during 15 
minutes. Bars represent mean S.E.M of accumulated seconds or number of entries. #p<0.05, 
##p<0.01 significant differences between male and female mice.  
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Furthermore, we analyzed other dependent variables such as total food consumed and 
total ambulation in the T-maze (data are shown in table 2). The factorial ANOVA (sex x 
treatment) on the miligrams of pellets consumed did not show an effect of sex 
(F(1,23)=1.84, p=0.18), or of treatment (F(1,1)=1.72, p=0.20), and no interaction 
(F(1,23)=0.51, p=0.48). Finally, the factorial ANOVA (sex x treatment) on general 
locomotion in the T-maze showed an effect of sex (F(1,24)=25.08, p<0.01), but no effect 
of treatment (F(1,1)=1.95, p=0.17), and no interaction (F(1,24)=3.35, p=0.07).  
 
 
Table 2. Effect of vehicle or TBZ (8 mg/kg) on total sucrose consumed (5% sucrose fluid plus 
10% sucrose fluid), on pellet intake, and on general locomotion in the T-maze task in both sexes. 
Mean (± SEM) of milliliters consumed during the test, or milligrams of palatable pellets 
consumed or crosses between compartments during the T-maze test. ## p<0.01 significant 
differences between sexes.  
 
Experiment 6. Effect of TBZ and bupropion combination on behavioral activation 
assessed in the FST in male and female mice. Factorial ANOVA on immobility 
assessed in the FST did not show a significant effect of sex (F(1,1)=3.07, p=0.08), or sex 
by treatment interaction (F(2,54)=0.44, p=0.64). However, there was an effect of 
treatment (F(1,2)=22.59, p<0.01). Two separate one-way ANOVAs for the factor 
treatment in each sex demonstrated an effect on immobility time in male mice 
(F(2,34)=10.71, p<0.01) and also in female mice (F(2,35)=4.20, p<0.05). In males, 
planned comparisons revealed that TBZ-veh treated mice spent significantly more time 
 Vehicle TBZ 
 Male Female Male Female 
Total sucrose solutions 
consumed (ml) 
1.8 ± 0.2 1.1 ± 0.2 1.0 ± 0.3 1.0 ± 0.1 
Pellet intake (mg) 100.4 ± 21.1 191.3 ± 45.4 176.5 ± 55.2 213.8 ± 41.5 
General locomotion 
(crosses) 
27.0 ± 3.4 73.6 ± 6.5## 28.5 ± 4.2 62.7 ± 9.1## 
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immobile (p<0.01) in comparison with the veh-veh group. Moreover, TBZ-BUP10 mg/kg 
was able to decrease immobility in comparison with the TBZ-veh treated male mice 
(p<0.01). In females, planned comparisons revealed the same pattern of effects than in 
males; TBZ-veh treated females significantly increased immobility compared to the veh-
veh group (p<0.01), and TBZ-BUP10 mg/kg spent less time immobile than TBZ-veh 
treated female mice (p<0.01) (Figure 6A).  
Factorial ANOVA (sex x treatment) on time spent swimming in the FST did not show a 
significant effect of sex (F(1,1)=0.24, p=0.62), and no interaction (F(2,54)=0.73, p=0.48). 
However, there was a significant effect of treatment (F(1,2)=14.72, p<0.01). Separate 
one-way ANOVAs for the factor treatment in each sex demonstrated an effect on 
swimming in male mice (F(2,34)=6.94, p<0.01), and also in female mice (F(2,35)=3.43, 
p<0.05).  Planned comparisons for males revealed that TBZ-veh treated mice spent 
significantly less time swimming in comparison with the veh-veh group (p<0.05), and 
TBZ-BUP10 mg/kg was able to reverse the effect, increasing time male mice spent 
swimming in comparison with the mice TBZ-veh group (p<0.01). In females, planned 
comparisons also showed how TBZ-veh significantly decreased time swimming in 
comparison with the veh-veh group (p<0.01), and the combination of TBZ- BUP10 mg/kg 
significantly increased the time female mice spent swimming in comparison with the 
TBZ-veh treated female mice (p<0.01) (Figure 6B).  
Finally, the factorial ANOVA on climbing showed an effect of sex (F(1,1)=8.46, p<0.01) 
and an effect of treatment (F(1,2)=5.55, p<0.01), but there was no significant interaction 
(F(2,54)=1.10, p=0.33). Separate one-way ANOVAs for the factor treatment in each sex 
demonstrated an effect on climbing in male mice (F(2,34)=4.66, p<0.01), but not in 
female mice (F(2,35)=1.27, p=0.29). Planned comparisons showed that TBZ-veh treated 
male mice reduced significantly climbing in comparison with the veh-veh group (p<0.01) 
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and TBZ-BUP10 mg/kg was able to reverse this effect compared with the TBZ-veh 
treated male mice (p<0.05) (Figure 6C). 
 
Figure 6. Effect of TBZ and bupropion combination (vehicle+vehicle, TBZ+vehicle, TBZ+10 
mg/kg of bupropion) in male and female mice on duration of immobility (A), swimming (B) and 
climbing (C) in the FST assessed during 6 minutes. Bars represent mean ± S.E.M of accumulated 
seconds. *p<0.05, **p<0.01 significantly different from vehicle/vehicle. +p<0.05, ++p<0.01 
significant differences between TBZ-veh and TBZ-Bupropion10 mg/kg, ##p<0.01 significant 
differences between male and female mice.  
 
Experiment 7. Effect of TBZ and fluoxetine combination on behavioral activation 
assessed in the FST in male and female mice. Factorial ANOVA (sex x treatment) on 
immobility assessed in the FST did not show an effect of sex (F(1,1)=0.02, p=0.98) and 
interaction (F(2,46)=0.83, p=0.44) but there was an effect of treatment (F(1,2)=9.90, 
p<0.01). Separate one-way ANOVA’s for the factor treatment in each sex demonstrated 
an effect on immobility time in male mice (F(2,33)=4.64, p<0.01) and in female mice 
(F(2,33)=3.47, p<0.05). Planned comparisons revealed TBZ-treated male mice and male 
mice that received the combination of 8 mg/kg TBZ plus 20 mg/kg fluoxetine increased 
significantly time spent immobile in comparison with the vehicle-vehicle group (p<0.01 
and p<0.05 respectively) (Figure 7). Moreover, planned comparisons also showed TBZ-
treated female mice increased the immobility time (p<0.01) in comparison with the 
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control group and 20 mg/kg fluoxetine did not produce an effect on the immobility of 
female mice (Figure 7A)  
Factorial ANOVA (sex x treatment) on time swimming in the FST did not show an effect 
of sex (F(1,1)=0.91, p=0.34) and interaction (F(2,46)=0.54, p=0.58) but there was an 
effect of treatment (F(1,2)=7.68, p<0.01). Separate one-way ANOVA’s for the factor 
treatment in each sex demonstrated an effect on swimming time in male mice 
(F(2,33)=2.74, p<0.05) and in female mice (F(2,33)=3.49, p<0.05). Planned comparisons 
revealed the group of male mice that received 8 mg/kg TBZ plus vehicle decreased 
significantly the time swimming in comparison with the vehicle-vehicle group (p<0.05) 
and fluoxetine (20 mg/kg) did not change swimming behavior. Moreover, planned 
comparisons also showed a significant decreased on time spent swimming of the TBZ-
treated female mice (p<0.01) in comparison with their respective control group and 20 
mg/kg fluoxetine reversed the effect produced by TBZ and female mice that received the 
combination of TBZ (8 mg/kg) and fluoxetine (20 mg/kg) significantly increased time 
swimming in comparison with the TBZ-treated female mice (p<0.05) (Fig 7B). 
Finally, factorial ANOVA (sex x treatment) on climbing in the FST did not showed an 
effect of interaction (F(2,46)=2.60, p=0.08) but there was an effect of sex (F(1,1)=7.33, 
p<0.01) and an effect of treatment (F(1,2)=8.28, p<0.01). Separate one-way ANOVAs 
for the factor treatment in each sex demonstrated an effect on time climbing in male mice 
(F(2,33)=4.24, p<0.05) but there was any effect on climbing behavior in female mice 
(F(2,33)=0.39, p=0.67). Planned comparisons revealed TBZ-treated male mice 
significantly decreased the time spent climbing in comparison with the control group 
(p<0.01) and fluoxetine (20 mg/kg) failed to reverse the effect produced by TBZ, 
decreasing climbing on male mice that received the combination of both drugs (p<0.01) 
in comparison with the vehicle-vehicle group (Fig). Either TBZ (8 mg/kg) and fluoxetine 
(20 mg/kg) did not produce any effect on climbing behavior in female mice. Finally, 
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independent Students-t test demonstrated male mice spent more time climbing than 
female mice (t=-3.91, p<0.01) (Figure 7C) 
Figure 7. Effect of TBZ and fluoxetine combination (vehicle+vehicle, TBZ+vehicle, TBZ+ 20 
mg/kg of fluoxetine) in male and female mice on duration of immobility (A), swimming (B) and 
climbing (C) in the FST assessed during 6 minutes. Bars represent mean ± S.E.M of accumulated 
seconds. *p<0.05, **p<0.01 significantly different from vehicle/vehicle. +p<0.05 significant 
differences between TBZ-veh and TBZ-Fluoxetine 20 mg/kg, ##p<0.01 significant differences 
between male and female mice. 
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Discussion 
In the present work, we explored the effect of DA depletion in male and female mice on 
behavioral activation and preference for physical activities as   sessed in the novel 3-
choice-T-maze task. We also compared the results obtained in the T-maze task using other 
classic animal paradigms that evaluate depressive-like behaviors such as the FST, 
anxiety-like behaviors (DL box paradigm and EPM paradigm), social motivation 
evaluated in a social preference task and finally, the preference for sucrose liquid or food. 
Moreover, we also tried to observe if there were differences between male and female 
mice in the treatment response administering two antidepressants (bupropion or 
fluoxetine) after DA depletion and evaluating the outcome behavior in the FST.  
There were no differences between male and female mice on passive behaviors 
(immobility) evaluated in the FST. Therefore, in control conditions, both sexes displayed 
almost the same time spent immobile in the tank. Moreover, male and female mice did 
not differ either in the time they spent swimming in the FST although it seemed that male 
mice were more active than female mice since male mice spent significantly more time 
climbing trying to escape. Previous studies have found similar results when comparing 
male and female rats (Hong et al, 2012; Wilkin et al, 2012) and also male and female 
mice (Kazavchinsky et al, 2019; Kara et al, 2017). Both sexes do not differ in time spent 
been immobile in the FST and display almost the same time swimming in the tank 
(Kokras et al, 2009; Warner et al, 2013; Kara et al, 2017). However, there are also reports 
showing that young and middle-aged female rats spent less time immobile, although, this 
sex difference disappeared at senescence (Fernández-Guasti et al, 2017). In terms of sex 
differences on vigorous escaping behaviors (climbing), previous studies are in accordance 
with the present results; female rats and mice spent less time climbing in the FST 
(Wegener et al, 2012; Hong et al, 2012; Masuda et al, 2001). After the administration of 
8 mg/kg TBZ, a dose that has been demonstrated to decrease DA levels in mice ventral 
striatum (López-Cruz et al, 2018), and potentiates passive behaviors, decreasing also 
active behaviors in the FST (Carratalá-Ros et al, 2020), we did not observed differences 
between sexes due to treatment; both male and female mice decreased significantly time 
swimming, increasing time spent immobile in the FST. Because the baseline for climbing 
is very low in females, DA depletion had significant effects only in male mice. 
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When evaluating male and female mice on classic paradigms to assess anxiety-like 
behaviors, we found that, under control conditions, there were not significant differences 
between male and female mice on time spent in the lit chamber of the DL box. However, 
female mice spent significantly more time in the open arms of the EPM than male mice, 
indicating females are less anxious than males in this paradigm. Previous studies also 
have found that female rodents are less anxious than male rodents in the EPM (Voikar et 
al, 2001; Rodgers et al, 1993; Imhof et al, 1993). If this were the case, it would explain 
why female mice spent less time climbing in the FST than male mice suggesting that 
females could be less anxious than male mice. However, TBZ did not affect any of the 
anxiety parameters either in the DL box (time spent in the bright chamber) or in the EPM 
(time in the open arms) paradigms, and there were no sex differences. All of these results 
confirm the idea that drugs that modify DA transmission do not affect anxiety-related 
parameters. However, in terms of the activity parameter in the DL box (crosses between 
compartments), the TBZ administration reduced significantly locomotion equally in both 
sexes, consistently with previous finding in male mice (Correa et al, 2018; Carratalá-Ros 
et al., 2020). In the EPM the pattern of results was quite different. Under control 
conditions, female mice displayed more crosses than male mice, but 8 mg/kg TBZ did 
not affect locomotion either in male or in female mice. Higher levels of locomotion in 
female rats have been seen in previous studies (Fernandes et al, 1999). However, this 
study also found differences in anxiety in the EPM, and males were more anxious than 
females (Fernandes et al, 1999). 
Social motivation was also assessed in male and female mice using a social preference 
task. This kind of task allows the study of spontaneous motivation for social contact (in 
this case in non-socially isolated animals) manifested by social preference or avoidance 
and also has been used to evaluate anxiety in rodents (File and Hyde, 1978; Guy and 
Gardner, 1985; López-Cruz et al, 2016). In our experiment, male and female mice had to 
choose between interacting with a same sex-conspecific or spent time investigating an 
object. Male and female mice did not differ on direct exploration of any of the stimulus 
or time spent in any of the compartments, and TBZ administration did not change 
behavior. There are only a few studies about the social interaction processes in female 
rodents (Perkins et al, 2016; Veenema et al, 2012), and in those few studies it has been 
shown that there are no differences between sexes in social exploration neither in young 
168 
 
nor in adult rats, although there were aging-related declines in social behavior in females 
(Perkins et al, 2016).  
In addition, the preference for different concentrations of liquid sucrose was also 
evaluated in male and female mice. Both sexes clearly preferred the higher concentrated 
solution (10% versus 5%) and TBZ did not change this preference and did not reduced 
the total amount of fluid consumed. Previous studies also have shown no baseline 
difference between female and male rodents on liquid sucrose intake and preference, 
although female rats tend to drink more under conditions that generate pain (O Henderson 
et al, 2017; Dalla et al, 2008). Sweet taste can act as a powerful natural reward (Levine et 
al, 2003; Yamamoto, 2003). Moreover, preferences for higher concentrations seem to 
invigorate behavior to work harder for those solutions, when a lower, but freely available, 
sucrose concentration is concurrently available (Pardo et al, 2015; SanMiguel et al, 2018). 
A previous study in hour laboratory using male rats, evaluated the impact of TBZ on 
preference and total drinking of two sucrose solutions freely and concurrently available 
(Pardo et al, 2015). In this study TBZ did not produce any change on concentration 
preference or the total volume consumed. However, it did shift preferences when rats had 
to work in order to obtain the highly concentrated sucrose (Pardo et al, 2012). Thus, from 
present and previous work it seems that administration of TBZ, which produces DA 
depletion in ventral striatum (López-Cruz et al, 2018; Nunes et al, 2013; Pettibone et al, 
1984), does not affect aspects of sucrose motivation such as intake, preference and 
hedonic reactivity when animals can freely choose without doing an effort. However, the 
intake of liquid sucrose can change under effortful conditions indicating that DA regulates 
behavioral activation, leaving intact the directional aspect of motivation (approaching to 
a palatable reward where effort is not required) (Pardo et al, 2015).  
Behavioral activation can be studied using operant procedures and maze procedures. Most 
of the animal studies that use operant tasks are performed in male rodents, although there 
is some literature on performance of female rodents in operant tasks. Thus, it has been 
observed that female mice lever-press less in a progressive ratio operant task (Lloyd et al, 
2018), and the same pattern is observed in female rats using fixed ratios (van Haaren et 
al, 1990). However, so far there are no published studies assessing female performance 
in effort-based decision-making tasks. The present results in the 3-choice-T-maze task 
demonstrate that, under control conditions, there are not differences on behavioral 
performance and preference for the reinforcers between male and female mice. Therefore, 
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both male and female mice spent most of the time running in the RW, then eating the 
sucrose pellets and finally, sniffing the non-social odor. Thus, the level of preference for 
active reinforcers seems to be identical in both sexes. However, sex differences are 
revealed in terms of time spent in the different compartments (figures 5 A-C); female 
seem to spent significantly more time than males in the food compartment provably 
indicating higher place preference associated to this compartment or it is also possible 
than females eat more slowly than males. In parallel, female mice reduced time spent in 
the RW compartment, but there were no differences in time spent in the odor 
compartment. Interestingly, the total number of entries into each compartment is higher 
in female mice, and total number of crosses between compartments was also higher, 
indicating that female mice were more active than male mice in exploring the T-maze in 
general, consistently with the results in the EPM. Previous studies have already shown 
that female rodents are more active than male rodents as demonstrated by the use of RW 
(Hyde and Jerussi, 1983; Slob et al, 1981; Basso and Morrell, 2017) and it seems female 
rodents are more likely to engage in different activities not loosing focus from the main 
task (van Haaren et al, 1990).  
In terms of the effects of DA depletion on female preferences in the T-maze suggest that 
there are no differences compared to male preferences. Previous studies have 
demonstrated that the administration of a wide range of doses of TBZ in male mice tested 
in this 3-choice-T-maze task partially shift behavior from the RW to the sucrose pellets 
with no change in the fruit odor sniffing (López-Cruz et al, 2018; Carratalá-Ros et al, 
2020). The present study corroborates those results in males, and show that TBZ 
significantly reduced time running in the RW and increased time eating palatable pellets. 
Moreover, there were no differences between sexes. In addition, TBZ did not affect either 
male or female mice on measures of place preference assessed as time spent in each 
compartment, and on exploration evaluated as total of entries to each compartment. These 
data indicate that male and female mice did not avoid being in close proximity to the 
reinforcers and showed normal exploration of the T-maze, although TBZ-treated female 
mice displayed more entries to each compartment and showed more general locomotion 
than TBZ-treated male mice.  
Our second objective in the present work was to characterize, the potential “therapeutic” 
effect of different categories of antidepressants that differ in their mechanism of action, 
by assessing their capability of revering the behavioral impairments induced by the DA 
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depleting agent. Therefore, we evaluated the response of male and female mice in the 
FST after TBZ or TBZ plus bupropion, a catecholamine reuptake inhibitor that acts on 
the DA transporter (DAT) and elevates DA release in Nacb (Randall et al, 2014). 
Bupropion has demonstrated to treat effectively some symptoms of depression in humans 
(Feighner et al, 1986; Kiev et al, 1994; Weihs et al, 2000; Pae et al 2007; Papakostas et 
al, 2006; Cooper et al, 2014), and also to increase active behaviors in animal models that 
evaluate depressive-like behaviors (Carratalá-Ros et al.; Yamada et al, 2004; Kitamura et 
al, 2010; Yuen et al, 2017). However, little is known about the effect of bupropion on the 
behavioral output of female rodents. In our experiment, the administration of 8 mg/kg 
TBZ produced the same effect that we described previously: male and female mice 
decreased swimming behavior and increased immobility, but there were differences in 
climbing between male and female and TBZ only affected climbing in male mice that had 
a higher baseline. The administration of 10 mg/kg of bupropion, a dose that is effective 
at increasing active behaviors in male mice assessed in the FST (see chapter 2), alleviated 
the behavioral activation impairment induced by TBZ increasing time spent swimming 
and decreasing immobility in both sexes. However, bupropion only was able to increase 
climbing behavior in male mice.  
Secondly, a different group of male and female mice received the serotonin transport 
inhibitor fluoxetine. In humans, this antidepressant is useful to treat emotional symptoms 
present in depression (Papakostas et al, 2008; Hieronymus et al, 2016; Rizvi et al, 2013; 
Rosenblau et al, 2012), but seems ineffective for treating motivational dysfunctions, and 
in fact, it can exacerbate or induce these symptoms such as fatigue in some patients (Nutt 
et al, 2007; Targum and Fava, 2011; Padala et al, 2012; Stenman and Lilja, 2013; 
Rothschild et al, 2014; Fava, 2014). In animal models, the administration of fluoxetine 
alone increases active behaviors (swimming and climbing) and decreases immobility in 
male rodents (Jang et al, 2009; Castagné et al, 2010; Petit-Demouliere et al, 2005; see 
previous chapter), and also in female rodents (Fernández-Guasti et al, 2017; Jones and 
Lucki, 2005). Experiments done previously in our lab have demonstrated that the 
combination of TBZ (8 mg/kg) and fluoxetine (20 mg/kg) exacerbates the behavioral 
activation impairment induced by the DA depleting agent in male mice (see previous 
chapter). In the present experiment, TBZ alone induced behavioral activation 
impairments in both male and female mice, decreasing active behaviors and increasing 
immobility, and the administration of fluoxetine (20 mg/kg) had sex dependent effects. 
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Thus, the combination of 8 mg/kg TBZ and 20 mg/kg fluoxetine did not reverse the effect 
of TBZ in immobility and in climbing. In females, this SERT blocker reversed the effect 
produced by TBZ in swimming and immobility. However, because of the low baseline in 
climbing in females neither TBZ nor TBZ plus fluoxetine had an impact on female 
climbing. Some studies have indicated that fluoxetine is more effective in female than in 
male rodents since lower doses of this SERT blocker are required in females than in males 
in order to improve behavior in the FST (Jones and Lucki, 2005; Fernández-Guasti et al, 
2017). Thus, present and previous data support observation in the clinical field suggesting 
that women have a better outcome after fluoxetine treatment than men, at least for some 
depressive symptoms (Khan et al, 2005; Young et al, 2009; Kornstein et al, 2000). 
In summary, this study provides information about the behavioral performance of female 
mice under basal conditions, and also under DA depletion in different animal paradigms, 
comparing them with the behavior of male mice. Moreover, the present study indicates 
that DA is involved in behavioral activation, and thus, suggesting that pro-dopaminergic 
drugs may be able to improve depressive symptoms related to reduce behavioral 
activation in humans. Moreover, the differential pharmacological response between male 
and female mice shown in this study, support the differential efficacy of distinct 
monoamine uptake inhibitors in the treatment on motivational symptoms in both sexes. 
These ideas are consistent with the research domain criterion (RDoC) approach that 
highlights the importance of describing the neural circuits that mediate specific symptoms 
in psychopathology, and not simply the traditional diagnostic categories (Cuthbert and 
Insel, 2013). Furthermore, it highlights the fact that relatively limited basic research has 
been devoted to developing animal models and consequently describing drug treatments 
which are sensitive to sex differences. These results suggest caution should be exercised 
in interpreting the results from female rodents in tests validated on males. 
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Table 3. Summary of male and female differences in spontaneous behaviors. = indicates no 
significant difference, + indicates more behavior, - indicates less behavior. 
 
 
 
 Sex differences 
FST Immobility 
Swimming 
Climbing 
= 
= 
Female - 
DL Time in light 
Crosses 
= 
= 
EPM Time open arm 
Total crosses 
Female + 
Female + 
Social Interaction Time sniffing conspecific 
 Time conspecific compart. 
Total crosses 
= 
= 
= 
Sucrose Preference Preference  
Total sucrose intake 
= 
= 
Choice T-maze task Interaction with stimulus 
Time in food compartment 
Time in RW compartment 
Time in odor compartment 
Total food intake 
Exploration of compartments 
= 
Female + 
Female - 
= 
= 
Female + 
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GENERAL CONCLUSIONS 
 
The present thesis characterizes behaviorally and pharmacologically a new animal model 
for the evaluation of preference for reinforcers that require high levels of behavioral 
activation: the 3-choice-T-maze task (Chapter 1) 
The use of this paradigm allowed to understand the role of mesolimbic DA in the 
regulation of behavioral activation and the voluntary exertion of effort in motivation, a 
component that is often affected in psychiatric disorders such as depression.  
 It has been observed that physical activities have intrinsic motivational properties, and 
the choice to engage in voluntary physical activity is undertaken, most of the times, in 
relation and competing with other alternatives that are more sedentary (i.e. drugs, foods, 
social stimuli, etc.). The results from Chapter 1 show how using the 3-choice-T-maze 
task, which allows mice to freely engage in running on a RW or doing sedentary activities 
such as consuming sucrose pellets or sniffing a non-social odor, we can stablish a 
hierarchy of preferences. In this case on the top, and significantly different from the other 
two, is interacting with a running wheel that allows a high degree of voluntary physical 
exercise. Moreover, the administration of a wide range of doses of the vesicular 
monoamine transport type 2 blocker; tetrabenazine (TBZ) which depletes DA, reduced 
the time engaged in the RW, although no dose suppressed the preference for the RW as 
the first option. Furthermore, at the highest doses, TBZ produced a reorganization of 
behavior, compensating for the loss of interaction with the vigorous reinforcer, by 
increasing time engaged in consuming non-habitual and highly palatable food, that has 
been used in other rodent paradigms as the most preferred reinforcer (in choice-operant 
procedures for example). This shift suggests that the animal is not generally anhedonic, 
since it increases food consumption, and is not fundamentally impaired motorically, since 
still spends more time running. The third stimuli generated minimal attraction since it was 
a fruit odor that was never associated to food or any other more powerful reinforcer. This 
third option only increased in preference when the fruit odor was substituted by a social 
odor from the same or different sex conspecific. Thus, increasing the salience and 
potential value of the olfactory stimuli, increased the time dedicated to explore it, 
specially, when it was an odor from a female.  
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Furthermore, ample behavioral characterization of the conditions that modulate 
preferences for the RW versus other less preferred reinforcers were performed in order to 
discard potential confounding factors such as force, aversion, loss or increase in appetite, 
etc., in the interpretation of the TBZ results. Thus, a series of experiments (in Chapters 
1 and 3) were design to modify the motivational value of the reinforcers available in the 
T-maze task. We started by changing factors that affect the RW value, such as increasing 
RW resistance to turn and, consequently, increasing the force required to run. This 
manipulation reduced the time running but did not increase food consumption. Also, 
making the compartment of the RW aversive by placing an anxiogenic light over the RW 
produced a partial shift towards food, but also increase avoidance of the RW chamber, 
something that was not produced by DA depletion. In the increase force experiment 
animals reduced time spent running, but they stay in proximity of the RW, although taking 
more pauses. Increases or decreases in food appetite by satiation or deprivation of food, 
or making the food aversive by adding a bitter flavor, did not produce the same pattern 
than the pharmacological manipulations that increase or decrease DA.  
This new animal model for the study of anergia after DA depletion with TBZ, was 
systematically compared with a classical animal model of anergia induced, in this case, 
by learned helplessness in an aversive context; the forced swim test (FST). TBZ produced 
a very similar pattern of results in both paradigms for the study of anergia; the FST and 
the 3-choice-T-maze task. There are important differences between both paradigms. For 
instance, the FST uses an acute and unescapable stressor (a tank with water) to generate 
baseline anergia; the animal rapidly learns that it can not escape and minimizes effort 
staying immobile or mildly swimming to keep afloat. This is used as a model of 
depressive behavior. DA depletion potentiates that baseline inactivity. However, in the 
case of the 3-choice-T-maze task among the 3 different reinforcers, all of them appetitive, 
the spontaneous behavior of any mice is to select the one that allows voluntary vigorous 
exercise, the RW. Thus, DA depletion is required in order to generate anergia. This 
anergia leads to a partial reorganization of preferences. While the FST tries to model a 
pathological state, the T-maze is intended for the study of factors that modulate normal 
behavior. 
Because an important part of depressed patients also have anxiety, we evaluated if DA 
depletion induces an anxiogenic or anixiolitic effects. However, TBZ was not effective at 
modulating anxiety-related parameters (Chapters 1-5) or social interaction, neither in 
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male nor in female mice (Chapter 5). TBZ effects in most of those rodent paradigms 
(DL, EPM and SI) produced a reduction in exploration of the environment, but no change 
in social preference or in avoidance to aversive stimuli (intense light or open elevated 
spaces). 
In addition, we compared the impact of two of the most common antidepressant drugs 
used in the clinical practice: fluoxetine and bupropion, for their effects in both models of 
anergia. Both of these drugs are monoamine uptake inhibitors, but they seem to differ 
substantially in their improvement of motivational disfunctions such as fatigue seen in 
some people with depression. Thus, bupropion, a cathecolamine uptake blocker which 
main action is to block DAT, thus, increasing striatal DA (Chapter 2), and fluoxetine, a 
SERT inhibitor (Chapter 3), were evaluated on their own or in combination with TBZ 
on these animal models of anergia and on anxiety. We also assess their impact on 
postsynaptic DA receptor function by analyzing phosphorylation of DARPP-32 in Nacb 
core, a central brain nuclei for the regulation of the activational component in motivated 
behavior (Chapters 2 and 3).  
In Chapter 2, bupropion on its own, increased time engaged in running in the T-maze 
task and also increased time climbing in the FST with no effect on anxiety. Bupropion 
also was able to reverse the effects of DA depletion in both animal models suggesting a 
“therapeutic” effect on anergia. Moreover, TBZ increased phosphorylation of DARPP-
32 at Thr34, and bupropion was able to decrease TBZ induced pDARPP-32(Thr34) 
immunoreactivity, suggesting that the actions of these two drugs on behavior could be 
mediated by their actions on Nacb DA receptor containing neurons; the medium spiny 
neurons (MSN). From previous studies in rats (Nunes et al., 2013) we know that the effect 
of TBZ increasing pDARPP-32(Thr34) occurs in D2 receptor containing neurons in Nacb 
core, neurons that also release enkephalin. In those studies pDARPP-32(Thr75) was also 
increased after TBZ administration to rats, but that increase occurred in D1 containing 
neurons that release Substance P. In our studies with mice, TBZ did not produce a 
significant effect on DARPP-32 phosphorylated at Thr75 on Nacb core. However, it is 
worth mentioning that TBZ produced a clear tendency to reduce pDARPP-32(Thr75) 
immunoreactivity that did not reach statistical significance, even after using a different 
antibody and a different technique (western blotting). The tendency to suppress pDARPP-
32(Thr75) compared to vehicle was observed better using immunofluorescent techniques. 
Thus, in further studies we should use this procedure to try to assess if this tendency is 
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stable, although, it is possible that to observe a reduction of a marker that at baseline 
levels is already quite low, is difficult technically. Interestingly, we found that there was 
a partial co-localization of pDARPP-32(Thr75) immunoreactivity in enkephalin-
containing neurons located in Nacb core, suggesting that this effect of TBZ is also 
occurring on D2 receptor containing neurons.  
The SERT inhibitor fluoxetine, was evaluated in Chapter 3. As with bupropion, we 
evaluated its effects alone or in combination with the most effective dose of TBZ on 
behavioral activation and on anxiety parameters. We confirmed that fluoxetine was 
effective at inducing behavioral activation in the FST, as it had been previously 
demonstrated. The highest doses of fluoxetine increased swimming and climbing. 
However, in the 3-choice-T-maze task fluoxetine produced anergia-like pattern of 
behaviors, very similar in fact to what was characteristic of TBZ: reduction in running 
and increasing time consuming sucrose pellets. Moreover, fluoxetine administered alone 
produced an anxiogenic effect. Furthermore, fluoxetine failed to reverse the behavioral 
impairment produced by TBZ in the FST, and it was not able to reverse TBZ-induced 
suppression of time running in the RW. However, fluoxetine in TBZ treated animals 
suppressed consumption of sucrose pellets. Thus, fluoxetine given in combination with 
TBZ reduced time interacting with both reinforcers; RW and food, and there was no 
compensation towards the neutral odor either. The reduction of food consumption 
produced by fluoxetine did not resemble the effect produced by changing the value of the 
food. It is possible that the interaction TBZ-fluoxetine produces an impairment in 
locomotion since crosses between compartments is reduced, not only in the EPM, but also 
in the T-maze. It has been previously demonstrated that DA release in Nacb core, a central 
area for the regulation of spontaneous locomotion, is reduced by fluoxetine alone (Yohn 
et al., 2016). Consistent with this finding, in chapter 3 we demonstrate that fluoxetine on 
its own and also the combination of TBZ-fluoxetine significantly reduced pDARPP-
32(Thr34) and also pDARPP-32(Thr75) in Nacb core, suggesting an overall decrease of 
DA transmission in this area.  
The effects of different antidepressants on the FST and on effort-based decision making 
operant paradigms are well known in basic studies that use male rodents. However, there 
is little evidence on the effect of these drugs in females, despite of the fact that in humans, 
epidemiological data show that depression is twice as common in women than in men, 
and that the pharmacological response to treatment also differs between sexes. Thus, 
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Chapter 4 compare male and female mice on their response to these antidepressants, and 
on their performance in these different behavioral paradigms that assess anergia and 
anxiety. The most effective dose of TBZ from chapter 1 was used in male and female 
mice in order to assess its impact on behavioral activation in the T-maze task and the FST. 
Anxiety parameters, social motivation and consumption and preference for sucrose 
solutions were also evaluated in male and female mice after the administration of TBZ. 
First of all, the results on spontaneous behavior in most of all these paradigms do not 
show significant differences between sexes. The most important exception been climbing 
in the FST, and locomotion during the exploration of the T-maze. TBZ produced a similar 
pattern of behavior in both sexes in the T-maze task inducing behavioral activation 
impairments; decreasing running on a wheel but increasing sucrose consumption. In the 
FST, TBZ decreased swimming in both sexes but only affected to climbing behavior in 
male mice, since baseline climbing was already low in females. DA depletion did not 
affect social interaction and sucrose preference neither in male nor in female mice, and 
anxiety in both sexes was not affected by TBZ, although female seem less anxious in the 
EPM compared to male. 
Bupropion and fluoxetine were also used in both sexes in order to reverse TBZ effects in 
the FST. Bupropion was able to reverse the effects of DA depletion in both, male and 
female mice. However, fluoxetine failed to reverse TBZ-induced behavioral impairments 
in male in all three parameters; immobility, swimming and climbing. TBZ treated females 
improved after receiving fluoxetine in immobility and in swimming. However, climbing 
in females was neither impaired nor improved by TBZ or TBZ plus fluoxetine or TBZ 
plus bupropion, indicating that this is not an important behavior in the study of FST in 
females. 
In conclusion, a translational outcome of the present dissertation is that not all 
antidepressants are adequate for the treatment of psychomotor slowing and anergia 
symptoms commonly seen in depression. Moreover, sex differences are key in order to 
approach the pharmacological response to these different symptoms. This idea of 
different therapeutic drugs having positive actions for some symptoms, but no effect or 
even negative actions on other symptoms, is consistent with the research domain criterion 
(RDoC) approach that highlights the importance of describing the neural circuits that 
mediate specific symptoms in psychopathology, and not simply the traditional diagnostic 
categories.  
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Effects of fluoxetine on the T-maze running wheel choice 
task in female and male rats: lack of modulation by 5HT-2C 
receptor antagonists. 
 
APPENDIX I 
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Introduction 
 
The development of novel animal models in the study of effort-related aspects of 
motivation are necessary in order to continue gaining new insights into this complex 
aspect of behavior. Effort-based choice tasks such as the FR5/chow feeding choice and 
PROG/chow feeding choice tasks use food as the reinforcer for both high and low effort 
options. Complications using these types of methods can develop when pharmacological 
agents known to produce appetite suppressing effects are used to alter task performance. 
Running on a running wheel (RW) has been shown to be an intrinsically reinforcing 
activity in rats (Kagan and Berkun 1954, Collier and Hirsch 1977, Pierce et al. 1986, 
Iversen 1993), subject to multiple types of reinforcement schedules. Recent mouse studies 
have reported on the use of a T-maze running wheel task choice task in mice. When given 
the option to run on a RW or consume sucrose, mice preferred the RW (Correa et al. 
2016). With all of this in mind, a RW/chow feeding choice task for rats was developed 
that allowed animals to choose between consumption of food (lab chow) vs. engaging in 
voluntary physical activity in the RW. This new procedure with two different motivating 
factors can be used to tease apart the changes in behavior that can become muddied with 
a single motivating factor. The present studies examined the effects of the 5-HT uptake 
inhibitor and antidepressant fluoxetine (FLX) and the ability of the 5HT-2c receptor 
antagonist SB in reverse the effects produced by FLX. In addition, the blockade of the 
SERT transporte leads to the stimulation of the different 5-HT receptors thus, we suggest 
that using a 5HT-2c receptor antagonist would reverse the effects produced by FLX in 
the T-maze running wheel task.  
 
Materials and Methods. 
Subjects. Male (N=6) and female (N=8) Sprague Dawley rats (Envigo) were used. Rats 
were food restricted to their 90% free-feeding weight and allowed modest growth. Water 
was available ad libitum.  
Pharmacological agents. Doses of fluoxetine (FLX, Tocris) (vehicle, 5, 10, and 15 
mg/kg IP) were given 90 minutes prior to testing. Drug testing was completed utilizing a 
repeated measures design, with rats receiving one drug treatment per week, in a randomly 
varied order. The dose of SB (Tocris) (1.0 mg/kg, IP) was given 25 min before the test.  
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Running Wheel/Chow Feeding Choice Task. Behavioral sessions occurred in a 
Plexiglas T-maze apparatus consisting of a start arm (29 x 21 x 21 cm) and two test arms 
(99 x 32 x 59 cm). Within the maze, a clear box (47.6 x 25.9 x 20.9 cm) with a hole (10.3 
cm diameter) cut in the front was placed in either the right or left arm. This box housed 
the RW (Starr Life Sciences Corp.) (33.02 cm diameter) apparatus with an attached 
counter to record RW rotations during sessions. A wall (32 x 59 cm) with an entry hole 
was placed in front of the box to keep the rats from moving around the sides of box during 
the task. The opposite arm contained a ceramic bowl (9 cm diameter) (PetCo) containing 
standard lab chow. 
Training took a total of 6 weeks. Rats were first only granted access to the RW by being 
placed directly into the box with the entry hole blocked for two weeks. The following two 
weeks, the side containing the bowl was blocked off and rats were placed in the middle 
of the maze facing the wall. This required the rat to learn to use the entry hole of the RW 
box. The final two weeks of training, the maze was open for the rat to explore both arms 
with an empty ceramic bowl placed opposite to the RW. On completion of the training 
period, weighed amounts of chow became concurrently available. The start arm was never 
utilized during this task and each rat began the session in the middle of the maze facing 
the wall. Each session lasted 30 minutes. At the end of each session, each rat was 
immediately removed from the maze, the number of completed RW rotations was 
recorded and the amount of chow consumed during the task was determined by weighing 
the remaining chow (including spillage). Drug testing began once RW activity and chow 
consumption reached stable baseline levels. 
 
 
 
 
 
 
 
Figure 1. Schematic of RW/chow feeding choice task 
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Results 
Experiment 1. Effect of fluoxetine on preference between RW or chow in the T-maze 
choice task. Factorial ANOVA (sex x treatment) on preference for the RW showed 
overall effects of sex (F(1,12)=15.00, p<0.01). and of fluoxetine (F(3,36)=34.24, p<0.01), 
and also a significant interaction (F(3,36)=18.67, p<0.01). Planned comparisons revealed 
that in male rats, when compared with the vehicle group the two highest doses of 
fluoxetine (10 and 15 mg/kg) decreased significantly RW rotations (p<0.01). In female 
rats all doses of fluoxetine (5, 10 and 15 mg/kg) significantly reduced the RW rotations 
in comparison with the vehicle group (p<0.01 for all doses). Moreover, male and female 
where only different when they received the vehicle treatment (p<0.01) but there were 
not differences between sexes at any other dose of fluoxetine.  
The factorial ANOVA (sex x treatment) on chow intake showed significant effects of sex 
(F(1,12)=197.32, p<0.01), and fluoxetine (F(3,36)=34.29, p<0.01), and also a significant 
interaction (F(3,36)=18.67, p<0.01). Planned comparisons revealed that all doses of 
fluoxetine (5, 10 and 15 mg/kg) reduced significantly chow consumption in the male rats 
compared with the vehicle treatment (p<0.05 for 5 mg/kg, and p<0.01 for 10 and 15 
mg/kg of fluoxetine). Fluoxetine-treated female rats significantly decreased the amount 
of chow consumed in comparison with the vehicle at all doses of fluoxetine tested 
(p<0.01). Moreover, vehicle treated females consumed significantly less chow than the 
male group (p<0.01), and that difference was also significant between both sexes when 
treated with 5 and 10 mg/kg (p<0.01).  
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Figure 2. Comparison of RW activity measured by the number of rotations completed by 
the RW and the total of chow intake between male and female rats. An overall significant 
difference was seen in RW activity and chow intake (#p<0.01) between the sexes. An 
overall significant effect of FLX was seen in males (**p<0.01 at 10 and 15 mg/kg) and 
females (**p <0.01 at all doses) on RW activity and chow intake.  
 
Experiment 2. Impact of the 5HT-2C antagonist on the effects of fluoxetine in the T-
maze choice task. Factorial ANOVA (sex x treatment) on preference for the RW showed 
overall effects of sex (F(1,12)=29.19, p<0.01), treatment (F(2,24)=58.95, p<0.01), and a 
significant interaction (F(2,24)=15.43, p<0.01). Planned comparisons revealed that 
fluoxetine-treated male rats and also male rats that received the combination of fluoxetine 
plus 1.5 mg/kg SB1 reduced significantly RW rotations in comparison with their 
respective vehicle control (p<0.01). The same pattern was true for female rats; female rats 
that received fluoxetine (12.5 mg/kg), and the combination of fluoxetine plus SB1 also 
significantly reduced the RW rotations in comparison with the vehicle treatment (p<0.01). 
Male and female groups were different only under vehicle condition (p<0.01).   
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Factorial ANOVA (sex x treatment) on chow consumption showed significant effects of 
sex (F(1,12)=22.13, p<0.01), treatment (F(2,24)=26.12 p<0.01), and also a significant 
interaction (F(2,24)=13.93, p<0.01). Planned comparisons revealed that male rats that 
received 12.5 mg/kg of fluoxetine and the combination of fluoxetine plus 1.5 mg/kg SB1 
reduced significantly chow consumption in comparison with vehicle (p<0.01). However, 
these treatments did not produce significant differences in female rats. Differences 
between male and female were only significant when receiving vehicle (p<0.01).  
Figure 3. RW activity and chow intake (grams) between male and female rats. An overall 
significant difference was seen in RW activity and chow intake (##p<0.01) between 
sexes. An overall significant effect of FLX and the combination of FLX and SB was seen 
in males (**p<0.01) and females (**p<0.01) in RW activity. There was an overall effect 
of FLX and the combination of FLX and SB on the chow intake in male rodent (**p<0.01) 
but not in female rats.  
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Discussion 
There was a significant overall effect of fluoxetine dose, a significant difference between 
males and females, and a significant sex x dose interaction. Whereas females tended to 
show more RW activity and less chow consumption the males showed the opposite. FLX 
administration induced an overall reduction in running wheel activity at all 3 doses 
administered. This is consistent with recent studies in mice (Carratalá-Ros et al. 
submitted). FLX administration induced a reduction in chow intake in both males and 
females (2 highest doses in male and all 3 doses in females). It is important to note that 
even with the significant difference between behavior, FLX administration had the same 
general effect across both sexes. Thus, these studies demonstrate that FLX decreased 
selection of RW activity in rats, consistent with previous mouse studies. Moreover, the 
5-HT2c antagonist was not able to reverse the effect produced by FLX both in male and 
female rats and in fact, exacerbated the effect of the 5-HT uptake inhibitor in the RW 
activity. The same effect was seen in the total of chow intake in male rats but female rats 
did not change the total of chow consumption after the administration of FLX and the 
combination of FLX and SB in comparison with the control group.  
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